publication_id,tool,quote,best_match_source,best_match,similarity
1528,PRECIS-2,"Interventions: Participants randomly allocated to the adjustment group received six group treatment sessions. The control group received usual care, which did not include psychological interventions.",fulltext,"Interventions: Participants randomly allocated to the adjustment group received six group treatment sessions. The control group received usual care, which did not include psychological interventions.",100.0
1528,PRECIS-2,The CONSORT14 diagram of the recruitment and follow-up of participants is shown in Figure 1.,fulltext,The CONSORT 14 diagram of the recruitment and follow-up of participants is shown in Figure 1.,100.0
1528,PRECIS-2,"Participants: People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",fulltext,"Participants: People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",100.0
1528,PRECIS-2,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",fulltext,"The groups were delivered by two Band 5 assistant psychologists, who were supervised by a Band 8a clinical psychologist, experienced in working with people with multiple sclerosis.",100.0
1528,PRECIS-2,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post. This booklet included the measures administered at baseline, the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and in addition the BDI-II,6 a measure of the severity of depression.",fulltext,"Four and eight months after random allocation, participants were sent a booklet of outcome questionnaires to complete and return by post. This booklet included the measures administered at baseline, the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and in addition the BDI-II, 6 a measure of the severity of depression.",100.0
1528,PRECIS-2,"Of the 311 patients identified, 221 (71%) met the criteria for having low mood. Of these, 72 were randomly allocated to receive treatment and 79 to usual care. Over eight months follow-up there was a decrease in the combined average costs of £378 per intervention respondent and an increase in BDI score of 2.14 points.",fulltext,"Of the 311 patients identified, 221 (71%) met the criteria for having low mood. Of these, 72 were randomly allocated to receive treatment and 79 to usual care. Over eight months follow-up there was a decrease in the combined average costs of £378 per intervention respondent and an increase in the costs of £297 p",95.29780564263322
1528,PRECIS-2,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",fulltext,"People with multiple sclerosis were screened on the General Health Questionnaire 12 and Hospital Anxiety and Depression Scale, and those with low mood were recruited.",100.0
1528,PRECIS-2,"The EQ-5D9 was included as a generic quality of life measure. To ascertain costs, a questionnaire was used to assess the use of NHS services and prescribed medication in the previous three months.",fulltext,"The EQ-5D 9 was included as a generic quality of life measure. To ascertain costs, a questionnaire was used to assess the use of NHS services and prescribed medication in the previous three months.",100.0
1529,PRECIS-2,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the fourth session).",fulltext,"The intervention consisted of: defining depression, stress, anxiety, and their symptoms, defining happiness, and explaining its necessity, reviewing the results of previous studies on happiness (the first session); the technique of increasing physical activity, the technique of being productive, and doing useful and meaningful things (the second session); the principles of planning and better organization–the technique of removing concerns, the technique of reducing expectations and wishes (the third session); the technique of enhancing creativity, the technique of living at present (the F. K",97.87234042553192
1529,PRECIS-2,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",fulltext,"The inclusion criteria were being definitely diagnosed with MS and having records in the Society and the exclusion criteria having history of other psychiatric disorders including major depressive disorder (according to the medical records and the physician's examinations) or bipolar disorder (except for cognitive disorders by which MS is characterized), substance dependency, any neurological disorders, history of taking corticosteroids or the disease recurrence within the previous six months.",100.0
1529,PRECIS-2,"Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale before and immediately and three months after the implementation of FHM.",fulltext,"Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale before and immediately and three months after the implementation of FHM.",100.0
1529,PRECIS-2,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted. For blinding, the patients of the control group referred to the Society on certain days of week and those of the experimental on other days.",fulltext,"The intervention was implemented within two days a week. For the control group, a routine protocol was conducted. For blinding, the patients of the control group referred to the Society on certain days of week and those of the experimental on other days.",100.0
1529,PRECIS-2,"Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale",fulltext,"Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale",100.0
1529,PRECIS-2,"In this clinical trial, 140 MS patients assigned to experimental and control groups. Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale before and immediately and three months after the implementation of FHM.",fulltext,"In this clinical trial, 140 MS patients assigned to experimental and control groups. Depression, anxiety, stress, and fatigue were measured by Depression Anxiety Stress Scale-21 and Piper Standard Scale before and immediately and three months after the implementation of FHM.",100.0
1567,PRECIS-2,The intervention included eight weekly 2-h group sessions (teleconference or in-person) led by a neuropsychologist,fulltext,The intervention included eight weekly 2-h group sessions ,50.877192982456144
1567,PRECIS-2,"Cognitive Performance Outcomes: Five neuropsychological tests from the Minimal Assessment of Cognitive Function in MS (MACFIMS) were used to measure cognitive performance. Benedict and colleagues presented evidence for the reliability, construct and concurrent validity of the MACFIMS battery in a sample of 291 persons with MS. Based on the findings from our earlier pilot study, we selected 5 of the 7 tests to limit redundancy and participant burden. The 70-min battery included the following widely used tests: the Controlled Oral Word Association Test (COWAT) - verbal fluency and word finding; The California Verbal Learning Test, 2nd ed. (CVLT-II) - verbal learning and remembering; The Brief Visuospatial Memory Test - Revised (BVMT-R) - nonverbal learning and memory; The Paced Auditory Serial Addition Test (PASAT) - auditory information processing speed and flexibility, as well as calculation abilities; and The Symbol Digit Modalities Test (SDMT) - complex scanning and visual tracking.",fulltext,"Cognitive Performance Outcomes: Five neuropsychological tests from the Minimal Assessment of Cognitive Function in MS (MACFIMS), were used to measure cognitive performance. Benedict and colleagues 25 presented evidence for the reliability, construct and concurrent validity of the MACFIMS battery in a sample of 291 persons with MS. Based on the findings from our earlier pilot study, 2 we selected 5 of the 7 tests to limit redundancy and participant burden. The 70-min battery included the following widely used tests: the Controlled Oral Word Association Test (COWAT) 26 - verbal fluency and word finding; The California Verbal Learning Test, 2nd ed, (CVLT-II) 27 - verbal learning and remembering; The Brief Visuospatial Memory Test e Revised (BVMT-R) 28 nonverbal learning and memory; The Paced Auditory Serial Addition Test (PASAT) 29 - auditory information processing speed and flexibility, as well as calculation abilities; and The Symbol Digit Modalities Test (SDMT) 30 - complex scanning and visual tracking.",99.7997997997998
1567,PRECIS-2,"Using effect size estimates from prior research a total sample size of 180 was determined to be sufficient to detect an effect size (f) of .28 as statistically significant (assuming an alpha level of .05). Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Using effect size estimates from prior research 2 a total sample size of 180 was determined to be sufficient to detect an effect size (f) of .28 as statistically significant (assuming an alpha level of .05). 18 Following approval by the Institutional Review Board for the University of Texas at Austin, participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,"The intervention included eight weekly 2-h group sessions (teleconference or in-person) led by a neuropsychologist (e.g., sleep, fatigue, pain, etc.). The treatment manual was developed as a key outcome in the ACTIVE trials of older adults, assesses cognitive ability to reason and solve problems encountered in daily living.",fulltext," developed as a key outcome in the ACTIVE trials of older adults, 32 assesses cognitive ability to reason and solve problems encountered in daily living.",46.15384615384615
1567,PRECIS-2,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy. Internal consistency reliability coefficients for all self-report measures were .80 or above. Descriptive analyses were performed to obtain a profile of the sample. The groups were compared at baseline on demographic and disease variables. Preliminary analysis for assumptions of normality, independence of errors, homogeneity of variance, and outliers suggested that assumptions had generally been met and therefore data transformations were deemed unnecessary.",fulltext,"Data analyses were conducted using SPSS, version 24.0 for Windows (SPSS Inc., Chicago, IL, USA). Neuropsychological data were scored by the testers and verified by a second staff member. Data were entered and checked for accuracy. Internal consistency reliability coefficients for all self-report measures were .80 or above. Descriptive analyses were performed to obtain a profile of the sample. The groups were compared at baseline on demographic and disease variables. Preliminary analysis for tests of assumptions such as normality, independence of errors, homogeneity of Table 1 Selected examples of cognitive tasks/games in Lumosity program. Game Cognitive Domain Construct Birdwatching Attention Visual field WordBubbles Flexibility/Executive Functioning Verbal fluency MonsterGarden Memory Working memory BytheRules Problem Solving Logical reasoning PenguinPursuit Processing Speed Spatial orientation A.K. Stuifbergen et al. / Disability and Health Journal 11 (2018) 427e434 429 variance, and outliers suggested that assumptions had generally been met and therefore data transformations were deemed unnecessary.",99.71139971139971
1567,PRECIS-2,"The intervention included eight weekly 2-h group sessions (teleconference or in-person) led by a neuropsychologist (e.g., sleep, fatigue, pain, etc.).",fulltext,The intervention included eight weekly 2-h group sessions ,38.66666666666667
1567,PRECIS-2,"Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",fulltext,"Participants were recruited from three large metropolitan communities in Texas: Houston, San Antonio and Dallas. Participants were recruited via physician referral, targeted mailings to persons with MS on the mailing list of the National MS Society, contact with support groups, and notices in MS newsletters and web sites.",100.0
1567,PRECIS-2,"Prior to the initiation of data collection, we used a 1:1 ratio to randomly assign participants to groups. Randomization assignment was recorded on a letter sealed in an opaque envelope. Following the completion of baseline testing, the project manager opened the next envelope in the sequence and assigned the participant to either the active intervention or the usual care comparison group.",fulltext,"Prior to the initiation of data collection, we used a 1:1 ratio to randomly assign participants to groups. Randomization assignment was recorded on a letter sealed in an opaque envelope. Following the completion of baseline testing, the project manager opened the next envelope in the sequence and assigned the participant to either the active intervention or the usual care comparison group.",100.0
1568,PRECIS-2,Included in intention-to-treat analysis (n=42),prompt,included in the analysis o,52.17391304347826
1568,PRECIS-2,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,fulltext,The relapse rate and the global brain atrophy rate were the primary outcomes of this study.,100.0
1568,PRECIS-2,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopulos and Felson Duchan)13: (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",fulltext,"The supervised exercise sessions were performed twice weekly for the full study period of 48 weeks, and was planned on the basis of four principles (adapted from Stathopoulos and Felson Duchan) 13 : (1) individual tailoring, (2) application of exercise types matching the goal of the intervention, (3) progressive overload and (4) sufficient intensity to induce the desired effects of the intervention.",100.0
1568,PRECIS-2,"The exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients' individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks. In brief, the exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRmax.",fulltext,"the exercise intervention was planned as high-intense aerobic exercise, monitored relative to the patients’ individual maximal heart rate (HRmax), and progressed within and between 4 meso cycles of 12 weeks. In brief, the exercise intervention included 3892 minutes of aerobic exercise at an average intensity of 76.2% HRma",99.38461538461539
1568,PRECIS-2,"The purpose of providing health educational sessions throughout the study period of 48 weeks was primarily to facilitate adherence in the control group, as a previous study showed no effect of health education on MS-related symptoms and a null effect on the outcomes of the present study was therefore expected.14",fulltext,"The purpose of providing health educational sessions were primarily to facilitate adherence in the control group, as a previous study showed no effect of health education on MS-related symptoms and a null effect on the outcomes of the present study was therefore expected. 1",86.90095846645367
1568,PRECIS-2,Patients (n=84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,fulltext,Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society.,100.0
1568,PRECIS-2,The study is approved by The Central Denmark Region Committees on Health Research Ethics (1-10-72-388-17) and registered at the Danish Data Protection Agency (2016-051-000001 (706)) and clinicaltrials.gov (NCT03322761).,fulltext,The study is approved by The Central Denmark Region Committees on Health Research Ethics (1-10-72-388-17) and registered at the Danish Data Protection Agency (2016-051-000001 (706)) and clinicaltrials.gov (NCT03322761).,100.0
1568,PRECIS-2,"Patients (n=84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩾2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",fulltext,"Patients (n = 84) were recruited in collaboration with six Danish regional MS clinics and The Danish MS Society. Inclusion criteria were (1) 18–60 years of age, (2) ⩽2 years since clinical diagnosis with relapsing remitting MS (RRMS) and (3) no relapses or changes in medication status 8 weeks prior to inclusion.",100.0
1569,PRECIS-2,"The experimental group was allocated to a 12-weeks home-based task-oriented program with monthly in-hospital visits (Phase 1). Methods: 36 PwMS with EDSS 4–5.5 and unassisted walking have been randomly assigned to 10 supervised TOCT sessions over two weeks (Phase 1) followed by a 12-weeks home-based task-oriented program (Phase 2) or to a delayed-treatment group. At the end of Phase 2, the delayed-treatment group (usual care) received the same TOCT protocol.",fulltext,"ed by a 12-weeks home-based task-oriented program with monthly in-person visits. Methods: 36 PwMS with EDSS 4–5.5 and unassisted walking have been randomly assigned to 10 supervised TOCT sessions over two weeks (Phase 1) followed by a 12-weeks home-based task-oriented program (Phase 2) or a delayed-treatment group. At the end of Phase 2, the delayed-treatment group (usual care) received the same TOCT protocol.",87.87878787878788
1569,PRECIS-2,Clinical and instrumental assessments after 12-weeks without intervention,fulltext,s and instrumental measurements the wee,45.205479452054796
1569,PRECIS-2,"At home, we recommended 60-minute sessions three times/week. The home-based program includes overground walking practice and exercises with similar modalities and difficulty as learnt during Phase 1. Patients recorded the frequency and duration of the training in a pre-compiled logbook. Patients were given the contact number of the hospital to contact if they needed it. Home-based adherence was monitored using a Visual Analog Scale during each monthly visit. Moreover, the accuracy and the number of repetitions achieved for each exercise were assessed to provide further feedback and adapt the program to the subjects' skills.",fulltext," At home, we recommended 60-minute sessions three times/week. The home-based program includes overground walking practice and exercises with similar modalities and difficulty as learnt during Phase 1. Patients recorded the frequency and duration of the training in a precompiled logbook. Patients were given the contact number of the hospital to contact if they needed it. Home-based adherence was monitored using a Visual Analog Scale during each monthly visit. Moreover, the accuracy and the number of repetitions achieved for each exercise were assessed to provide further feedback and adapt the program to the subjects’ skills",99.68304278922345
1569,PRECIS-2,"A superiority of TOCT on delayed-TOCT was verified by the significant interaction time∗treatment (F, 2.88 = 7.80; p<0.001) for the primary outcome measure (Table 2).",fulltext," A superiority of TOCT on delayed-TOCT was verified by the significant interaction time-treatment (F, 2,88 = 7.80; p<0.001) for the primary outcome measure (Table 2)",99.39393939393939
1569,PRECIS-2,The Multiple Sclerosis Task-Oriented Circuit Training (MS TOCT) trial is an assessor-blinded randomized controlled trial approved by the Ferrara Ethics Committee (registration number 140489) and registered on the ClinicalTrials.gov database (NCT02421744). Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation.,fulltext, The Multiple Sclerosis Task-Oriented Circuit Training (MS_TOCT) trial is an assessor-blinded randomized controlled trial approved by the Ferrara Ethics Committee (registration number 140489) and registered on the ClinicalTrials.gov database (NCT02421744). Patients have been recruited at Ferrara University Hospital from patients who attend the Rehabilitation Outpatient Clinic for gait rehabilitation,99.50248756218906
1569,PRECIS-2,"The experimental primary outcome was the 6-minute walking test (6MWT) for walking endurance (Goldman et al., 2008). As secondary outcomes, we selected: i) Timed 25-Foot Walk (T25FW) (Gijbels et al., 2012) for gait speed; ii) Timed Up and Go Test (TUG) for mobility (Podsiadlo and Richardson, 1991); iii) Dynamic Gait Index (DGI) for balance (Forsberg et al., 2013); iv) Modified Fatigue Impact Scale (MFIS) (Téllez et al., 2005) for perceived fatigue.",fulltext,"e primary outcome measure was the 6-minute walking test (6MWT) for walking endurance (Goldman et al., 2008). As secondary outcomes, we selected: i) Timed 25-Foot Walk (T25FW) (Gijbels et al., 2012) for gait speed; ii) Timed Up and Go Test (TUG) for mobility (Podsiadlo and Richardson, 1991); iii) Dynamic Gait Index (DGI) for balance (Forsberg et al., 2013); iv) Modified Fatigue Impact Scale S. Straudi et al. Multiple Sclerosis and Related Disorders 60 (2022) 103721 3 (MFIS) (T ´ ellez et al., 2005) for physica",93.12638580931264
1569,PRECIS-2,Modified Intention-To-Treat analysis (n= 18) Lost to 12-weeks assessment (n= 23): MS worsening (n=1) Personal issues (n=12),fulltext,"e 12-weeks home-based TOCT (1 due to MS worsening, 3 for personal issues,",42.27642276422764
1569,PRECIS-2,"Thirty-six PwMS were enrolled in the study (mean age 50.82, 13 males, 11.6 MS years). One patient in the TOCT group and one in the delayed-TOCT group did not receive the allocated treatment due to a post-randomization drop-out.",fulltext,"Thirty-six PwMS were enrolled in the study (mean age 50.82, 13 males, 11.6 MS years). One patient in the TOCT group and one in the delayed-TOCT group did not receive the allocated treatment due to a post-randomization drop-out.",100.0
1570,PRECIS-2,"Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI",fulltext,"Age between 14 – 50 yrs, definite diagnosis of MS based on clinical manifestations and performing MRI",100.0
1570,PRECIS-2,"For comparison of the primary and final EDSS in each group the paired samples t.test, for comparison of the changes in the primary and final EDSS between the groups, the One-Way ANOVA test and for comparison of side effects between the three drugs, the Pearson- chi-square were used.",fulltext,"For comparison of the primary and final EDSS in each group the paired samples t.test, for comparison of the changes in the primary and final EDSS between the groups, the One-Way ANOVA test and for comparison of side effects between the three drugs, the Pearson- chi-square were used.",100.0
1570,PRECIS-2,"The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 2005-2006, who had the following criteria:",fulltext,"Methods The study was a randomized clinical trial and included all the patients with MS referring to the Farshchian Hospital, Hamadan (West Iran) during the year 20052006, who had the following c",95.40816326530613
1570,PRECIS-2,Finally analysis was performed using SPSS v13.,fulltext,Finally analysis was performed using SPSS v13.,100.0
1570,PRECIS-2,At the onset of treatment all of the patients had an EDSS of less than 6.,fulltext,At the onset of treatment all of the patients had an EDSS of less than 6.,100.0
1570,PRECIS-2,The obtained information were entered in a questionnaire so that the amount of increase or decrease of the patients' disability after the end of treatment in the three groups could be evaluated and compared.,fulltext," analysis The obtained information were entered in a questionnaire so that the amount of increase or decrease of the patients` disability after the end of treatment in M. Mazdeh, et al. Acta Medica Iranica, Vol. 48, No. 2 (2010) 85 the three groups could be evaluated and",95.16908212560386
1570,PRECIS-2,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate.",fulltext,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate.",100.0
1570,PRECIS-2,"Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 10⁹/ L , platelet count ≤ 100 x 10⁹/ L , neutrophil count ≤ 1.5 x 10⁹/ L ,and hemoglobin level ≤ 8.5 g/dl",fulltext," than 6. Exclusion criteria were as follows: 1) history of malignancy within the past five years 2) history of HIV infection, positive serology for hepatitis B and C 3) history of infectious disease within six weeks prior to the study and need for hospitalization from an infectious cause within two months prior to the study 4) any kind of hematological abnormality such as lymphocyte count ≤ 1 x 10 9 / L , platelet count ≤ 100 x 10 9 / L , neutrophil count ≤ 1.5 x 10 9 / L ,and hemoglobin level ≤",97.57085020242914
1570,PRECIS-2,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate. For comparison of the primary and final EDSS in each group, the paired samples t.test, the One-Way ANOVA test and the Pearson- chi-square were used.",fulltext,"The patients were divided into three equal groups: group 1 received Av, group 2 received Re and group 3 received Be, and after 24 months, comparison was done by calculating primary and final EDSS and the relapse rate. For comparison of the primary and final EDSS in each group, the relapse rate between the groups and side effects between the drugs, the paired samples t.test, the One-Way ANOVA test and the Pearson- chi-square were used.",100.0
1769,PRECIS-2,"25% of the patients complained of feeling bloated and some found that they had gained up to 14 lb. (6 kg.) in weight. 1 patient felt that her skin had become rather pigmented, but continued treatment.",fulltext,"5% of the patients complained of feeling bloated and some found that they had gained up to 14 lb. (6 kg.) in weight. 1 patient felt that her skin had become rather pigmented, but continued treatment.",99.5
1769,PRECIS-2,"The trial was carried out in three centres-Belfast, Leeds, and Manchester.",fulltext," was started in 1963 in three citiesBelfast, Leeds, and Manchester.",74.32432432432432
1769,PRECIS-2,The clinical experience with these patients are similar in general to those recorded at the other centres. All our patients received corticotrophin 20 units daily,fulltext,The clinical experiences with these patients are similar in general to those recorded at the other centres. All our patients received corticotrophin 20 units daily,100.0
1769,PRECIS-2,"Corticotrophin was reduced from 15 to 10 units daily and ampicillin was advised for the urinary infection. She was admitted to hospital on May 6, 1966, in bacteraemic shock; temperature 103°F (39-3°C), pulse-rate 120 per minute, blood-pressure 70/40 mm. Hg. Despite intravenous hydrocortisone and other drugs, the muscular cortisone acetate, and chloromycetin she died the following day.",fulltext,"Corticotrophin was reduced from 15 to 10 units daily and ampicillin was advised for the urinary infection. She was admitted to hospital on May 6, 1966, in bacteraemic shock: temperature 103&deg;F (393&deg;C), pulse-rate 120 per minute, blood-pressure 70/40 mm. Hg. Despite intravenous hydrocortisone and noradrenaline, intramuscular cortisone acetate, and chloromycetin she died the following day.",97.1576227390181
1769,PRECIS-2," As mentioned earlier, we decided as a matter of policy to admit to our trial only patients who appeared to have had a clearcut relapse in the eighteen months before their acceptance.",fulltext," As mentioned earlier, we decided as a matter of policy to admit to our trial only patients who appeared to have had a clearcut relapse in the eighteen months before their acceptance.",100.0
1769,PRECIS-2,181 patients with multiple sclerosis were treated with corticotrophin daily for eighteen months. There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,fulltext,81 patients with multiple sclerosis were treated with corticotrophin daily for eighteen months. There was no evidence that treatment prevented deterioration or reduced the number or severity of the relapses when compared with 169 control patients observed and scored in a similar way for the same period of time.,99.68051118210862
1769,PRECIS-2,The treated and control groups did not differ either in the amount of deterioration of the disease or in the reduction in number or severity of relapses.,fulltext,The treated and control groups did not differ either in the amount of deterioration of the disease or in the reduction in number or severity of relapses.,100.0
1770,PRECIS-2,"To compare the demographic data and treatment results in both groups, the two-sided Mann-Whitney U test was used with exception of the disease stages (RR, PR, and PP) in which we used the Chi-square test.",fulltext,"To compare the demographic data and treatment results in both groups, the two-sided Mann-Whitney U test was used with exception of the disease stages (RR, PR, and PP) in which we used the Chi-square test.",100.0
1770,PRECIS-2,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",fulltext,"Three neurological departments in the Netherlands (University Hospital Groningen, Streekziekenhuis Almelo, Diaconessenhuis Meppel) participated in this study.",100.0
1770,PRECIS-2,"Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged. This was due to a changing attitude towards bed rest and the introduction of short term high dose methylprednisolone treatment (9), which rapidly has gained a wide acceptance among neurologists.",fulltext,"Only 29 patients entered the trial. The number of patients was much smaller than was hoped for when the study was envisaged. This was due to a changing attitude towards bed rest and the introduction of short term high dose methylprednisolone treatment (9), which rapidly has gained a wide acceptance among neurologists.",100.0
1770,PRECIS-2,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depolpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5).",fulltext,"Patients were allocated in a stratified randomisation to treatment with either bed rest during 3 weeks and a synthetic ACTH depotpreparation (1 mg, 100 units, tapered over 12 weeks), and Vitamin B-complex or bed rest and Vitamin B-complex intramuscular injections in the same scheme (5)",99.30313588850174
1770,PRECIS-2,"Only patients with a clinical or laboratory supported definite diagnosis of MS according to the Poser criteria, suffering from a relapse, were included.",fulltext,"ported definite diagnosis of MS according to the Poser criteria (6), suffering from a relapse, were included.",69.07894736842105
1770,PRECIS-2,"Follow-up lasted one year. In some Kurtzke Functional Systems, the Ambulation Index and the Kurtzke Incapacity Scale a transient greater improvement in the ACTH-treated patients was observed. These superior results in the ACTH group were no longer present at 6 months.",fulltext,"Follow-up lasted one year. In some Kurtzke Functional Systems, the Ambulation Index and the Kurtzke Incapacity Scale a transient greater improvement in the ACTH-treated patients was observed. These superior results in the ACTH group were no longer present at 6 months.",100.0
1771,PRECIS-2,"Participants underwent the BRB-N which is a cognitive performance test battery purposely developed to examine cognitive performance in specific cognitive domains in pwMS.25 In order to avoid a training effect from T0 to T24, two alternative Danish versions (A or B) of the BRB-N were administered in a randomized and stratified alternating order (i.e. A-B-A or B-A-B) under the same circumstances.",fulltext,"Participants underwent the BRB-N which is a cognitive performance test battery purposely developed to examine cognitive performance in specific cognitive domains in pwMS. 25 In order to avoid a training effect from T0 to T24, two alternative Danish versions (A or B) of the BRB-N were administered in a randomized and stratified alternating order (i.e. A-B-A or B-A-B) under the same circumstances.",100.0
1771,PRECIS-2,"In brief, the session volume increased from 30 to 60 minutes during the intervention while the intensity for the 12 subjects=87.8% of HRmax. There were 13 dropouts after 24 weeks (RCT dropout=15.1%), with no difference between PAE and waitlist (7 and 6 dropouts, respectively). The PAE intervention was well tolerated, with no serious adverse events.",fulltext," during the last 8 weeks of the intervention (mean intensity for the 12 subjects = 87.8% of HR max ). There were 13 dropouts after 24 weeks (RCT dropout = 15.1%), with no difference between PAE and waitlist (7 and 6 dropouts, respectively). The PAE intervention was well tolerated, with no serious adverse events.",83.71428571428572
1771,PRECIS-2,"Participants were recruited between April 2016 and October 2017. From a total of 148 patients invited to participate, 86 were enrolled (Figure 1) and randomly assigned to the PAE or waitlist group (Table 1).",fulltext,"Participants were recruited between April 2016 and October 2017. From a total of 148 patients invited to participate, 86 were enrolled (Figure 1) and randomly assigned to the PAE or waitlist group (Table 1).",100.0
1771,PRECIS-2,"The PAE group underwent supervised high-intensity PAE for 24 weeks, while the waitlist group continued their habitual lifestyle (including ongoing physiotherapy treatment).",fulltext,"The PAE group underwent supervised highintensity PAE for 24 weeks, while the waitlist group continued their habitual lifestyle (including ongoing physiotherapy treatment) ",99.4186046511628
1771,PRECIS-2,"Consistent with contemporary statistical guidelines, the use of p values for secondary and other comparisons was toned down when interpreting the results of this study (i.e. p values were included but not in the conventional, dichotomous way).",fulltext,"Consistent with contemporary statistical guidelines, the use of p values for secondary and other comparisons was toned down when interpreting the results of this study (i.e. p values were included but not in the conventional, dichotomous way).",100.0
1771,PRECIS-2,"Participants gave written informed consent. The study was approved by the ethical committee of the Central Denmark Region, Denmark (Record No. 1-10-72-291-15).",fulltext,"Participants gave written informed consent. The study was approved by the ethical committee of the Central Denmark Region, Denmark (Record No. 1-10-72-291-15).",100.0
1771,PRECIS-2,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see Langeskov-Christensen et al.",fulltext,"Eighty-six participants were recruited from Danish MS clinics (Aarhus University Hospital, Viborg Regional Hospital, Odense University Hospital, and the MS Clinic of Southern Jutland (Kolding)). For inclusion and exclusion criteria, see LangeskovChristensen et al.",99.62264150943396
1771,PRECIS-2,"Total group. For the initial exercise group, results at T48 showed that after 24 weeks of self-guided physical exercise, the improvements in cardiorespiratory fitness following PAE disappeared (−2.8 (−3.8 to −1.8) mL O2/min/kg; p < 0.01).",fulltext,"Total group. For the initial exercise group, results at T48 showed that after 24 weeks of self-guided physical exercise, the improvements in cardiorespiratory fitness following PAE disappeared (–2.8 (–3.8 to –1.8) mL O 2 / min/kg; p < 0.01).",100.0
1772,PRECIS-2,"The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15]. This was measured using the Global Satisfaction subscale score on the TSQM v1.4, where higher scores indicate greater satisfaction.",fulltext,"t The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15]. This was measured using the Global Satisfaction subscale score on the TSQM v1.4, where higher scores indicate greater satisfactio",99.38837920489296
1772,PRECIS-2,"For the primary endpoint, enrollment of 1000 patients (750 fingolimod; 250 iDMT) would provide 90% power to detect a significant difference between fingolimod and each iDMT group in the change from baseline, assuming an effect size of 0.25, a significance level of 5% and a 10% rate of unevaluable patients.",fulltext,"For the primary endpoint, enrollment of 1000 patients (750 fingolimod; 250 iDMT) would provide 90% power to detect a significant difference between fingolimod and each iDMT group in the change from baseline, assuming an effect size of 0.25, a significance level of 5% and a 10% rate of unevaluable patients.",100.0
1772,PRECIS-2,"Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) score of 0–5.5 were eligible to participate in the study.",fulltext,"a Men and women aged 18–65 years with relapsing forms of MS, as defined by the 2005 revised McDonald criteria [14], and an Expanded Disability Status Scale (EDSS) Calkwood et al. BMC Neurology 2014, 14:220 Page 2 of 11 http://www.biomedcentral.com/1471-2377/14/220 score of 0–5.5 were eligible to participate in the stud",99.08256880733946
1772,PRECIS-2,The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15].,fulltext,t The primary post hoc study endpoint was the least-squares mean (LSM) change in Treatment Satisfaction Questionnaire for Medication (TSQM) Global Satisfaction score from baseline to 6 months [15,98.97435897435898
1772,PRECIS-2,Patients randomized to the iDMT group either remained on the iDMT they were taking at randomization or were switched immediately to another approved iDMT.,fulltext,"Patients randomized to the iDMT group either remained on the same therapy or, following consultation with a physician, were switched immediately to another approved iDMT.",87.01298701298701
1773,PRECIS-2,"The CG followed their habitual daily activities during the study period and they did not follow any kind of structured physical activity. Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, average power and muscle endurance.",fulltext,"The CG followed their habitual daily activities during the study period and they did not follow any kind of structured physical activity. Dependent variables included maximal voluntary isometric contraction (MVIC), maximal torque, aver",88.34586466165413
1773,PRECIS-2,"MVIC test was performed in the same knee extension device described for the training program. It consisted of pushing against the fixed lever arm of the knee extension machine as hard as possible for 5 seconds with a knee flexion of 90° under strong verbal encouragement. Before the test, the lever arm of the knee extension machine was aligned with the center of rotation of the knee joint. A strain gauge (Globus Ergo Meter®, Italy; sample rate 1000 Hz) was placed in between the chains used to fix the lever arm of the machine, to measure the isometric strength of both legs.",fulltext,"MVIC test was performed in the same knee extension device 526 C. Medina-Perez et al. / Effects of a RTP and subsequent detraining on muscle strength and muscle power in MS patients described for the training program. It consisted of pushing against the fixed lever arm of the knee extension machine as hard as possible for 5 seconds with a knee flexion of 90 ◦ under strong verbal encouragement. Before the test, the lever arm of the knee extension machine was aligned with the center of rotation of the knee joint. A strain gauge (Globus Ergometer ® , Italy; sample rate 1000 Hz) was placed in between the chains used to fix the lever arm of the machine, to measure the isometric strength of both legs.",99.82698961937716
1773,PRECIS-2,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",100.0
1773,PRECIS-2,The study was approved by the Research Ethics Committee of the University of Leon.,fulltext,The study was approved by the Research Ethics Committee of the University of Leon.,100.0
1773,PRECIS-2,None of the patients had previous experience with resistance training.,fulltext,None of the patients had previous experience with resistance training.,100.0
1773,PRECIS-2,All subjects taking part in the study (n = 42) completed all the scheduled testing protocols. Adherence to the training intervention (for the EG) averaged 92.9 ± 1.5 sessions from a total of 24 planned sessions. All participants from the EG completed more than 75% of the sessions included in the resistance training program.,fulltext,All subjects taking part in the study (n = 42) completed all the scheduled testing protocols. Adherence to the training intervention (e.g. EG) averaged 22.9 ± 1.5 sessions from a total of 24 planned sessions. All participants from the EG completed more than 75% of the sessions included in the resistance training program.,97.84615384615385
1773,PRECIS-2,"All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain). After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",fulltext,"All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain). After a group meeting where the details of the investigation were described to the patients, including possible risks and discomfort associated to the intervention, a formal invitation to take part in the study was offered.",99.70326409495549
1773,PRECIS-2,This study was designed to evaluate the effects of a 12-week detraining period on muscle strength (isometric and endurance) and muscle power of multiple sclerosis (MS) patients that had previously carried out a 12-week resistance training program (RTP).,fulltext,This study was designed to evaluate the effects of a 12-week detraining period on muscle strength (isometric and endurance) and muscle power of multiple sclerosis (MS) patients that had previously carried out a 12-week resistance training program (RTP).,100.0
1773,PRECIS-2,All participants were recruited among six MS rehabilitation centers within the region of Castilla y León (Spain).,fulltext,All participants were recruited among six MS rehabilitation centers within the region of Castilla y Le´on (Spain).,99.11504424778761
648,PRECIS-2,"The trial was overseen by an independent trial steering committee. An independent data monitoring committee monitored effectiveness and safety annually. The data monitoring committee used the Haybittle–Peto14,15 approach to interim analyses using three standard errors as the cutoff for consideration of early cessation, preserving the type-one error rate across the trial.",fulltext,"The trial was overseen by an independent trial steering commit tee. An independent data monitoring committee monitored effectiveness and safety annually. The data monitoring committee used the Haybittle–Peto 11,12 approach for interim analyses using three standard errors as the cutoff for consideration of early cessation, preserving the type-one error rate across the trial.",99.19571045576407
648,PRECIS-2,"Each regional coordinator (one per country, except India, which was split into two regions) started and documented a training programme that ensured that surgeons operating within the trial were familiar with the techniques being compared before participating.",fulltext,"Each regional coordinator (one per country, except India, which was split into two regions) started and documented a training programme that ensured that surgeons operating within the trial were familiar with the techniques being compared before participating.",100.0
648,PRECIS-2,"As prespecified in the analysis plan, no tests for interaction were done for the primary outcome because there was no evidence of main effects for the primary outcome.",fulltext," As prespecified in the analysis plan, no tests for interaction were done because there was no evidence of main effects for the primary outcome",85.02994011976048
648,PRECIS-2,The focus of the primary analysis was the main effects of the five intervention pairs analysed separately. Pairwise interactions were planned if the analyses showed any statistically significant differences for the primary outcome only.,fulltext,The focus of the primary analysis was the main effects of the five intervention pairs analysed separately. Pairwise interactions were planned if the analyses showed any statistically significant main effects for the primary outcome only.,97.88135593220339
648,PRECIS-2,"Between May 20, 2007, and Dec 31, 2010, 15 935 women were recruited. There were no statistically significant differences within any of the intervention pairs for the primary outcome: blunt versus sharp entry risk ratio 1·03 (95% CI 0·91–1·17), exterior versus intra-abdominal repair 0·96 (0·84–1·08), single-layer versus double-layer closure 0·96 (0·85–1·08), closure versus non-closure 1·06 (0·94–1·20), and chromic catgut versus polyglactin-910 0·90 (0·78–1·04).",fulltext,"Between May 20, 2007, and Dec 31, 2010, 15 935 women were recruited. There were no statistically significant differences within any of the intervention pairs for the primary outcome: blunt versus sharp entry risk ratio 1·03 (95% CI 0·91–1·17), exterior versus intra-abdominal repair 0·96 (0·84–1·08), single-layer versus double-layer closure 0·96 (0·85–1·08), closure versus non-closure 1·06 (0·94–1·20), and chromic catgut versus polyglactin-910 0·90 (0·78–1·04).",100.0
648,PRECIS-2,"After widespread consultation and agreement at a workshop in Oxford, UK, to discuss the protocol for a randomised trial of caesarean section surgical techniques (CORONIS), five pairs of interventions were chosen.",fulltext,C. Discussion CORONIS was a large randomised trial of caesarean section surgical techniques,36.79245283018868
648,PRECIS-2,The CORONIS trial is registered with Current Controlled Trials: ISRCTN31089967.,fulltext,The CORONIS trial is registered with Current Controlled Trials: ISRCTN31089967.,100.0
648,PRECIS-2,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at 6 weeks after delivery. Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit. Serious adverse events were assessed by the chief investigator and data monitoring committee as soon as they were reported to the international coordinating centre.",fulltext,"Data were collected at trial entry, immediately after surgery, at hospital discharge (including hospital transfer or death), and at about 6 weeks after delivery. Women who did not return at 6 weeks were located and interviewed by telephone or during a home visit. Serious adverse events were assessed by the chief investigator and data monitoring committee as soon as they were reported to the international coordinating centre.",100.0
648,PRECIS-2,"All investigators, surgeons, and participants were unmasked to treatment allocation.",fulltext,"All investigators, surgeons, and participants were unmasked to treatment allocation.",100.0
648,PRECIS-2,"The primary outcome was the composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit.",fulltext,"The primary outcome was a composite of death, maternal infectious morbidity, further operative procedures, or blood transfusion of more than 1 unit of whole blood or packed cells up to the 6-week follow-up visit.",98.5981308411215
648,PRECIS-2,"Eligibility for inclusion as a trial intervention was based on a range of criteria including the clinical importance of resolving the uncertainty for short-term or long-term outcomes, the likelihood of resolving uncertainty, and the feasibility of undertaking the interventions in the participating countries.",fulltext,"Eligibility for inclusion as a trial intervention was based on a range of criteria including the clinical importance of resolving the uncertainty for short-term and long-term Lancet 2013; 382: 234–48 Published Online May 28, 2013 http://dx.doi.org/10.1016/ S0140-6736(13)60441-9 This publication has been corrected. The corrected version first appeared at thelancet.com on July 19, 2013 See Comment page 188 *Investigators listed at end of paper Correspondence to: Prof Peter Brocklehurst, Institute for Women’s Health UCL, Medical School Building, 74 Huntley Street, London WC1E 6AU, UK p.brocklehurst@ucl.ac.uk Articles www.thelancet.com Vol 382 July 20, 2013 235 outcomes, the quality and quantity of available evidence, and the feasibility of undertaking the interventions in the participating countries.",98.05825242718447
648,PRECIS-2,"CORONIS was a pragmatic international 2×2×2×2×2 non-regular fractional, factorial, unmasked, randomised controlled trial that examined five elements of the caesarean section technique in intervention pairs.",fulltext,"CORONIS was a pragmatic international 2×2×2×2×2 non-regular fractional, factorial, unmasked, randomised controlled trial that examined five elements of the caesarean section technique in intervention pairs.",100.0
648,PRECIS-2,"The primary analysis of the primary outcome was by intention to treat, excluding women who withdrew consent to use their data or for whom data were missing.",prompt,"the analysis of the primary outcome? For example, score 5 for a very pragmatic approach using intention to treat with",45.51282051282052
650,PRECIS-2,All the family practices of one regional organisation of GPs (a so-called 'care group') in the North of the Netherlands were eligible to participate in the study. GPs were asked to participate in the SMS project. Their PNs for diabetes care were randomly assigned to an intervention or control arm.,fulltext,All the family practices of one regional organisation of GPs (a so-called ‘care group’) in the South of the Netherlands were eligible to participate in the study. GPs were asked to participate in the SMS project. Their PNs for diabetes care were randomly assigned to an intervention or control arm.,99.32885906040269
650,PRECIS-2,"Practice nurses (PNs) in the Netherlands work according to guidelines that focus on medical and behavioural management. Furthermore, the financial reimbursement of care and patients' health outcomes are determined by biomedical targets.",fulltext,"Practice nurses (PNs) in the Netherlands work according to guidelines that focus on medical and behavioural management. 11 12 Furthermore, the financial reimbursement of care and patients’ health outcomes are determined by biomedical targets.",100.0
650,PRECIS-2,"From the 117 participants, 80% completed all of the follow-up measurements. In 10% of the sample, one follow-up measurement was missing. Three patients did not complete the baseline measurement and gave informed consent at the 4-month follow-up measurement.",fulltext,"who participated in the trial, 80% completed all of the follow-up measurements. In 10% of the sample, one follow-up measurement was missing. Three patients did not complete the baseline measurement and gave informed consent at the 4-month follow-up measuremen",94.55252918287937
650,PRECIS-2,"Owing to the variety of PNs working solo versus in a team, and in one versus more practices, PNs were instructed into working along in a practice, working in a team and working in different settings. The randomisation was performed by an independent research assistant who used a random number seed computer program to assign PNs to either condition.",fulltext,"Owing to the variety of PNs working solo versus in a team, and in one versus more practices, PNs were stratified into working alone in a practice, working in a team and working in different settings. The randomisation was performed by an independent research assistant who used a random number seed computer program to assign PNs to ",93.71428571428572
650,PRECIS-2,"In collaboration with a regional care group of general practitioners (GPs) in the Netherlands and the insurer, the SMS ('Self-Management Support') implementation project was initiated to realise a shift from biomedically oriented care towards a biopsychosocial approach in diabetes care.",fulltext,"In collaboration with a regional care group of general practitioners (GPs) in the Netherlands and a health insurer, the SMS (‘Self-Management Support’) implementation project was initiated to realise a shift from biomedically oriented care towards a biopsychosocial approach in diabetes care.",99.65156794425087
650,PRECIS-2,"The glycaemic control of patients was measured during consultations. For the baseline measure, we used data from the first consultation after the patient's baseline measurement (within a maximum interval of 3 months). The consultation following this first consultation was used as the 4-month follow-up measurement. The last measurement was the assessment approximately 1 year after the patient's baseline measurement (at least more than 6 months after the first consultation).",fulltext,"The glycated haemoglobin in mmol/mol was measured during consultations. For the baseline measure, we used data from the first consultation after the patient’s baseline measurement (with a maximum interval of 3 months). The consultation following this first consultation was used as the 4-month follow-up measurement. The last measurement was the assessment approximately 1 year after the patient’s baseline measurement (at least more than 6 months after the first consultation).",96.43605870020964
650,PRECIS-2,"The starting point was a nurse-led minimal psychological intervention. A previous randomised trial has shown that this intervention was cost-effective for patients with diabetes with minor to moderate depression: 9 months after receiving the intervention, depressive symptoms were significantly lower, there was a positive effect on patients' quality of life, and patients experienced less anxiety, possessed more self-efficacy and demonstrated better glycaemic control and showed more participation in comparison to control patients.",fulltext,"The starting point was a nurse-led minimal psychological intervention. A previous randomised trial has shown that this intervention was cost-effective for patients with diabetes with minor to moderate depression: 9 months after receiving the intervention, depressive symptoms were significantly lower, there was a positive effect on patients’ quality of life, and patients experienced less anxiety, possessed more selfefficacy skills, demonstrated better glycaemic control and showed more participation in comparison to control patients.",99.25093632958801
650,PRECIS-2,The effect of SMS on patients' daily functioning was measured by means of the DFT. The DFT was dichotomised to compare the number of patients who were improved in their daily functioning and had apparently found a satisfactory way to live with the consequences of their diabetes (DFT ≤4) with patients who still perceived a burden of diabetes on their daily functioning (DFT >4).,fulltext,"The effect of SMS on patients’ daily functioning was measured by means of the DFT. The DFT was dichotomised to compare the number of patients who were improved in their daily functioning and had apparently found a van Dijk-de Vries A, et al. BMJ Open 2015;5:e007014. doi:10.1136/bmjopen-2014-007014 3 Open Access on July 17, 2023 at University of Basel. Protected by copyright. http://bmjopen.bmj.com/ BMJ Open: first published as 10.1136/bmjopen-2014-007014 on 25 June 2015. Downloaded from satisfactory way to live with the consequences of their diabetes (DFT ≤4) with patients who still perceived a burden of diabetes on their daily functioning (DFT >4).",100.0
651,PRECIS-2,"We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist (LTRA) as compared with either an inhaled glucocorticoid for first-line asthma-controller therapy or a long-acting beta2-agonist (LABA) as add-on therapy in patients already receiving inhaled glucocorticoid therapy.",fulltext,"We conducted two parallel, multicenter, pragmatic trials to evaluate the real-world effectiveness of a leukotriene-receptor antagonist (LTRA) as compared with either an inhaled glucocorticoid for first-line asthma-controller therapy or a long-acting beta 2 agonist (LABA) as add-on therapy in patients already receiving inhaled glucocorticoid therapy.",100.0
651,PRECIS-2,"Patients who met the eligibility criteria completed a validated asthma-symptom diary28 for 2 weeks before the baseline visit for an assessment of PEF variability and to record current symptoms. After the screening visit (week −2) and baseline visit (week 0), study assessments by telephone or in the clinic were scheduled at months 2, 6, 12, 18, and 24.",fulltext,"Patients who met the eligibility criteria completed a validated asthma-symptom diary 28 for 2 weeks before the baseline visit for an assessment of PEF variability and to record current symptoms. After the screening visit (week –2) and baseline visit (week 0), study assessments by telephone or in the clinic were scheduled at months 2, 6, 12, 18, and 24.",100.0
651,PRECIS-2,"Other eligibility criteria for both trials included, at screening, a peak expiratory flow (PEF) greater than 50% of the predicted value after an inhaled beta2-agonist had been withheld for 4 hours or longer and, at the baseline visit, evidence of impaired asthma-related quality of life (a score ≤6 on the Mini Asthma Quality of Life Questionnaire25,26 [MiniAQLQ]) or impaired asthma control (a score ≥1 on the Asthma Control Questionnaire27 [ACQ]).",fulltext,"Other eligibility criteria for both trials included, at screening, a peak expiratory flow (PEF) greater than 50% of the predicted value after an inhaled beta 2 -agonist had been withheld for 4 hours or longer and, at the baseline visit, evidence of impaired asthma-related quality of life (a score ≤6 on the Mini Asthma Quality of Life Questionnaire 25,26 [MiniAQLQ]) or impaired asthma control (a score ≥1 on the Asthma Control Questionnaire 27 [ACQ]).",100.0
651,PRECIS-2,"The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years. Analysis of covariance was used, with treatment as a fixed effect and the baseline value as a covariate.",fulltext,"The primary effectiveness analysis was an intention-to-treat analysis of the MiniAQLQ score at 2 months (the primary time point) and at 2 years. Analysis of covariance was used, with treatment ",77.51004016064257
651,PRECIS-2,"We randomly assigned patients to 2 years of open-label therapy, under the care of their usual physician, with LTRA (148 patients) or an inhaled glucocorticoid (158 patients) in the first-line controller therapy trial and LTRA (170 patients) or LABA (182 patients) added to an inhaled glucocorticoid in the add-on therapy trial.",fulltext,"We randomly assigned patients to 2 years of open-label therapy, under the care of their usual physician, with LTRA (148 patients) or an inhaled glucocorticoid (158 patients) in the first-line controller therapy trial and LTRA (170 patients) or LABA (182 patients) added to an inhaled glucocorticoid in the add-on therapy trial.",100.0
651,PRECIS-2,"Double-blind treatment, although ideal for internal validity, would have severely affected the external validity (applicability) of this study. First, not revealing treatment assignments to the patients and health care providers would have hampered our goal of assessing the effect of differential adherence to oral versus inhaled therapy under conditions of usual patient and physician behaviors and preferences.",fulltext," Double-blind treatment, although ideal for internal validity, would have severely affected the external validity (applicability) of this study. First, not revealing treatment assignments to the patients and health care providers would have hampered our goal of assessing the effect of differential adherence to oral versus inhaled therapy under conditions of usual patient and physician behaviors and preferences",99.75786924939467
651,PRECIS-2,Eligible primary care patients 12 to 80 years of age had impaired asthma-related quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,fulltext,Eligible primary care patients 12 to 80 years of age had impaired asthmarelated quality of life (Mini Asthma Quality of Life Questionnaire [MiniAQLQ] score ≤6) or inadequate asthma control (Asthma Control Questionnaire [ACQ] score ≥1).,99.57627118644068
651,PRECIS-2,"Although such poor and differential adherence potentially reduces assay sensitivity (particularly when coupled with treatment crossover), thus biasing results toward equivalence, both poor and differential adherence rates are realities of real-world prescribing.",fulltext," Although such poor and differential adherence potentially reduces assay sensitivity (particularly when coupled with treatment crossover), thus biasing results toward equivalence, both poor and differential adherence rates are realities of real-world prescribing",99.61832061068702
651,PRECIS-2,"The study was powered for equivalence in the MiniAQLQ score, with the equivalence boundary set at a 95% CI of less than 0.3 for the MiniAQLQ score (i.e., equivalence was declared if the 95% CI was wholly included between −0.3 and 0.3). This difference reflects our use of an a priori conservative approach (0.3 is substantially lower than the MID of 0.5 for the MiniAQLQ29) because of uncertainty about its variability in real-world patients.",fulltext,"The study was powered for equivalence in the MiniAQLQ score, with the equivalence boundary set at a 95% CI of less than 0.3 for the MiniAQLQ score (i.e., equivalence was declared if the 95% CI was wholly included between –0.3 and 0.3). This difference reflects our use of an a priori conservative approach (0.3 is substantially lower than the MID of 0.5 for the MiniAQLQ 26 ) because of uncertainty about its variability in real-world patients.",99.77375565610859
651,PRECIS-2,"The primary outcome measure was the MiniAQLQ score.25,26 Secondary outcome measures included the ACQ score27; the score on the not-yet-validated Royal College of Physicians 3-item asthma questionnaire (RCP3) (range of scores, 0 to 3, with higher scores indicating worse asthma control)30; the score on the validated 14-item Mini Rhino-conjunctivitis Quality of Life Questionnaire (MiniRQLQ) (range of scores, 0 to 6, with higher scores indicating worse rhinitis-related impairment and with an MID of 0.7)31; and the frequency of asthma exacerbations, which were defined as the need for an oral course of glucocorticoids or hospitalization for asthma.",fulltext,"The primary outcome measure was the MiniAQLQ score. 25,26 Secondary outcome measures included the ACQ score 27 ; the score on the not-yet-validated Royal College of Physicians 3-item asthma questionnaire (RCP3) (range of scores, 0 to 3, with higher scores indicating worse asthma control) 30 ; the score on the validated 14-item Mini Rhinoconjunctivitis Quality of Life Questionnaire (MiniRQLQ) (range of scores, 0 to 6, with higher scores indicating worse rhinitis-related impairment and with an MID of 0.7) 31 ; and the frequency of asthma exacerbations, which were defined as the need for an oral course of glucocorticoids or hospitalization for asthma.",99.84615384615385
651,PRECIS-2,"Adherence to an LTRA was better than it was to the other drugs in both trials, with adherence rates that were numerically higher in the first-line controller therapy trial (65% vs. 41% for an inhaled glucocorticoid) and significantly higher in the add-on therapy trial (74% vs. 46% for a LABA).",fulltext," Adherence to an LTRA was better than it was to the other drugs in both trials, with adherence rates that were numerically higher in the firstline controller therapy trial (65%, vs. 41% for an inhaled glucocorticoid) and significantly higher in the add-on therapy trial (74%, vs. 46% for a LABA)",99.31972789115646
651,PRECIS-2,"An automated, computerized telephone center randomly assigned eligible patients to a baseline visit.",fulltext,"An automated, computerized telephone center randomly assigned eligible patients at baseline ",91.0
655,PRECIS-2,"Patients were instructed to report any adverse events and medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",fulltext,"patient was assessed, medical treatment was revised and optimized, educational reinforcement was provided, 6-minute walk test (6MWT) and spirometry tests were carried out and HRQoL measures were taken.",82.70042194092827
655,PRECIS-2,Patients were provided with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session,fulltext, with a user guide with detailed instructions on the use of the mobile device to deliver data collected to the web-based platform after completion of each scheduled session,88.65979381443299
655,PRECIS-2,"At each follow-up visit, patients were advised to continue doing exercise and attending follow-up appointments even if they decided not to comply with the assigned maintenance exercises, supporting the intention-to-treat principle",fulltext,"At each visit, patients were advised to continue doing exercise and attending follow-up appointments even if they decided not to comply with the assigned maintenance exercises, supporting the intention-to-treat principle",95.65217391304348
655,PRECIS-2,"A patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",fulltext," patient in the IG arm was classified as a non-complier if he/she did not perform scheduled exercises for at least 8 consecutive weeks, unless there were clear clinical reasons not to.",99.45945945945947
655,PRECIS-2,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,fulltext,Patients in the IG were asked to continue at home with a similar training schedule to that completed in the hospital.,100.0
655,PRECIS-2,"Continuous variables are described using either the mean and standard deviation or the median and range, depending on the data distribution. Categorical variables are described using frequencies and percentages. The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",fulltext,"Continuous variables are described using either the mean and standard deviation or the median and range, depending on the data distribution. Categorical variables are described using frequencies and percentages. The main efficacy analysis used analysis of covariance (ANCOVA) techniques to test for differences between groups in outcome variables at the 12-month visit, adjusted for baseline values.",100.0
655,PRECIS-2,The primary outcome was the change in the 6-min walk distance (6MWD) at 12 months.,fulltext, Change Over Time in the 6-Minute Walk Test Distance ,43.90243902439024
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017.,fulltext,This was a multicentre open-label pragmatic parallel-group randomized clinical trial involving 13 hospitals and was conducted between 2014 and 2017,99.32432432432432
655,PRECIS-2,This was a multicentre open-label pragmatic parallel-group randomized clinical trial conducted. Two groups were created at completion of an 8-week intensive outpatient hospital PR programme.,fulltext, A multicentre open-label pragmatic parallel-group randomized clinical trial was conducted. Two groups were created at completion of an 8-week intensive outpatient hospital PR programme.,95.78947368421052
655,PRECIS-2,Patients in the control group (CG) were advised to exercise regularly (usual care).,fulltext,Patients in the control group (CG) were advised to exercise regularly (usual care).,100.0
657,PRECIS-2,"In August 2015, 1 of the 6 municipalities included in the study sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic.",fulltext,"In August 2015, 1 of the MS nurses at the Department of Neurology, Nordland Hospital Trust in Bodø, Norway, sent out invitation letters with a consent form to 160 persons with MS who were registered at the MS outpatient clinic,",89.61748633879782
657,PRECIS-2,The primary outcome was balance and trunk control in individuals with MS.,fulltext,n balance and trunk control in individuals with MS.,68.49315068493152
657,PRECIS-2,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway. Standard care included the usual care for individuals with MS in the same municipalities.,fulltext,The GroupCoreDIST intervention was conducted by 6 physical therapists in 6 municipalities in Norway. Standard care included the usual care for individuals with MS in the same municipalities.,100.0
657,PRECIS-2,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,fulltext,Eighty people with Expanded Disability Status scores of 1 to 6.5 participated in this trial.,100.0
657,PRECIS-2,"Assessments were undertaken at baseline and at weeks 7, 18, and 30. Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",fulltext,"Assessments were undertaken at baseline and at weeks 7, 18, and 30. Outcomes were measured with the Trunk Impairment Scale–Norwegian Version, Mini Balance Evaluation Systems Test, and Patient Global Impression of Change–Balance.",100.0
657,PRECIS-2,"One individual missed all postintervention tests, leaving 79 participants in the intention-to-treat analysis.",fulltext,"One individual missed all postintervention tests, leaving 79 participants in the intention-to-treat analysis.",100.0
657,PRECIS-2,Six neurological physical therapists conducted the intervention over being trained in GroupCoreDIST for 5 days. The training included practical and theoretical training.,fulltext,Six neurological physical therapists conducted the intervention after being trained in GroupCoreDIST for 5 days. The training included practical and theoretical training.,98.81656804733728
657,PRECIS-2,"The physical therapists had varied experience in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy.",fulltext,"The physical therapists had varied experience (between 7–25 years) and certification (2 had both a master’s degree in neurological physical therapy and were clinical specialists in neurological physical therapy, 1 was a clinical specialist in neurological physical therapy, and 3 were generalists in physical therapy)",100.0
657,PRECIS-2,Participants allocated to the intervention group were divided into 13 training groups by B.N. and E.C.A. according to geography. The physical therapists conducted an individual clinical examination of each participant.,fulltext,Participants allocated to the intervention group were divided into 13 training groups by B.N. and E.C.A. according to geography. The physical therapists conducted an individual clinical examination of each participant.,100.0
657,PRECIS-2,"At enrollment, all participants underwent a clinical examination by a neurologist (F.O.) to assess their EDSS scores and review their medical history, noting the type of MS, age, sex, weight, height, and medications.",fulltext,"At enrollment, all participants underwent a clinical examination by a neurologist (F.O.) to assess their EDSS scores and review their medical history, noting the type of MS, age, sex, weight, height, and medications.",100.0
662,PRECIS-2,"Fifty were excluded, and three declined to be randomised.",fulltext,"Fifty were excluded, and three declined to be randomised.",100.0
662,PRECIS-2,"Of the 40 randomised participants, 17 (42%) had PPMS, and 23 (57.5%) had SPMS. The overall sample was 55% female, predominantly white British (90%), with a mean age of 52.7 years (SD = 9.5), with the majority married or cohabiting (77.5%).",fulltext,"Of the 40 randomised participants, 17 (42%) had PPMS, and 23 (57.5%) had SPMS. The overall sample was 55% female, predominantly white British (90%), with a mean age of 52.7 years (SD = 9.5), with the majority married or cohabiting (77.5%).",100.0
662,PRECIS-2,Eighteen of the 19 participants completed the mindfulness intervention. One participant dropped out after the first session due to changes in personal circumstances but continued to complete the study questionnaires.,fulltext,Eighteen of the 19 participants completed the mindfulness intervention. One participant dropped out after the first session due to changes in personal circumstances but continued to complete the study questionnaires.,100.0
662,PRECIS-2,The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype videoconferences.,fulltext,The treatment phase took place between February 2013 and July 2013. We delivered the programme in eight hour-long sessions over an eight-week period via Skype video conferences.,100.0
662,PRECIS-2,Participants could see each other and communicate as a group.,fulltext,Participants could see each other and communicate as a group.,100.0
662,PRECIS-2,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M)19 and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10).20",fulltext,"Exclusion criteria were severe cognitive impairment, as determined by a score of 20 or smaller on the Telephone Interview for Cognitive Status-Modified (TICS-M) 19 and high suicide risk, as assessed by a score of 20 or greater on the Clinical Outcome of Routine Evaluation (CORE-10). 2",99.64788732394366
662,PRECIS-2,The remaining 18 participants continued participating in the mindfulness course until the end of the intervention. All the participants attended four or more of the eight mindfulness sessions and 14 (73.7%) attended six or more sessions.,fulltext,The remaining 18 participants continued participating in the mindfulness course until the end of the intervention. All the participants attended four or more of the eight mindfulness sessions and 14 (73.7%) attended six or more sessions.,100.0
662,PRECIS-2,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,fulltext,We recruited potential participants through adverts on the MS Society website and from National Health Service (NHS) MS centres across the UK.,100.0
662,PRECIS-2,"Participants completed standardised questionnaires to measure mood, impact of MS and symptom severity, quality of life and service costs at baseline, post-intervention and three-month follow-up.",fulltext,"Participants completed standardised questionnaires to measure mood, impact of MS and symptom severity, quality of life and service costs at baseline, post-intervention and threemonth follow-up.",99.48453608247422
662,PRECIS-2,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies. The content of the manual was adapted from the Mindfulness-Based Cognitive Therapy (MBCT) course book.22",fulltext,"The format and manual for the mindfulness group, including length of sessions and individual mindfulness practices, were developed in partnership with patients with MS through initial experimental case studies. The content of the manual was adapted from the Mindfulness-Based Cognitive Therapy (MBCT) course book. ",99.36507936507937
662,PRECIS-2,The GHQ12 is designed to measure general levels of distress. The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS.26 Higher scores on this scale represent high distress.,fulltext,The GHQ 17 is designed to measure general levels of distress. The GHQ is uncontaminated by the experience of MS-related somatic symptoms and is the most treatment-responsive measure of psychological distress in MS. 26 Higher scores on this scale represent high distress.,99.6268656716418
662,PRECIS-2,"Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone. Inclusion criteria were the presence of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12).17",fulltext,"Recruitment took place between December 2012 and May 2013. We administered the screening questionnaires via telephone. Inclusion criteria were diagnosis of PPMS or SPMS, Internet access and some level of distress determined by a score of 3 or greater on the General Health Questionnaire (GHQ-12). 1",96.01328903654485
663,PRECIS-2, section) and targeted advertisements sent out via the Danish MS Society.,fulltext, section) and targeted advertisements sent out via the Danish MS Society.,100.0
663,PRECIS-2,"The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still completed successful execution in more than 50% of the attempts/time.",fulltext,"The therapists were instructed to aim for a level of difficulty, where the participants experienced failure but still reached successful execution in more than 50% of the attempts/time.",96.79144385026738
663,PRECIS-2,"The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers. All training sessions were supervised by physiotherapists who were trained to deliver the intervention.",fulltext,"The exercises were conducted in machines that targeted the specified muscle groups, but type of machines could vary between centers. All training sessions were supervised by physiotherapists who were trained to deliver the intervention.",100.0
663,PRECIS-2,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,fulltext,The follow-up test was performed within 7 days of the last intervention session or after the last day of being on the waitlist.,100.0
663,PRECIS-2,Groups of 3–6 patients were referred to physiotherapy clinics that were randomly assigned to provide either PRT or BMCT or to a waitlist CON. Allocation of interventions was done by a cluster randomization conducted whenever a sufficient number of patients were established at three different participating clinics.,fulltext,Groups of 3–6 patients were referred to physiotherapy clinics that were randomly assigned to provide either PRT or BMCT or to a waitlist CON. Allocation of interventions was done by a cluster randomization conducted whenever three groups could be established at three different participating clinics.,91.11111111111111
663,PRECIS-2,"Analyses were carried out as intention-to-treat, where all participants were included regardless of their adherence to the allocated intervention. Carry forward imputations were not used to replace missing data in the primary intention to treat analysis.",fulltext,"Analyses were carried out as intention-to-treat, where all participants who completed the baseline assessment were included regardless of their adherence to the allocated intervention. Carry forward imputations were not used to replace missing data in the primary intention to treat analysis.",100.0
663,PRECIS-2,The primary outcomes were walking speed assessed by the T25FW20 and complex walking assessed by the SSST.21 Both outcomes were obtained at the fastest safe walking speed and conducted in accordance with the original descriptions.,fulltext,The primary outcomes were walking speed assessed by the T25FW 20 and complex walking assessed by the SSST. 21 Both outcomes were obtained at the fastest safe walking speed and conducted in accordance with the original descriptions.,100.0
663,PRECIS-2,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",fulltext,"The inclusion criteria were as follows: age > 18, confirmed diagnosis of MS, Expanded Disability Status Scale (EDSS): 2.0–6.5, Six Spot Step Test (SSST) score > 8 seconds or Timed 25-Foot Walk (T25FW) > 5 seconds, relapse-free within the past 8 weeks, and no adjustment of disease-modifying medication or medication that affects gait performance and spasticity within the past 8 weeks.",100.0
663,PRECIS-2,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in ",fulltext,"Participants were included from September 2016 to October 2018, after being invited via seven MS clinics (specified in ",100.0
664,PRECIS-2,Two supervised and two home-exercise sessions (weeks 7–12). Cognitive-behavioural techniques promoted long-term exercise behaviour change. Outcomes were blindly assessed at baseline and at three and six months after randomisation.,fulltext, supervised and two home-exercise sessions (weeks 7–12). Cognitivebehavioural techniques promoted long-term exercise behaviour change. Outcomes were blindly assessed at baseline and at three and nine months after randomisation.,97.3913043478261
664,PRECIS-2,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ).14,fulltext,The primary outcome was self-reported exercise behaviour at three months using the Godin Leisure Time Exercise Questionnaire (GLTEQ). 1,99.25925925925925
664,PRECIS-2,The objective of this study was to assess the effects of a practically implemented exercise programme on self-directed exercise behaviour and important health outcomes in PwMS to nine months of follow-up.,fulltext,The objective of this study was to assess the effects of a practically implemented exercise programme on self-directed exercise behaviour and important health outcomes in PwMS to nine months of follow-up.,100.0
664,PRECIS-2,Participants in the usual care group were offered three exercise sessions at the university research facility and individual exercise advice after the study.,fulltext,Participants in the usual care group were offered three exercise sessions at the university exercise research facility and individual exercise advice after the study.,100.0
664,PRECIS-2,"A total of 13 participants (six from the intervention group and seven from the usual care group) were lost to follow-up at three months. An additional eight participants were lost to follow-up at nine months (five from the intervention group and three from the usual care group; Figure 1). Participants who dropped out of the study were slightly younger than the study completers (43.3 vs 46.3 years) and had higher baseline EDSS and total fatigue scores (4.5 vs 3.6 and 48.0 vs 42.6, respectively). During the nine-month study period, 16 MS relapses were experienced by 14 of the usual care participants in comparison to 10 MS relapses experienced by nine participants in the exercise group. Participants were encouraged to rejoin the trial following recovery, and complete or partial follow-up data were obtained for 21 of the 23 relapsing participants.",fulltext,"A total of 13 participants (six from the intervention group and seven from the usual care group) were lost to follow-up at three months. An additional eight participants were lost to follow-up at nine months (five from the intervention group and three from the usual care group; Figure 1). Participants that dropped out of the study were slightly younger than the study completers (43.3 vs 46.3 years) and had higher baseline EDSS and total fatigue scores (4.5 vs 3.6 and 48.0 vs 42.6, respectively). During the nine-month study period, 16 MS relapses were experienced by 14 of the usual care participants in comparison to 10 MS relapses experienced by nine participants in the exercise group. Participants were encouraged to rejoin the trial following recovery, and complete or partial follow-up data were obtained for 21 of the 23 relapsing participants.",99.76608187134502
664,PRECIS-2,"Participants on disease-modifying therapy (interferon beta, glatiramer acetate and natalizumab) had been stable on this treatment for at least three months. Exclusion criteria were comorbid conditions impairing the ability to be physically active three times per week; unwilling to be randomised; living more than 20 miles from the trial centre; already engaged in structured exercise or brisk walking ≥ 3 times per week for ≥ 30 minutes per session for at least six months.",fulltext,"Participants on disease-modifying therapy (interferon beta, glatiramer acetate and natalizumab) had been stable on this treatment for at least three months. Exclusion criteria were comorbid conditions impairing the ability to be physically active three times per week; unwilling to be randomised; living more than 20 miles from the trial centre; already engaged in structured exercise or brisk walking ≥ 3 times per week for ≥ 30 minutes per session for at least six months.",100.0
664,PRECIS-2,"An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme. During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",fulltext,"An exercise physiologist supervised the delivery of the intervention but with physiotherapist input during the early stages of the programme. During weeks 1–6, participants attended two supervised sessions per week at a university exercise research facility and engaged in one additional self-directed exercise session in their home environment.",100.0
664,PRECIS-2,"PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches. All patients were assessed by a consultant neurologist with an interest in MS prior to entering the trial. The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria,9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",fulltext,"PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches. All patients were assessed by a consultant neurologist with an interest in MS prior to entering the trial. The inclusion criteria for the trial were clinical diagnosis of MS, as defined by the modified McDonald criteria, 9 with an Expanded Disability Status Scale (EDSS) score of 1.0–6.5, and able to walk a 10-metre distance; aged 18–65 years; clinically stable for at least four weeks prior to entering the study; physically able to participate in exercise three times per week; able to provide written informed consent.",100.0
664,PRECIS-2,PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,fulltext,PwMS were recruited via the Sheffield MS Clinic and flyers/community adverts displayed at the local South Yorkshire MS Society branches.,100.0
664,PRECIS-2,"Supervised exercise sessions involved up to three participants and lasted for approximately one hour. Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS.10,11 Hence, the programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",fulltext,"Supervised exercise sessions involved up to three participants and lasted for approximately one hour. Studies show that aerobic exercise, resistance exercise and combined programmes bring health benefits to PwMS. 10,11 Hence, the programme was designed to be pragmatic and accessible, taking into account exercise preferences and giving choices.",100.0
665,PRECIS-2,"A client service receipt inventory was used at baseline, 8 weeks and 21 weeks to identify concomitant medication and service use in both arms: the research protocol did not manualise or restrict treatment as usual.",fulltext,"A client service receipt inventory was used at baseline, 8 weeks and 21 weeks to identify concomitant medication and service use in both arms: the research protocol did not manualise or restrict treatment as usual.",100.0
665,PRECIS-2,Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis; organic mental disorder or addictive disorder; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).,fulltext,"Exclusion criteria were: poor English language skills or cognitive function (score of less than 24 on Mini Mental State Examination [20]); BDI score of at least 29 on two consecutive occasions; active suicidal ideas; current or life-time diagnosis of psychosis, organic mental disorder or substance dependency; Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above [21]).",97.14285714285714
665,PRECIS-2,"Four participants received some kind of talking therapy outside of the research protocol during the trial, one in the CCBT arm and three in the TAU arm. Thirteen participants received anti-depressants during the trial: seven in the CCBT arm; six in the TAU arm.",fulltext,"Four participants received some kind of talking therapy outside of the research protocol during the trial, one in the CCBT arm and three in the TAU arm. Thirteen participants received anti-depressants during the trial: seven in the CCBT arm; six in the TAU arm.",100.0
665,PRECIS-2,"The collection of outcome data by postal questionnaire proved to be challenging, with multiple reminders needed to obtain data from many participants, particularly at later outcome assessment points.",fulltext,"The collection of outcome data by postal questionnaire proved to be challenging, with multiple attempts to obtain data from many participants, particularly at later outcome assessment points.",93.46733668341709
665,PRECIS-2,We invited 582 people diagnosed with MS to screen for a study evaluating an intervention for low mood by completing a screening questionnaire including prognostic and eligibility criteria and a copy of the Beck Depression Inventory II-21 item (BDI) [18].,fulltext,We invited 582 people diagnosed with MS to screen for a study evaluating an intervention for low mood by completing a screening questionnaire including prognostic and eligibility criteria and a copy of the Beck Depression Inventory II-21 Item (BDI) [18].,100.0
665,PRECIS-2,"After consent, we randomised participants either to CCBT using ",fulltext,"After consent, we randomised participants either to CCBT using ",100.0
665,PRECIS-2,"A recent systematic Cochrane review identified a number of strategies proven to be effective in increasing response to postal questionnaires [34]. Fortunately, we had employed a few of these strategies including using a short, personalised (screening) questionnaire and including a second copy of the questionnaire at follow up. We also highlighted the University's involvement in the study.",fulltext,"A recent systematic Cochrane review identified a number of strategies proven to be effective in increasing response to postal questionnaires [34]. Fortunately, we had employed a few of these strategies including using a short, personalised (screening) questionnaire and including a second copy of the questionnaire at follow up. We also highlighted the University’s involvement in the study.",100.0
665,PRECIS-2,"Delivery of CCBT (home/external) and variation in delivery and use In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine service.",fulltext,"Delivery of CCBT (home/external) and variation in delivery and use In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine Pati",98.25436408977556
665,PRECIS-2,"The patient reported outcome measure which the participants felt best reflected their concerns was the MSIS-29. During the telephone interviews, participants expressed concern about completing the measures and this may affect completion rates and validity in terms of consistency of participants' approach to responses throughout the course of the study.",fulltext, participants expressed concerns about completing the measures and this may affect completion rates and validity in terms of consistency of participants’ approach to responses throughout the course of the study.,59.32203389830508
665,PRECIS-2,"The pre-specified primary outcome was the recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who entered the trial.",fulltext,"The pre-specified primary outcome was the recruitment rate, calculated as the proportion of those invited to fill in a screening questionnaire who were consented into the trial.",98.7878787878788
665,PRECIS-2,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions. Of these six patients, the median time (IQR) to complete all eight CCBT sessions was 15 (13 to 20) weeks against an intended eight weeks time frame.",fulltext,"Of the 12 patients in the CCBT arm, 9 (75%) completed at least four CCBT sessions. This translated to a reasonably high compliance rate of CCBT although only six (50%) of the patients in this arm completed all intended eight CCBT sessions. Of these six patients, the median Table 2 Q",72.42268041237114
665,PRECIS-2, (Ultrasis Ltd) or to usual care (Treatment as Usual - TAU). A Central web-based randomisation service delivered by the Sheffield Clinical Trials Research Unit was used after patient eligibility had been confirmed.,fulltext, (Ultrasis Ltd) or to usual care (Treatment as Usual - TAU). A central webbased randomisation service delivered by the Sheffield Clinical Trials Research Unit was used after patient eligibility had been confirmed.,99.53271028037383
665,PRECIS-2,"No issues were identified with the client service receipt inventory designed for the collection of cost and activity data. Identification of prognostic variables, particularly the EDSS and MS Type, from patient records was not always possible and had to be obtained directly from participants' neurologists for the purposes of the study in some cases.",fulltext,"No issues were identified with the client service receipt inventory designed for the collection of cost and activity data. Identification of prognostic variables, particularly the EDSS and MS Type, from patient records was not always possible and had to be obtained directly from participants’ neurologists for the purposes of the study in some cases.",100.0
665,PRECIS-2,"At Sheffield potential participants were identified from clinic attenders, MS nurse patient visits and from patients with MS referred to the neuropsychology service.",fulltext,"At Sheffield potential participants were identified from clinic attenders, MS nurse patient visits and from patients with MS from the caseload of the neuropsycholog",90.9090909090909
665,PRECIS-2,Follow-up data collection was achieved by postal questionnaire plus telephone interviews to collect service use data.,fulltext, Data collection by postal questionnaire ,35.04273504273504
665,PRECIS-2,"Postal screening via the Walton Centre resulted in 10 participants in 5 months, face to face recruitment at STH resulted in 14 participants in 9 months. From this evidence a full trial of 180 participants would require at least 13 sites, particularly considering that recruitment may be slower in a full-scale trial, where a team is reliant on other centres.",fulltext,"Postal screening via the Walton Centre resulted in 10 participants in 5 months, face to face recruitment at STH resulted in 14 participants in 9 months. From this evidence a full trial of 180 participants would require at least 13 sites, particularly considering that recruitment may be slower in a full-scale trial, where a team is reliant on other centres,",100.0
665,PRECIS-2,"In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine service.",fulltext,"In the Sheffield region, Primary Care Trust (PCT) mental health care teams administered the CCBT, facilitating access and undertaking safety monitoring (PCTs were publicly funded organisations responsible for commissioning acute services for local populations). The CCBT service provided to trial participants was the routine Pati",97.90419161676647
665,PRECIS-2,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non-compliance, protocol deviations and withdrawal.",fulltext,"Primary analysis was an Intention To Treat (ITT) analysis which analysed all 24 participants according to their randomised treatment assignment ignoring non compliance, protocol deviations and withdrawal.",100.0
666,PRECIS-2,This study was conducted in full accordance with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Good Clinical Practice Consolidated Guideline (E6) and any applicable national and local laws and regulations.,fulltext,This study was conducted in full accordance with the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Good Clinical Practice Consolidated Guideline (E6) and any applicable national and local laws and regulations.,100.0
666,PRECIS-2,"Safety assessments were recorded in clinic visits and included adverse events (AEs) throughout the study, vital sign measurements, concomitant medication usage, and clinical laboratory test results at screening and Months 1, 3, and 6. Safety variables monitored also included the percentage of early treatment discontinuation patients who prematurely discontinued from the study due to AEs, as well as the time to withdrawal.",fulltext,"Safety assessments were recorded in clinic visits and included adverse events (AEs) throughout the study, vital sign measurements, concomitant medication usage, and clinical laboratory test results at screening and Months 1, 3, and 6. Safety variables monitored also included the percentage of early treatment discontinuation patients who prematurely discontinued from the study due to AEs, as well as the time to withdrawal.",100.0
666,PRECIS-2,"Following screening for eligibility, 861 patients were randomized to either the GA40 (n = 431) or the GA20 (n = 430) treatment. Most patients (n = 399 in the GA40 group and 395 in the GA20 group) completed the 6-month treatment period (core phase). GA, glatiramer acetate; GA20, GA 20 mg once daily; GA40, GA 40 mg/mL three times weekly; ITT, intent-to-treat.",fulltext,"Following screening for eligibility, 861 patients were randomized to either the GA40 (n = 431) or the GA20 (n = 430) treatment. Most patients (n = 399 in the GA40 group and 395 in the GA20 group) completed the 6-month treatment period (core phase). GA, glatiramer acetate; GA20, GA 20 mg once daily; GA40, GA 40 mg three times weekly; ITT, intention-to-treat.",99.16434540389972
666,PRECIS-2,"For patients who discontinued the study due to AEs, as well as the time of early treatment discontinuation, they scored 5 = somewhat satisfied, 6 = very satisfied, or 7 = extremely satisfied) from baseline compared with those in the GA20 group (3.9 at Month 1 and 4.0 at Month 6).",fulltext,"eater treatment satisfaction (ie, they scored 5 = somewhat satisfied, 6 = very satisfied, or 7 = extremely satisfied) from baseline compared with those in the GA20 group (39.6% in GA40 versus 28.1% in GA20 at Month 6).",66.78571428571429
666,PRECIS-2,"Patients who perceive their medication to be ineffective or inconvenient are less likely to be adherent to treatment, with potentially significant consequences on long-term clinical outcomes. Many patients with multiple sclerosis (MS) are nonadherent to treatment despite demonstrated efficacy of disease-modifying therapies (DMTs).",fulltext,"Patients who perceive their medication to be ineffective or inconvenient are less likely to be adherent to treatment, with potentially significant consequences on long-term clinical outcomes. Many patients with multiple sclerosis (MS) are nonadherent to treatment despite demonstrated efficacy of disease-modifying therapies (DMTs).",100.0
666,PRECIS-2,"In this phase 4, open-label, interventional study, we used the Medication Satisfaction Questionnaire (MSQ) (Caruso et al., 2010) to compare patient-reported medication satisfaction, and Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) (Wicks et al., 2011) to assess the adherence of patients with RRMS on GA40 versus those on GA20.",fulltext,"In this phase 4, open-label, interventional study, we used the Medication Satisfaction Questionnaire (MSQ) (Canuso et al., 2010) to compare patient-reported medication satisfaction, and Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ) (Wicks et al., 2011) to assess the adherence of patients with RRMS on GA40 versus those on GA20.",99.70930232558139
666,PRECIS-2,"Patients' adherence to treatment measured at Months 1, 3, and 6 using the MS-TAQ questionnaire showed consistently greater adherence to treatment in patients receiving GA40 compared with those receiving GA20",fulltext,"Patients' adherence to treatment measured at Months 1, 3, and 6 using the MS-TAQ questionnaire showed consistently greater adherence to treatment in patients receiving GA40 compared with those receiving GA20",100.0
666,PRECIS-2,The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ).,fulltext,The primary endpoint was patient-reported medication satisfaction using the Medication Satisfaction Questionnaire (MSQ).,100.0
666,PRECIS-2,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",fulltext,"The CONFIDENCE study was a multinational, multicenter, randomized, parallel-group, phase 4, open-label study conducted at 88 study centers in 14 countries (Russia, Poland, Italy, France, Croatia, US [including Puerto Rico], Mexico, Spain, Austria, Turkey, Belgium, Argentina, Germany, and Finland) across different geographic regions.",100.0
668,PRECIS-2,"Participants were recruited through a statewide organization providing education and support to people with MS, and a large specialist MS outpatient clinic.",fulltext,"Participants were recruited through a statewide organization providing education and support to people with Dodd et al. 1363 MS, and a large specialist MS outpatient clinic.",100.0
668,PRECIS-2,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",fulltext,"The experimental group completed a 10-week (two times per week), PRT program in one of four community gymnasiums in metropolitan and regional areas.",100.0
668,PRECIS-2,"All exercises were completed on weight machines. The training intensity was based on the recommendations of the American College of Sports Medicine (2009)7 and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached).",fulltext,"All exercises were completed on weight machines. The training intensity was based on recommendations of the American College of Sports Medicine (2009) 7 and consisted of two sets of 10–12 repetitions of each exercise, at a training intensity of 10–12 repetition maximum (that is, only 12 consecutive repetitions of each exercise could be completed before muscle fatigue was reached).",98.96373056994818
668,PRECIS-2,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",fulltext,"Outcome measurements were taken three times: at baseline, after 10 weeks to determine the immediate effects of the intervention, and after a further 12 weeks (week 22) to determine if any benefits from the program had been sustained.",100.0
668,PRECIS-2,"After completing their 10-week intervention programs, participants were asked to return to their usual activities and not to continue or commence resistance training until after the follow-up assessment session.",fulltext,"After completing their 10-week intervention programs, participants were asked to return to their usual activities and not to continue or commence resistance training until after the follow-up assessment session.",100.0
668,PRECIS-2,Changes in walking endurance were measured with the 2MWT.,fulltext,Changes in walking endurance were measured with the 2,92.98245614035088
668,PRECIS-2,The exercises targeted the key lower limb muscles for supporting body weight and for generating speed absorbing power during walking (Table 1).,fulltext,The exercises targeted the key lower limb muscles for supporting body weight and for generating and absorbing power during walking (Table 1).,97.2027972027972
668,PRECIS-2,"Changes in muscle strength were determined by the amount of weight that could be lifted in a single seated leg press (1RM, 1 repetition maximum) and a single reverse leg press (resistance of the combined movement of hip flexion, knee flexion and ankle dorsiflexion) (1RM). In adults with MS, a single 1RM leg press has been measured with high levels of retest reliability (r > 0.93).",fulltext,"Changes in muscle strength were determined by the amount of weight that could be lifted in a single seated leg press (1RM, 1 repetition maximum) and a single reverse leg press (resistance of the combined movement of hip flexion, knee flexion and ankle dorsiflexion) (1RM). In adults with MS, a single 1RM leg press has been measured with high levels of retest reliability (r > 0.93).",100.0
668,PRECIS-2,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",fulltext,"To be included, people had to be aged 18 years or more, have a confirmed diagnosis of relapsing–remitting MS, have an Ambulation Index score 19 of 2, 3 or 4 (mild to moderate walking disabilities), and have received medical clearance to participate.",100.0
668,PRECIS-2,"To determine sample size, power analysis was completed using data from a pilot study.13 Based on the most conservative of the walking performance effect sizes from that study (d = 0.75, the 2MWT), with power of 0.80, a sample size of 35 participants was required in each group to detect a difference between groups.",fulltext,"To determine sample size, power analysis was completed using data from a pilot study. 13 Based on the most conservative of the walking performance effect sizes from that study (d ¼ 0.75, the 2MWT), with power of 0.80, a sample size of 35 participants was required in each group to detect a difference between groups.",99.68253968253968
668,PRECIS-2,"Intention-to-treat analysis was applied, with all participants who commenced their program included in analysis.",fulltext,"Intention-to-treat analysis was applied, with all participants who were allocated and commenced their program included in analysis.",100.0
669,PRECIS-2,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport. Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport. Adults diagnosed with MS were included based on the ability to walk 5 km without rest or use of assistive device.",100.0
669,PRECIS-2,"Exclusion criteria were reports of cardiovascular contra-indications, logistic problem or Automated segmentation of MRI.",fulltext,Exclusion criteria were reports ,26.66666666666667
669,PRECIS-2,"Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%). In all, 25 of 41 missed training sessions were related to training-related complaints, such as repetitive strain injury of the ankle (n=2; 9 sessions), training-related fatigue (n=2; 7 sessions), hip and groin pain (n=1; 6 sessions), and calf muscle strain (n=1; 3 sessions). The remaining missed sessions were caused by external factors such as work, holiday, and flu.",fulltext,"Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%). In all, 25 of 41 missed training sessions were related to trainingrelated complaints, such as repetitive strain injury of the ankle (n = 2; 9 sessions), training-related fatigue (n = 2; 7 sessions), hip and groin pain (n = 1; 6 sessions), and calf muscle strain (n = 1; 3 sessions). The remaining missed sessions were caused by external factors such as work, holiday, and flu.",99.800796812749
669,PRECIS-2,"Aerobic capacity was assessed on an electronically braked cycle ergometer (eBike Basic®; General Electric GmbH, Bitz, Germany) with continuous pulmonary gas exchange analysis (Oxycon, Erich Jaeger GmbH, Germany), and heart rate (HR) monitoring (Polar®). Oxygen uptake (VO2), expiratory volume, and respiratory exchange ratio were collected breath-by-breath and averaged every minute.",fulltext,"Aerobic capacity was assessed on an electronically braked cycle ergometer (eBike Basic ® ; General Electric GmbH, Bitz, Germany) with continuous pulmonary gas exchange analysis (Oxycon, Erich Jaeger GmbH, Germany), and heart rate (HR) monitoring (Polar ® ). Oxygen uptake (VO 2 ), expiratory volume, and respiratory exchange ratio were collected breath-by-breath and averaged every minute.",100.0
669,PRECIS-2,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",fulltext,"Adults with MS were recruited through announcements at REVAL rehabilitation research institute (UHasselt), Flemish MS rehabilitation centers and MS Society, and Move-to-Sport.",100.0
669,PRECIS-2,Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%).,fulltext,Participants who completed the training program showed high adherence. The EXP group completed 607 of 648 prescribed sessions (94%).,100.0
669,PRECIS-2,"The running intervention was successful to increase aerobic capacity. The 6% change in VO2max exceeded biological variability, while the 13% change in workload (in W) was in between the range of 6%–25% found during supervised bicycle training in pwMS with comparable or higher disability.",fulltext,"The running intervention was successful to increase aerobic capacity. The 6% change in VO 2max exceeded biological variability, 45 while the 13% change in workload (in W) was in between the range of 6%– 25% found during supervised bicycle training in pwMS with comparable or higher disability.",100.0
670,PRECIS-2,"The MSSE survey was originally developed and validated by Schwartz et al. (1996), based on the work of Lorig et al. (1989), who created a similar tool for use with people suffering from arthritis.",fulltext,"The MSSE survey was originally developed and validated by Schwartz et al. (1996), based on the work of Lorig et al. (1989), who created a similar tool for use with people suffering from arthritis.",100.0
670,PRECIS-2,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",fulltext,"Clients attending the clinic were interviewed, and their case histories recorded. The research project was explained, and written informed consent was obtained.",100.0
670,PRECIS-2,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",fulltext,"The data were analyzed on an intention to treat basis, with a focus on the differences between mean MSSE values of the control and intervention groups.",100.0
670,PRECIS-2,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",fulltext,"Clients were provided with information about the clinic by the local chapter of the Multiple Sclerosis Society, and self selected on that basis.",100.0
670,PRECIS-2,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",fulltext,"Participants were clients seen in the multiple sclerosis clinics at Sutherland-Chan School, in which the study was conducted.",100.0
670,PRECIS-2,"The decision as to the length of the treatment series was pragmatic and related to the length of the students' specialty clinic rotations, which are scheduled over an eight week period.",fulltext,"The decision as to the length of the treatment series was pragmatic and related to the length of the students' specialty clinic rotations, which are scheduled over an eight week period.",100.0
670,PRECIS-2,"The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey. For both treatment and control groups, self-efficacy scores were obtained before the first treatment, mid-treatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",fulltext,"The outcome measures for the current research were the scores yielded by the Multiple Sclerosis Self Efficacy (MSSE) survey. For both treatment and control groups, self-efficacy scores were obtained before the first treatment, midtreatment series, after the last treatment in the series, four weeks after the final treatment and again eight weeks after the final treatment had been received.",99.74489795918367
671,PRECIS-2,"Assessments were done independently and away from the participant's home. At each assessment timepoint, research therapists were asked whether they were unmasked to group allocation; 114 (89%) of 128 answers at week 20 and 110 (87%) of 126 at week 36 were ",fulltext,"assessments were done independently and away from the participant’s home. At each assessment timepoint, research therapists were asked whether they were un masked to group allocation; 114 (89%) of 128 answers at week 20 and 110 (87%) of 126 at week 36 were ",100.0
671,PRECIS-2,"This allowed for a graduated introduction to standing. At the end of the 20-week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",fulltext,"This allowed for a graduated introduction to standing. At the end of the 20 week period, participants were encouraged to continue to regularly stand, although no further physiotherapy support was provided.",100.0
671,PRECIS-2,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",fulltext,"Participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",100.0
671,PRECIS-2,Individuals were invited consecutively until the allocated number of standing frames (dependent on availability according to usual practice) had been reached.,fulltext,Individuals were invited consecutively until the allocated number of standing frames (dependent on commissioning costs) at each health care organisation had been reached.,84.81012658227847
671,PRECIS-2,Full inclusion and exclusion criteria are reported in the protocol paper.,fulltext,Full inclusion and exclusion criteria are reported in the protocol paper.,100.0
671,PRECIS-2,"The primary clinical outcome was motor function as measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population (excluding only patients who were deemed ineligible after randomisation, those who did not provide baseline and week 36 measurements).",fulltext,"The primary clinical outcome was motor function measured by the Amended Motor Club Assessment (AMCA) score at week 36, analysed in the modified intention-to-treat population (excluding only patients who were deemed ineligible after randomisation, those who withdrew from the trial and were unwilling for their previously collected data to be used, or those who did not provide baseline and week 36 measurements).",99.03536977491962
671,PRECIS-2,"The primary outcome was clinician-rated and measured by a masked assessor, which was further enhanced by the masked, self-managed intervention that could be routinely implemented in clinical practice.",fulltext,"e-based, self-managed intervention that could be routinely implemented in clinical practice ",46.0
671,PRECIS-2,"The usual care group was not offered an intervention and hence, we could not exclude that placebo effects might have contributed to the benefits experienced by the standing frame group.",fulltext,"The usual care group was not offered an intervention and hence, we could not exclude that placebo effects might have contributed to the benefits experienced by the standing frame group.",100.0
671,PRECIS-2,A 9-point AMCA score change was considered a minimal clinically important difference and was used throughout the 36 weeks and analysed in the modified intention-to-treat population.,fulltext,A 9-point AMCA score change was considered clinically meaningful a priori. Adverse events were collected through a daily preformatted patient diary throughout the 36 weeks and analysed in the modified intention-to-treat population.,87.84530386740332
671,PRECIS-2,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",fulltext,"Participants were recruited through eight health-care organisations, including the UK National Health Service (NHS) Trusts, social enterprises, and third sector multiple sclerosis therapy centres, in two regions (Devon–Cornwall and East Anglia) of the UK.",100.0
671,PRECIS-2,"Participants were asked to stand for 30 min, three times per week over 20 weeks, and to document their standing time in a diary.",fulltext,"participants were asked to stand in the frame for 30 min three times per week over 20 weeks, and to record the frequency and duration of each stand in a daily diary.",88.28125
673,PRECIS-2,"The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights. The exercises were to sit to stand/squat, bridging, resisted shoulder flexion, walking/cycling, resisted elbow flexion, lunges or resisted knee extension, hip extension and calf raises; working to an intensity whereby the aim was to be failing on the 12th repetition of the exercise, with the load increased by 2–5%, when 12 repetitions were achieved with ease.",fulltext,"The PT-led exercise provided was pre-defined. It consisted of a circuit-style class of exercises that were either resisted by body weight or by the addition of free weights. The exercises were to sit to stand/squat, bridging, resisted shoulder flexion, walking/cycling, resisted elbow flexion, lunges or resisted knee extension, hip extension and calf raises; working to an intensity whereby the aim was to be failing on the 12th repetition of the exercise, with the load increased by 2–5%, when 12 repetitions were achieved with ease.",100.0
673,PRECIS-2,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",fulltext,"Eligible participants were over 18 years of age and had a diagnosis of MS that was confirmed by a consultant physician or neurologist. Persons with MS were excluded if they had a previous relapse or began steroid therapy in the 12 weeks prior to participating in the first assessment, were pregnant, or had a comorbidity that severely impacted their ability to safely participate in exercise.",100.0
673,PRECIS-2,"The primary outcome measure was the physiological component of the Multiple Sclerosis Impact Scale-29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS. It consists of 20 questions and it is scored from 0–100, with the higher scores indicating a greater impact of MS.",fulltext,"The primary outcome measure was the physical component of the Multiple Sclerosis Impact Scale29, version 2 (MSIS-29v2), a patient-reported outcome measure that assesses the physical impact of MS. It consists of 20 questions and it is scored from 0–100, with the higher scores indicating a greater impact of MS.",98.10126582278481
673,PRECIS-2,Repeated Measures ANOVA was conducted for the MSIS-29v2 physical subscale and the MFIS.,fulltext,Repeated Measures ANOVA was conducted for the MSIS-29v2 physical subscale and the MFIS.,100.0
673,PRECIS-2,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres. Participants were randomised to a physiotherapist (PT)-led class, fitness instructor (FI)-led class, yoga instructor (YI)-led class, or the control group (CG). The CG was asked not to change their exercise habit for the 10-week period between assessments.",fulltext,"All interventions took place in groups of eight, for an hour per week, for 10 weeks. They were delivered in community centres such as local gyms, hotels and health centres. Participants were randomised to a physiotherapist (PT)-led class, fitness instructor (FI)-led class, yoga class (Y) or to the control group (CG). The CG was asked not to change their exercise habit for the 10-week period between assessments.",95.32710280373831
673,PRECIS-2,"The yoga intervention was also not predefined, and detailed descriptions of the classes were gathered by nine of the instructors. Seven out of the nine instructors who returned details on the intervention commenced the class with breathing exercises, relaxation or 'body centering.'",fulltext,"The yoga intervention was also not predefined, and detailed descriptions of the classes were gathered by nine of the instructors. Seven out of the nine instructors who returned details on the intervention commenced the class 784 Multiple Sclerosis Journal 19(6) with breathing exercises, relaxation or ‘body centering.’",100.0
673,PRECIS-2,"They were delivered in community centres such as local gyms, hotels and health centres.",fulltext,"They were delivered in community centres such as local gyms, hotels and health centres.",100.0
673,PRECIS-2,"Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the participants to arrange a time and location for the first assessment.",fulltext,"Once consent for eight people of a strand in a specific geographical area was obtained, the regional office of MSI contacted the national coordinator (AL) who allocated that block of participants to ",80.3030303030303
673,PRECIS-2,"All statistical analyses were conducted using Predictive Analytics Software (PASW) Statistics 17. The distribution of the data was analysed using histograms, Quantile-Quantile plots and the Kolmogorov-Smirnov statistic. Depending on the nature and distribution of the data at baseline, a One-Way ANOVA (normally distributed data), Kruskal Wallis (skewed data), Chi-square for independence or Fisher's exact test (categorical data) was chosen and used to compare the groups at baseline.",fulltext,"All statistical analyses were conducted using Predictive Analytics Software (PASW) Statistics 17. The distribution of the data was analysed using histograms, QuantileQuantile plots and the Kolmogorov-Smirnov statistic. Depending on the nature and distribution of the data at baseline, a One-Way ANOVA (normally distributed data), Kruskal Wallis (skewed data), Chi-square for independence or Fisher’s exact test (categorical data) was chosen and used to compare the groups at baseline.",99.79381443298969
673,PRECIS-2,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical. As all groups were not treated similarly between weeks 12 and 24, and due to the high attrition rates at weeks 12 and 24, the results of our follow-up phase will be presented in a separate paper.",fulltext,"Outcome was assessed at week 24 for the intervention groups only, as it was felt that withholding a potentially beneficial treatment for longer than 12 weeks, from the controls, could be considered unethical. As all groups were not treated similarly between weeks 12 and 24, and due to the high attrition rates at weeks 12 and 24, the results of our follow-up phase will be presented in a separate paper.",100.0
674,PRECIS-2,"Kaplan-Meier estimates of risk for 6-month CDI with stratification by baseline Expanded Disability Status Scale (EDSS). Only patients with baseline EDSS ≥2.0 were included in the analysis of CDI; 154 (alemtuzumab, n = 105; subcutaneous interferon-β-1a [SC IFN-β-1a], n = 49) patients were excluded from the analysis for not meeting this criterion.",fulltext," Kaplan-Meier estimates of risk for 6-month CDI with stratification by baseline Expanded Disability Status Scale (EDSS). Only patients with baseline EDSS $2.0 were included in the analyses of CDI; 154 (alemtuzumab, n 5 105; subcutaneous interferon-b-1a [SC IFN-b-1a], n 5 49) patients were excluded from the analysis for not meeting this criterion",98.27089337175792
674,PRECIS-2,"Raters administered the MSFC18 3 times before baseline to attenuate practice effects, then every 6 months. MSFC is a multidimensional instrument comprising quantitative tests of neurologic performance in 3 critical domains: upper limb coordination and dexterity (9-Hole Peg Test [9-HPT], raw score measured in seconds); ambulation (25-Foot Timed Walking test, raw score measured in seconds); and cognition (Paced Auditory Serial Addition Test [PASAT]–3, raw score measured as number of correct responses).",fulltext," Raters administered the MSFC 16 3 times before baseline to attenuate practice effects, then every 6 months. MSFC is a multidimensional instrument comprising quantitative tests of neurologic performance in 3 critical domains: upper limb coordination and dexterity (9-Hole Peg Test [9-HPT], raw score measured in seconds); ambulation (25-Foot Timed Walking test, raw score measured in seconds); and cognitive function (Paced Auditory Serial Addition Test [PASAT]–3, raw score measured as number of correct responses)",99.60396039603961
674,PRECIS-2,"Alemtuzumab patients demonstrated 6-month confirmed disability improvement. The likelihood of achieving 6-month CDI was greater for alemtuzumab than SC IFN-β-1a (OR [95% confidence interval] 1.80 [1.06, 3.08]; p = 0.0300).",fulltext,alemtuzumab patients demonstrated 6-month confirmed disability improvement. The likelihood of improved vs stable/worsening MSFC scores was greater with alemtuzumab than SC IFN-,63.96396396396396
674,PRECIS-2,"In the phase 2 trial of alemtuzumab for RRMS (CAMMS223; NCT00050778) and the phase 3 Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis II (CARE-MS II; NCT00548405) trial, CDI was more likely in alemtuzumab-treated patients than those receiving subcutaneous interferon-β-1a (SC IFN-β-1a).",fulltext," In the phase 2 trial of alemtuzumab for RRMS (CAMMS223; NCT00050778) and the phase 3 Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis II (CARE-MS II; NCT00548405) trial, CDI was more likely in alemtuzumab-treated patients than those receiving subcutaneous interferon-b-1a (SC IFN",97.36842105263158
674,PRECIS-2,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year, randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial of alemtuzumab 12 mg with subcutaneous interferon-β-1a (SC IFN-β-1a) 44 μg in patients with RRMS.",fulltext,"Comparison of Alemtuzumab and Rebif Efficacy in Multiple Sclerosis (CARE-MS) II, a 2-year randomized, rater-blinded, active-controlled, head-to-head, phase 3 trial, compared efficacy and safety of alemtuzumab 12 mg with subcutaneous interferon-b-1a (SC IFN-b-1a) 44 mg in patients with RRMS.",98.47328244274809
674,PRECIS-2,"Differences in study drug administration and unique adverse event profiles precluded effective double-blinding. Blinded raters performed EDSS assessments at baseline, every 3 months, and at relapse; EDSS score changes of ≥1 point, confirmed over 3 or 6 months or longer, are accepted as clinically meaningful.",fulltext," Differences in study drug administration and unique adverse event profiles precluded effective double-blinding. Blinded raters performed EDSS assessments at baseline, every 3 months, and when relapse was suspected. EDSS score changes of $1 point, confirmed over 3 or 6 months or longer, are accepted as clinically meaningful",99.02912621359224
674,PRECIS-2,CDI is a metric reflecting durable and clinically meaningful EDSS score changes.,fulltext, CDI is a metric reflecting durable and clinically meaningful EDSS score changes,98.75
674,PRECIS-2,Alemtuzumab-treated patients were more likely than SC IFN-β-1a–treated patients to show improvement in EDSS scores (p < 0.0001) on all 7 functional systems.,fulltext,"Alemtuzumab-treated patients were more likely than SC IFN-b-1a–treated patients to show improvement in EDSS scores (p , 0.0001) on all 7 functional systems.",99.35897435897436
674,PRECIS-2,"Prespecified and post hoc disability outcomes based on Expanded Disability Status Scale (EDSS), Multiple Sclerosis Functional Composite (MSFC), and Sloan low-contrast letter acuity (SLCLA) are reported, focusing on improvement of preexisting disability in addition to slowing of disability accumulation.",fulltext,"Prespecified and post hoc disability outcomes based on Expanded Disability Status Scale (EDSS), Multiple Sclerosis Functional Composite (MSFC), and Sloan lowcontrast letter acuity (SLCLA) are reported, focusing on improvement of preexisting disability in addition to slowing of disability accumulation.",99.66996699669967
675,PRECIS-2,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",fulltext,"Primary outcomes included disease-specific and disease-aspecific HRQOL, depression, and fatigue.",100.0
675,PRECIS-2,A total of 150 patients were randomly assigned to the intervention (n = 76) or to UC (n = 74).,fulltext,A total of 150 patients were randomly assigned to the intervention (n = 76) or to UC (n = 74).,100.0
675,PRECIS-2,"Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p < 0.002); effect sizes, 0.4–0.9 posttreatment and 0.3–0.5 at follow-up.",fulltext,"Employing intention-to-treat analysis, MBI, compared with UC, improved nonphysical dimensions of primary outcomes at postintervention and follow-up (p  0.002); effect sizes, 0.4–0.9 posttreatment and 0.3–0.5 at follow-up.",100.0
675,PRECIS-2,"Assessments were made at baseline, postintervention, and 6 months follow-up.",fulltext,"Assessments were made at baseline, postintervention, and 6 months follow-up.",100.0
675,PRECIS-2,"We examined effects of a mindfulness-based intervention (MBI) compared to usual care (UC) upon HRQOL, depression, and fatigue among adults with relapsing-remitting or secondary progressive MS.",fulltext,"We examined effects of a mindfulness-based intervention (MBI) compared to usual care (UC) upon HRQOL, depression, and fatigue among adults with relapsing-remitting or secondary progressive MS.",100.0
675,PRECIS-2,MBI consisted of a structured 8-week program of mindfulness training.,fulltext,MBI consisted of a structured 8-week program of mindfulness training.,100.0
675,PRECIS-2,"MBI closely followed the program of mindfulness-based stress reduction and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10–15 participants/group; exercise did not exceed patients' level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day); emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",fulltext,"MBI closely followed the program of mindfulness-based stress reduction 23 and included 1) a personal intake interview to define realistic goals of participants and establish personal rapport; 2) 8 weekly 2.5-hour classes in mindfulness practices (10 –15 participants/group; exercises did not exceed patients’ level of functioning); 3) one Saturday, 7-hour session at week 6; 4) homework assignments (approximately 40 minutes/day), emphasized as essential to success of the program; 5) a postintervention interview to evaluate personal experiences, goal attainment, and future maintenance of acquired skills.",100.0
677,PRECIS-2,"Eighty-one patients with chronic stroke, traumatic brain injury (TBI) and multiple sclerosis (MS) were recruited; 50 out of 81 received one month of H-CAD intervention, with one training session a day lasting 30 minutes for 5 days a week.",fulltext,"eighty-one patients with chronic stroke, traumatic brain injury (tBI) and multiple sclerosis (MS) were recruited; 50 out of 81 received 1 month of H-caD intervention, with one training session a day lasting 30 minutes for 5 days a week.",98.73949579831933
677,PRECIS-2,"The tele-rehabilitation service is mainly addressed to neurological patients after traumatic brain injury (TBI), stroke or multiple sclerosis (MS).",fulltext,"the tele-rehabilitation service is mainly addressed to neurological patients affected by traumatic brain injury (tBI), stroke or multiple sclerosis (MS).",99.31972789115646
677,PRECIS-2,"The hypothesis is that the H-CAD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, TBI and MS patients when they are living at home.",fulltext,"the hypothesis is that the H-caD system is at least as effective as the usual care for arm/hand function, measured with outcome measures for arm/hand function, given to the stroke, tBI and MS patients when they are living at home.",100.0
677,PRECIS-2,"Outcome measures The outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel index (BI) and the Abilhand questionnaire.",fulltext,"Outcome measures The outcome measures used in the present study are in line with the international classification of functioning, disability, and health (ICF) model. The outcome measures on functioning level were: the Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT), the Barthel index (BI) and the Abilhand questionnaire.",100.0
677,PRECIS-2,"The H-CAD system is at least as effective as usual care for the arm/hand function in stroke, TBI and MS patients? The frequency and duration of the therapies from the usual care group were described. The frequency and duration of the H-CAD system of the intervention group was also described. It was, in fact, necessary to get insight in the intensity of both therapies to compare them and to enable good interpretation of the results.",fulltext,"the H-CAD system for one month at least as good as usual care for the arm/hand function in stroke, TBI and MS patient? the frequency and duration of the therapies from the usual care group were described. the frequency and duration of the use of the H-caD system of the intervention group was also described. It was, in fact, necessary to get insight in the intensity of both therapies to compare them and to enable good interpretation of the results.",97.24137931034483
677,PRECIS-2,All measurements were performed at the centre where the patient had been treated. The included subjects received a baseline measurement (T0). The second measurement (T1) was performed after the month of usual care (for intervention as well as control group). The third measurement (T2) was performed after the month of H-CAD intervention for the intervention group and 2 months after baseline for the control group.,fulltext,all measurements were performed at the centre where the patient had been treated. the included subjects received a baseline measurement (t0). the second measurement (t1) was performed after the month of usual care (for intervention as well as control group). the third measurement (t2) was performed after the month of H-caD intervention for the intervention group and 2 months after baseline for the control group.,100.0
677,PRECIS-2,The H-CAD system in the intervention group had an average of 10 hours a month of usual care per patient of the H-CAD intervention groups.,fulltext,"the H-caD system in the intervention group were 5 times a week, 30 minutes practicing with the H-caD system. this represented an average treatment time of 10 hours a month for each patient of the H-caD intervention groups.",90.51094890510949
677,PRECIS-2,"The Medical outcomes study 36-item short form health survey (SF-36), is used to measure physical and social functioning [7, 8]. It allows assessment across 8 health domains: physical functioning (PF), role limitations due to physical problems (RP), bodily pain (BP), general health (GH), vitality (VT), social functioning (SF), role limitations due to emotional problems (RE), and mental health (MH).",fulltext,"the Medical outcomes study 36-item short form health survey (SF-36), is used to measure physical and social functioning [7, 8]. It allows assessment across 8 health domains: physical functioning (PF), role limitations due to physical problems (rP), bodily pain (BP), general health (GH), vitality (Vt), social functioning (SF), role limitations due to emotional problems (re), and mental health (MH).",100.0
677,PRECIS-2,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium).",fulltext,"Patients were recruited from Unità Organica di Riabilitazione Intensiva Neuromotoria (UORIN, Italy), Foundation Institute Guttmann (FPING, Spain) and from National Multiple Sclerosis Centre (NMSC, Belgium).",100.0
677,PRECIS-2,"For this reason, in the following of the present paper it will be named ",fulltext,"For this reason, in the following of the present paper it will be named ",100.0
677,PRECIS-2,"The actual intervention with the H-CAD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",fulltext,"the actual intervention with the H-caD system at home consisted of one month, whereby the patients had an average of one training session a day lasting 30 minutes for at least 5 days a week.",100.0
677,PRECIS-2,"The ARA test showed that for all exercises but, as in the H-CAD system, the arm/hand function remained at the same level.",fulltext," exercises but, as in the usual care group, the arm/hand function remained at the same level.",66.94214876033058
677,PRECIS-2, system. The instrumented desk allows the execution and monitoring of a configurable set of home exercises the professionals may purposely design to improve the main arm functions.,fulltext, system. the instrumented desk allows the execution and monitoring of a configurable set of home exercises the professionals may purposely design to improve the main arm functions.,100.0
678,PRECIS-2,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT. We tested the differences between the two arms (expressed as differences between follow-up and baseline interviews) using one-way analysis of variance (ANOVA), checking statistical assumptions and adjusting for baseline scores. Our primary point of analysis was at 12 weeks (before the control group received the PCT).",fulltext,"We planned an intention-to-treat analysis, irrespective of whether patients were assessed as having palliative care needs or the nature of contact with the PCT. We tested the differences between the two arms (expressed as differences between follow-up and baseline interviews) using one-way analysis of variance (ANOVA), checking statistical assumptions and adjusting for baseline scores. Our primary point of analysis was at 12 weeks (before the control group received the PCT).",100.0
678,PRECIS-2,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1). Inclusion criteria were patients in South East London, living with MS and deemed by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",fulltext,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1). Inclusion criteria were patients in South East London, living with MS and deemed (by clinicians) to have one or more of unresolved symptoms, psychosocial concerns, end-of-life issues, progressive illness, or complex needs (i.e., palliative care needs).",100.0
678,PRECIS-2,"Much of the work was in patients' homes, with some specialist contact in hospital being reported. Interestingly, contrary to initial concerns, input from MS nurses was not lower in the fast-track group—in fact there was a nonsignificant trend for it to be higher.",fulltext,"Much of the work was in patients’ homes, with some specialist contact in hospital being reported. Interestingly, contrary to initial concerns, input from MS nurses was not lower in the fast-track groupdin fact there was a nonsignificant trend for it to be higher.",99.61977186311786
678,PRECIS-2,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS-8), comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0–4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers' burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",fulltext,"Our standardized questionnaires included the Palliative Care Outcome Scale (POS8), 24,25 comprising eight questions on anxiety, patient and carer concerns, and practical needs, each rated 0e4; a single-item POS pain score (rated 0 [best] to 4 [worst]); and caregivers’ burden (using the 12-item version of the Zarit Carer Burden Inventory [ZBI]).",99.41348973607037
678,PRECIS-2,"We conducted face-to-face interviews with patients and caregivers. At baseline, we collected demographic and clinical data, and the patient's functional status (using the Expanded Disability Status Scale [EDSS]) and interviewer-assessed using the Expanded Disability Status Scale [EDSS], administered by a consultant neurologist (E. S.)). We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control group—after they received PCT), and 24 weeks.",fulltext,"We conducted face-to-face interviews with patients and gave self-complete questionnaires to caregivers. At baseline, we collected demographic and clinical data, and the patient’s functional status (both self-report, using the United Kingdom Neurological Disability Scale [UNDS] 22 and interviewer-assessed using the Expanded Disability Status Scale [EDSS], 23 administered by a consultant neurologist [E. S.]). We collected outcome and cost data at baseline (before randomization) and at 6, 12, 18 (only control groupdafter they received PCT), and 24 weeks.",97.11340206185567
678,PRECIS-2,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1)",fulltext,"Subjects were 69 people with MS, 52 of whom took part in the trial (Fig. 1)",100.0
678,PRECIS-2,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,fulltext,Patients in South East London who were severely affected by MS were referred by clinicians to the trial.,100.0
678,PRECIS-2," Patients were randomized to receive either the PCT immediately (fast track) or usual best practice alone (control) for 12 weeks, after which they were offered the service.",fulltext," Patients were randomized to receive either the PCT immediately (fast track) or usual best practice alone (control) for 12 weeks, after which they were offered the service.",100.0
678,PRECIS-2,"Patients in South East London who were severely affected by MS were referred by clinicians to the trial. After baseline interview, patients were randomly allocated to either a multiprofessional palliative care team (PCT) immediately (fast track) or the control care group who continued best usual care for three months and then were offered the PCT.",fulltext,"Patients in South East London who were severely affected by MS were referred by clinicians to the trial. After baseline interview, patients were randomly allocated to either a multiprofessional palliative care team (PCT) immediately (fast track) or the control care group who continued best usual care for three months and then were offered the PCT.",100.0
678,PRECIS-2,"After initial assessment, treatment was recommended.",fulltext,"After initial assessment, treatment was recommended.",100.0
679,PRECIS-2,"After having identified and formulated individual stressors and aims, participants sign in for one or more group consultations, during which they verify whether their aims are realizable by asking the members of the multidisciplinary team for aim-related medical information [9].",fulltext,"After having identified and formulated individual stressors and aims, participants sign in for one or more group consultations, during which they verify whether their aims are realizable by asking the members of the multidisciplinary team for aim-related medical information [9].",100.0
679,PRECIS-2,"CDT focuses on the exploration of those stressors that confine patients to their physical, psychological or social roles regarding their disease and limitations; reduces relevant stressors; explores and pushes personal boundaries by making optimal use of the existing potential [9].",fulltext,"CDT focuses on the exploration of those stressors that confine patients to their physical, psychological or social roles regarding their disease and limitations; reduces relevant stressors; explores and pushes personal boundaries; and creates new personal boundaries by making optimal use of the existing potential [9].",100.0
679,PRECIS-2,"The members respected and understood the participants' individual qualities and differences, and they stimulated, defied and confronted them to explore and push their boundaries [9].",fulltext,"The members respected and understood the participants’ individual qualities and differences, and they stimulated, defied and confronted them to explore and push their boundaries [9].",100.0
679,PRECIS-2,"Multiple regression analysis with age, gender, disease duration, EDSS score and education as independent variables and MSSES-C at six months as a dependent variable showed no associations. At six months, 31 of 54 (57.4%) CDT patients and 26 of 56 (46.4%) control patients had an improved control self-efficacy, whereby improvement was defined as an increase of at least 75 points compared to baseline, being ≥0.5 SD baseline (n = 155).",fulltext," Multiple regression analysis with age, gender, disease duration, EDSS score and education as independent variables and MSSES-C at six months as a dependent variable showed no associations. At six months, 31 of 54 (57.4%) CDT patients and 26 of 56 (46.4%) control patients had an improved control self-efficacy, whereby improvement was defined as an increase of at least Effect of social cognitive treatment on control self-efficacy in multiple sclerosis PLOS ONE | https://doi.org/10.1371/journal.pone.0223482 October 10, 2019 7 / 14 75 points compared to baseline, being �0.5 SD baseline (n = 155)",99.77011494252874
679,PRECIS-2,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet.",fulltext,"Eligibility criteria for patients: diagnosis RRMS since at least one year, EDSS score ≤4.0, no symptoms suggestive of a relapse, no relapse in the preceding four weeks, willing and capable of participating in the investigations, and having access to the internet.",100.0
679,PRECIS-2,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",fulltext,"Participants were recruited from all over the Netherlands by the patient organisation NMSF, Rotterdam, the Netherlands. Interested patients were contacted by a registered nurse experienced in MS (MH) by phone to check diagnosis and eligibility criteria.",100.0
679,PRECIS-2,"Assessments were at baseline and at one, three and six months. Primary endpoint was control self-efficacy (Multiple Sclerosis Self-Efficacy Scale Control [MSSES-C] (minimum 90, maximum 900) at six months.",fulltext,"assessments were at one, three and six months. Primary endpoint was control self-efficacy (Multiple Sclerosis Self-Efficacy Scale Control [MSSES-C] (minimum 90, maximum 900) at six months.",92.15686274509804
679,PRECIS-2,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS [9]. All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS. The person with MS had experience with chronic symptoms and multiple disease-modifying treatments.",fulltext,"The multidisciplinary team included a psychiatrist, psychiatric nurse, neurologist, registered nurse specialized in MS, physiotherapist, dance therapist, and a person with MS [9]. All professional team members were formally trained in their respective disciplines and all members were experienced in the field of MS. The person with MS had experience with chronic symptoms and multiple disease-modifying treatments.",100.0
679,PRECIS-2,"Tertiary endpoint. The tertiary endpoint was change in care-related strain on support partners at six months, which was assessed by the Caregiver Strain Index (CSI) [17]. The CSI includes thirteen items yielding a total score between zero and 13. A higher score indicates higher care-related strain, and scores of seven or higher are associated with caregivers' self-reports of experiencing situations that conflict with giving help [17].",fulltext,"Tertiary outcome. The tertiary endpoint was change in care-related strain on support partners at six months, which was assessed by the Caregiver Strain Index (CSI) [17]. The CSI includes thirteen items yielding a total score between zero and 13. A higher score indicates higher care-related strain, and scores of seven or higher are associated with caregivers’ selfreports of experiencing situations that conflict with giving help [17].",98.40182648401826
679,PRECIS-2,The study population was low-disability RRMS patients with or without support partner.,fulltext,The study population was low-disability RRMS patients with or without support partner.,100.0
679,PRECIS-2,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months [12]. The MSSES is a specific and sensitive self-report questionnaire consisting of two 9-items subscales for control and functional self-efficacy, with a high internal consistency and test-retest reliability [12].",fulltext,"The primary study outcome was the change in control self-efficacy, assessed by the Multiple Sclerosis Self-Efficacy Scale (MSSES), at six months [12]. The MSSES is a specific and sensitive self-report questionnaire consisting of two 9-items subscales for control and functional self-efficacy, with a high internal consistency and test-retest reliability [12].",100.0
679,PRECIS-2,"We did a single-centre, randomized (1:1), unmasked, parallel-group, controlled trial in the Netherlands.",fulltext,"We did a single-centre, randomized (1:1), unmasked, parallel-group, controlled trial in the Netherlands.",100.0
680,PRECIS-2,The primary outcome was level of depressive symptoms at post and 20 week follow up which was measured with the Beck Depression Inventory-II (BDI-II) [26].,fulltext,The primary outcome was level of depressive symptoms at post and 3 month follow up which was measured with the Beck Depression Inventory-II (BDI-II) [26].,96.1038961038961
680,PRECIS-2,"Follow up assessments ended April, 2015. The trial was stopped after achieving a total number of 30 participants (15 in each group).",fulltext,"Follow up assessments ended April, 2015. The trial was stopped after achieving a total number of 30 participants (15 in each group).",100.0
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia.",100.0
680,PRECIS-2,"The aim of the 8-week tailored intervention is to significantly decrease level of depressive symptoms (primary outcome), anxiety, fatigue and pain impact and to contribute to improvements in levels of quality of life, sleep difficulties, MS illness acceptance, active coping skills, social support and resilience (secondary outcomes) in those newly diagnosed with MS.",fulltext,"The aim of the 8-week tailored intervention is to significantly decrease level of depressive symptoms (primary outcome), anxiety, fatigue and pain impact and to contribute to improvements in levels of quality of life, sleep difficulties, MS illness acceptance, active coping skills, social support and resilience (secondary outcomes) in those newly diagnosed with MS.",100.0
680,PRECIS-2,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.",fulltext,"The CBT intervention consisted of 8 individual modules which focused on CBT based principles and strategies. These strategies included progressive muscle relaxation, controlled breathing exercises, pleasant activity scheduling, problem solving skills, cognitive exercises which helped individuals identify, challenge and manage unhelpful thoughts and beliefs.",100.0
680,PRECIS-2,"Demographic and medical data: Demographic data (age, gender, level of education, employment status, marital status, ethnic background); MS data (MS type, months since first MS symptoms, current disease modifying medication); mental health data (anti-depressant medication use, previous diagnosis of depression and anxiety disorder); and level of ambulation was measured using the ambulation questions from the self-report Expanded Disability Status Scale (EDSS) [29] were collected from each participant at baseline.",fulltext,"Demographic and medical data Demographic data (age, gender, level of education, employment status, marital status, ethnic background); MS data (MS type, months since first MS symptoms, current disease modifying medication); mental health data (antidepressant medication use, previous diagnosis of depression and anxiety disorder); and level of ambulation was measured using the ambulation questions from the selfreport Expanded Disability Status Scale (EDSS) [29] were collected from each participant at baseline.",99.4186046511628
680,PRECIS-2,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",fulltext,"The study took place at a large teaching and research hospital in Melbourne, Australia. Participants were recruited through neurologists working in a large MS outpatient clinic at the hospital, advertisements on MS related websites and local press releases.",100.0
680,PRECIS-2,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,fulltext,Inclusion criteria were: 1) having a definite diagnosis of MS from a neurologist; 2) being within 5 years of receiving a diagnosis of MS; 3) scoring at least 10 on the Beck Depression Inventory-II (BDI-II) [26]; 4) not currently undertaking other psychological treatment for depressive or anxiety symptoms for the length of participation in the current trial; 5) speak English fluently; 6) no current or lifetime diagnosis of psychosis; 7) no current substance dependency; 8) no gross cognitive impairment; and 9) no changes to medications prior and during involvement in the trial.,100.0
680,PRECIS-2,Treatment as usual (TAU): Participants in the TAU group did not obtain any psychological treatment for depressive symptoms or anxiety for the entire length of their involvement in the trial (20 weeks) and received usual medical care from their neurologist which may include 1–3 visits for medication review during the course of involvement in the current trial.,fulltext,Treatment as usual (TAU) Participants in the TAU group did not obtain any psychological treatment for depressive symptoms or anxiety for the entire length of their involvement in the trial (20 weeks) and received usual medical care from their neurologist which may include 1–3 visits for medication review during the course of involvement in the current trial.,99.7229916897507
680,PRECIS-2,"One female senior clinical psychologist and one male provisional clinical psychologist undertook assessments. During this baseline interview, the goals and procedures were explained in detail and written consent was obtained from all participants.",fulltext,"One female senior clinical psychologist and one male provisional clinical psychologist undertook assessments. During this baseline interview, the goals and procedures were explained in detail and written consent was obtained from all participants.",100.0
681,PRECIS-2,"Outcome measures were carried out within the local hospital's rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",fulltext,"Outcome measures were carried out within the local hospital's rehabilitation unit. They were taken at baseline, after 8 and 12 weeks of the intervention period (i.e. either the exercise class or usual care).",100.0
681,PRECIS-2,"For the primary outcome measure, the Timed 25-Foot Walk Test, the ANOVA results demonstrated no statistically significant difference over time (Table 2). Although there was no statistically significant improvement in the Timed 25-Foot Walk Test, the mean scores improved by 7.2 seconds (24%) in the intervention group compared with the 3 seconds (19%) in the control group.",fulltext,"For the primary outcome measure, the Timed 25-Foot Walk Test, the ANOVA results demonstrated no statistically significant difference over time (Table 2). Although there was no statistically significant improvement in the Timed 25-Foot Walk Test the mean scores improved by 7.2 seconds (24%) in the intervention group compared with the 3 seconds (19%) in the control group.",99.73190348525469
681,PRECIS-2,Two community leisure centres.,fulltext,Two community leisure centres.,100.0
681,PRECIS-2,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises.",fulltext,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises.",100.0
681,PRECIS-2,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises. The control group received usual care.",fulltext,"The intervention group received 12 weeks of twice weekly, 60-minute group exercise sessions, including mobility, balance and resistance exercises. The control group received usual care.",100.0
681,PRECIS-2,The Timed 25-Foot Walk Test was chosen as the primary outcome measure.,fulltext,The Timed 25-Foot Walk Test 35 was chosen as the primary outcome measure.,100.0
681,PRECIS-2,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,fulltext,Of the 873 patients on the clinical register for multiple sclerosis 159 patients were deemed suitable for the study. These people were sent invitation letters and participant information sheets. Forty-three potential participants expressed an interest in participating.,100.0
681,PRECIS-2,Thirty-two participants with multiple sclerosis randomized into intervention or control groups.,fulltext,Thirty-two participants with multiple sclerosis randomized into intervention or control groups.,100.0
681,PRECIS-2,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",fulltext,"Potential participants were excluded if they had experienced exacerbation of their multiple sclerosis symptoms three months prior to the study, or had any medical condition which may preclude them from taking part in the exercise intervention.",100.0
682,PRECIS-2,"On Push Days, participants were instructed to do short bursts of moderate-high intensity exercise to their own tolerance (e.g. for 1–3 minutes) and then reduce to a more comfortable pace for 5–7 minutes and repeat as they are possible.",fulltext,"On Push Days, participants were instructed to do short bursts of moderate-high intensity exercise to their own tolerance (e.g. for 1–3 minutes) and then reduce to a more comfortable pace for 5–7 minutes and repeat as they are possible.",100.0
682,PRECIS-2,"Activity monitoring, a valid way of ascertaining intensity of physical activity for people with multiple sclerosis,22 was carried out using activPAL™, a commercially available device with excellent validity.23 To enhance inter-person reliability, each person was given the same device for repeated measurements.",fulltext,"Activity monitoring, a valid way of ascertaining intensity of physical activity for people with multiple sclerosis, 22 was carried out using activPAL™, a commercially available device with excellent validity. 23 To enhance inter-person reliability, each person was given the same device for repeated measurements.",100.0
682,PRECIS-2,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed and have a further follow-up after the second year.,fulltext,The intention was to follow participants for the first year of the intervention when the exercise programme was designed and adjusted as needed ,73.84615384615385
682,PRECIS-2,"People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites. During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility.",fulltext,"People were recruited from four multiple sclerosis clinics in three Canadian cities and from posting on media sites. During the clinic visit, the treating neurologist introduced the study to their patients and referred them to the research assistant who further explained the study and assessed eligibility.",100.0
682,PRECIS-2,The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis.,fulltext,The target population was community dwelling individuals aged 19 to 65 who have been diagnosed after 1994 with multiple sclerosis.,100.0
682,PRECIS-2,"The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months. The planned sample size was 240, 120 per group, based on 80% power, significance level of 0.05, and a hypothesized 20% response in the Guideline group and a 50% response in the MSTEP© group.9 A mixed effects model was used to analyse the results on average change in the primary outcome VO2peak.",fulltext,"The primary analysis was of the proportion of people making an absolute improvement at the final time point, 12 months. The planned sample size was 240, 120 per group, based on 80% power, significance level of 0.05, and a hypothesized 20% response in the Guideline group and a 50% response in the MSTEP© group. 9 A mixed effects model was used to analyse the results on average change in the primary outcome VO 2peak ",100.0
682,PRECIS-2,"The primary outcome was peak oxygen consumption (VO2peak) at 12 months; secondary outcomes were composite measures of physical function, fatigue, and health-related quality of life.",fulltext," Primary outcome was peak oxygen consumption (VO 2peak ) at 12 months; secondary outcomes were composite measures of physical function, fatigue, and health-related quality of life.",98.34254143646409
682,PRECIS-2,"Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS),10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",fulltext,"Specific inclusion criteria were (1) ambulatory (can walk 100 m, be capable of walking 100 metres without a walking aid corresponding to a classification of ⩽5.5 on the Expanded Disability Status Scale (EDSS), 10 even if they do use an aid for daily activities; and (2) self-reported to be sedentary or irregularly active at time of study entry (i.e. do not exercise 30 minutes or more twice per week of moderate to vigorous activity).",100.0
682,PRECIS-2,"Two different types of exercise interventions were contrasted. MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement. The goal of the MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person.",fulltext,"Two different types of exercise interventions were contrasted. MSTEP©, a personally adapted exercise regimen including a variety of exercises targeting endurance, muscular, and core strength, balance, flexibility, muscular power, and speed of movement. The goal of the MSTEP© programme is to promote regular bouts of activity most days per week, encouraging a balance between rest and activity, and taking into consideration the physical and emotional status and capacity of the person.",100.0
684,PRECIS-2,Setting: Community; subjects' homes.,fulltext,Setting: Community; subjects' homes.,100.0
684,PRECIS-2,"A total of 91 people were contacted, 41 agreed to participate and were screened. Of this group 11 were excluded; three people had poor cognition with a Mini Mental State Examination score less than 23, four had EDSS scores outside the required range, three were receiving regular physiotherapy and one person was unable to commit to the programme (see Figure 1).",fulltext,"A total of 91 people were contacted, 41 agreed to participate and were screened. Of this group 11 were excluded; three people had poor cognition with a Mini Mental State Examination score less than 23, four had EDSS scores outside the required range, three were receiving regular physiotherapy and one person was unable to commit to the programme (see Figure 1).",100.0
684,PRECIS-2,"The primary outcome measure for the study was the Multiple Sclerosis Impact Scale (MSIS29). The MSIS 29, which is a measure of the physical and psychological impact of MS, was the primary outcome measure for the study.",fulltext,"the outcome measures (below) were taken at each of the three assessments. The MS impact scale (MSIS 29), which is a measure of the physical and psychological impact of MS, 12 was the primary outcome measure for the study.",81.65137614678899
684,PRECIS-2,"Subjects: Thirty people moderately to severely affected by MS (Extended Disability Status Score, EDSS, 6.5–8) were randomized to an intervention or control group.",fulltext,"Subjects: Thirty people moderately to severely affected by MS (Extended Disability Status Score, EDSS, 6.5–8) were randomized to an intervention or control group.",100.0
684,PRECIS-2,"All outcome variables were summarized and comparisons made between groups and over time. Outcome variables that could be shown to be analysed using parametric procedures (e.g. F1M), were analysed using a two-factor repeated measures ANOVA with the two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time.",fulltext,"All outcome variables were summarized and comparisons made between groups and over time. Outcome variables that could be shown to be analysed using parametric procedures (e.g. FIM), were analysed using a two-factor repeated measures ANOVA with the two factors being time (0, 8 and 16) and group (1,2), thus allowing for possible interaction effects to assess whether groups react differently over time.",99.75124378109453
684,PRECIS-2,"The intervention group received twice weekly, home-based physiotherapy for eight weeks and the control group received usual care.",fulltext,"The intervention group received twice weekly, home-based physiotherapy for eight weeks and the control group received usual care.",100.0
684,PRECIS-2,"The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16). Primary outcome measure: Multiple Sclerosis Impact Scale (MSIS29) and secondary outcome measures assessed physical impairment, MS symptoms, quality of life, mood, and disability.",fulltext,"The following outcome measures were recorded at baseline, post-intervention (Week 8) and at follow-up (Week 16). Primary outcome measure: Multiple Sclerosis Impact Scale (MSIS29) and secondary outcome measures assessed physical impairment, MS symptoms, quality of life, mood, and disability.",100.0
684,PRECIS-2,"Each session lasted up to 60 minutes, and a task-specific programme was developed including upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and tilt board) and stretching activities were used depending on the subjects previously identified goals.",fulltext,"Each session lasted up to 60 minutes, and a task-specific programme included upper and lower limb strengthening using theraband, mobile pedals, and weights. Repetition of tasks such as sit to stand, gait, balance (using gym balls and sit fits) and stretching activities were used depending on the subjects previously identified goals.",93.16239316239316
685,PRECIS-2,Assessments were conducted at baseline and again six months later.,fulltext,Assessments were conducted at baseline and again six months later.,100.0
685,PRECIS-2,The only selection criterion was that the diagnosis of MS was confirmed by the general practitioner. There were no exclusion criteria.,fulltext,The only selection criterion was that the diagnosis of MS was con rmed by the general practitioner. There were no exclusion criteria.,98.50746268656717
685,PRECIS-2,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",fulltext,"The intervention comprised discussion of self-care based on client priorities, using an information booklet about self-care.",100.0
685,PRECIS-2,Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%).,fulltext,Two hundred and seventy-eight people with MS were invited to take part in the study. One hundred and eighty-nine people consented to take part (68%).,100.0
685,PRECIS-2,"Of these, 183 began the study and 169 (92.3%) completed it.",fulltext,"Of these, 183 began the study and 169 (92.3%) completed it.",100.0
685,PRECIS-2,"An independent person not involved in the study randomized each participant using random number tables, with odd/even number allocation to intervention/control group, with random draw.",fulltext,"An independent person not involved in the study randomized each participant using random number tables, with odd/even number allocation to intervention/control group, with random draw.",100.0
685,PRECIS-2,"A range of physical and psychological scales was included in order to obtain a comprehensive evaluation of the intervention. Total scores on a postal version of the Barthel Index,11 a scale measuring mobility,12 the United Kingdom version of the SF-3613 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",fulltext,"A range of physical and psychological scales was included in order to obtain a comprehensive evaluation of the intervention. Total scores on a postal version of the Barthel Index, 11 a scale measuring mobility, 12 the United Kingdom version of the SF-36 13 and one measure developed for the study; the Standard Day Dependency Record (SDDR), were the main outcome measures.",100.0
685,PRECIS-2,"The discussions lasted between 1 and 2 hours and were conducted on two occasions, over a one month period.",fulltext,"The discussions lasted between 1 and 2 hours and were conducted on two occasions, over a one month period.",100.0
685,PRECIS-2,The study was conducted with people with MS living in the community.,fulltext,The study was conducted with people with MS living in the community.,100.0
685,PRECIS-2,Two hundred and seventy-eight people with MS were invited to take part in the study.,fulltext,Two hundred and seventy-eight people with MS were invited to take part in the study.,100.0
685,PRECIS-2,Participants were volunteers with MS who were recruited through voluntary organizations.,fulltext,Participants were volunteers with MS who were recruited through voluntary organizations.,100.0
685,PRECIS-2,"Changes in health status were small. However, at follow-up the intervention group had better SF-36 health scores, in mental health (p = 0.04), and vitality (p = 0.05) and considered help with daily activities to be less essential, as measured by the SDDR (p = 0.04), than the control group.",fulltext,"Changes in health status were small. However, at follow-up the intervention group had better SF-36 health scores, in mental health (p = 0.04), and vitality (p = 0.05) and considered help with daily activities to be less essential, as measured by the SDDR (p = 0.04), than the control group.",100.0
685,PRECIS-2,Topics in the booklet covered many domains of life from the physical (e.g. mobility and exercises) to the social and the psychological (e.g. strategies to cope with stress).,fulltext,Topics in the booklet covered many domains of life from the physical (e.g. mobility and exercises) to the social and the psychological (e.g. strategies to cope with stress).,100.0
686,PRECIS-2,MS patients from the outpatient clinic of the Neurology Department of Pitié-Salpêtrière Hospital were prospectively enrolled in the study between March to July 2012.,fulltext,ents MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July,93.33333333333333
686,PRECIS-2,"The primary outcome was the change in QoL from inclusion to M6, assessed by the Multiple Sclerosis Impact Scale (MSIS-29) self-questionnaire. The MSIS-29 is a validated, reproducible and specific MS QoL scale4–5 that consists of 29 simple questions including eight questions on motor, nine on sensory, cognitive function, urinary and bowel trouble, social, emotional and mobility).",fulltext,"months. The primary outcome was the change in QoL from inclusion to M6, assessed by the Multiple Sclerosis Impact Scale (MSIS-29) self-questionnaire. The MSIS-29 is a validated, reproducible and specific MS QoL scale 35 that consists of 29 simple questions including six different subdomains (fatigue, cognitive function, urinary and bowel trouble, social, emotional and mo",90.02624671916011
686,PRECIS-2,"MS patients from the outpatient clinic of the Neurology Department of Pitié-Salpêtrière Hospital were prospectively enrolled in the study between March to July 2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neuro-urology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsychologist).",fulltext,"ents MS patients from the outpatient clinic of the Neurology Department of Pitie´-Salpeˆtrie`re Hospital were prospectively enrolled in the study between March 2010 and July 2012. Inclusion criteria were: having MS (MacDonald criteria); being able to complete a questionnaire; and being in need for a multidisciplinary approach, defined by the requirement, in addition to the neurology specialist, of at least two different medical (rehabilitation specialist, neurourology specialist, psychiatrist) or allied health professionals (physiotherapist, occupational therapist, social worker, psychologist, and neuropsycholo",98.03600654664486
686,PRECIS-2,"For the sample size, calculations were based on a preliminary study,12 including 40 MS patients. In this pilot study a mean improvement of 10 points over six months on the MSIS-29 scale in the IMD group and a mean worsening of six points in the control group was observed. The standard deviation for the change in the MSIS-29 was 14 points. With the same hypotheses, 22 patients per group were necessary to provide the study a power of 90% with a type 1 error rate of 0.05. To take into account a possible dropout rate, we randomized 25 patients per group.",fulltext,"ical analyses For the sample size, calculations were based on a preliminary study 12 including 40 MS patients. In this pilot study a mean improvement of 10 points over six months on the MSIS-29 scale in the IMD group and a mean worsening of six points in the control group was observed. The standard deviation for the change in the MSIS-29 was 14 points. With the same hypotheses, 22 patients per group were necessary to provide the study a power of 90% with a type 1 error rate of 0.05. To take into account a possible dropout rate, we randomized 25 patie",97.48201438848922
686,PRECIS-2,"An integrated intervention within a multidisciplinary outpatient clinic gathering the different team members is thought to offer the best management of MS. However, whether this multidisciplinary approach is more beneficial for the patient than more usual type of care, where interventions are not integrated but proposed through successive referrals to needed medical and allied health professionals, is unknown.",fulltext,"An integrated intervention within a multidisciplinary outpatient clinic gathering the different team members is thought to offer the best management of MS. However, whether this multidisciplinary approach is more beneficial for the patient than more usual type of care, where interventions are not integrated but proposed through successive referrals to needed medical and allied health professionals, is unknown.",100.0
686,PRECIS-2,"Patients were then randomized in two groups depending on the treatment strategy: (i) an integrated multidisciplinary (IMD) group, consisting of an IMD approach at the Pitié-Salpêtrière MS clinic, and (ii) a control group, consisting of successive, non-integrated interventions with different specialists and allied health professionals, at different times and sites (Figure 1). For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inclusion.",fulltext,"atio. Patients were then randomized in two groups depending on the treatment strategy: (i) an integrated multidisciplinary (IMD) group, consisting of an IMD approach at the Pitie´-Salpeˆtrie`re MS clinic, and (ii) a control group, consisting of successive, non-integrated interventions with different specialists and allied health professionals, at different times and sites (Figure 1). For patients in the IMD group, the multidisciplinary integrated outpatient clinic was planned at our MS clinic within a maximum three-month period after inc",98.15157116451016
687,PRECIS-2,"The website, which was used to deliver the intervention, was developed in collaboration with a patient steering group and incorporating recommendations from the MS Society accessibility policy and advice from the British Accessibility Information Forum.",fulltext,"The website, which was used to deliver the intervention, was developed in collaboration with a patient steering group and incorporating recommendations from the MS Society accessibility policy and advice from the Scottish Accessible Information Forum.",97.23320158102767
687,PRECIS-2,"Ethical approval was received from the West of Scotland Research Ethics Service (ref: 12/WS/0147) and participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",fulltext,"Ethical approval was received from the West of Scotland Research Ethics Service (ref: 12/ WS/0147) and participants were recruited from the Multiple Sclerosis Service, at the Douglas Grant Rehabilitation Centre, Irvine, Scotland.",100.0
687,PRECIS-2,"Outcome measures were recorded at baseline and at the end of the intervention period (week 13). The primary outcome measure, the timed 25 foot walk, has good reliability and validity in the MS population.",fulltext,"Outcome measures were recorded at baseline and at the end of the intervention period (week 13). The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
687,PRECIS-2,"The primary outcome measure, the timed 25 foot walk, has good reliability and validity in the MS population.",fulltext,"The primary outcome measure, the timed 25 foot walk, 14 has good reliability and validity in the MS population.",100.0
687,PRECIS-2,Setting: Rehabilitation centre and participants' homes.,fulltext,Setting: Rehabilitation centre and participants' homes.,100.0
687,PRECIS-2,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,fulltext,Thirty community dwelling adults moderately affected by MS (Expanded Disability Status Scale 5-6.5).,100.0
687,PRECIS-2,Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist. Participants were contacted by the physiotherapist each week to discuss progress and update their exercise programme as appropriate by changing any combination of the level of difficulty or number of repetitions.,fulltext,"Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist. Participants were contacted by the physiotherapist each week to discuss progress and update their exercise programme as appropriate by changing any combination of exercises, level of difficulty or number of repetitions.",99.48979591836735
687,PRECIS-2,"Participants were given unique log-in details to view their own, online personalised exercise programme. This was a pragmatic study with the content of the web-based programme being similar to the content if it had been delivered face-to-face. Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.",fulltext,"Participants were given unique log-in details to view their own, online personalised exercise programme. This was a pragmatic study with the content of the web-based programme being similar to the content if it had been delivered face-to-face. Participants were advised to undertake the exercise programme a minimum of twice a week and to complete their online exercise diary which was seen remotely by the physiotherapist.",100.0
688,PRECIS-2,Patients randomised to routine hospital care were followed as usual in the multiple sclerosis referral centres. A brief monitoring phone call once a month was used to obtain information about the patient's medical visits and hospital admissions in the previous month.,fulltext,Patients randomised to routine hospital care were followed as usual in their multiple sclerosis referral centres. A brief monitoring phone call once a month was used to obtain information about the patient’s medical visits and hospital admissions in the previous month.,100.0
688,PRECIS-2,Patients underwent the same set of measurements at baseline and at 12 months.,fulltext,patients underwent the same comprehensive interview as at baseline.,63.63636363636363
688,PRECIS-2,"For the intervention group, we estimated the costs to cover the local management and administration of the home based management scheme (for the operator, coordinator, telephone, and overheads). The costs used in the analysis were calculated on the basis of 1999 Italian prices converted to euros. The one year time horizon did not require discounting in the analysis.",fulltext," For the intervention group, we estimated the costs to cover the local management and administration of the home based management scheme (for the operator, coordinator, telephone, and overheads). The costs used in the analysis were calculated on the basis of 1999 Italian prices converted to euros. The one year time horizon did not require discounting in the analysis",99.72826086956522
688,PRECIS-2,"After 5 pm and during weekends and holidays the telephone was on, and recorded messages were regularly listened to by the operator. The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",fulltext,"After 5 pm and during the weekend an answering machine was on, and recorded messages were regularly listened to by the operator. The home based care multidisciplinary team included two neurologists, a urologist, a rehabilitation physician, a psychologist, a physical therapist, a nurse, a social worker, and a coordinator.",94.76923076923077
688,PRECIS-2,Ninety-seven consecutive patients with clinically definite multiple sclerosis were studied. They were randomised in a ratio 2:1 to an intervention group (133) or a control group (68).,fulltext, patients with clinically definite multiple sclerosis were studied. They were randomised in a ratio 2:1 to an intervention group (133) or a control group (68).,86.88524590163934
688,PRECIS-2,"Rome service area. Eligible patients were assessed for suitability by the coordinator of the home based care team (LP). Written informed consent was obtained for entry into the trial from the patients and, when appropriate, from their carers.",fulltext,"Rome service area. Eligible patients were assessed for suitability by the coordinator of the home based care team (LP). Written informed consent was obtained for entry into the trial from the patients and, when appropriate, from their carers.",100.0
688,PRECIS-2,"Functional outcomes were calculated as the mean change of scores from baseline to the final follow up at 12 months. No significant differences between intervention and control groups were detected for outcome measures, including EDSS, FIM, MMSE, CDQ, FSS, STAI, and STAXI.",fulltext,"Functional outcomes were calculated as the mean change of scores from baseline to the final follow up at 12 months. No significant differences between intervention and control groups were detected for outcome measures, including EDSS, FIM, MMSE, CDQ, FSS, STAI, and STAXI.",100.0
689,PRECIS-2,"Eighty-five participants met the criteria for inclusion and consented to participate in the study between September 2014 and January 2017 (Figure 1, and the baseline demographic data are detailed in Table 1. Thirty three participants dropped out over the course of the study and although there was no statistically significant difference in drop-out rates between the groups, the proportion was higher in the ankle-foot orthoses group.",fulltext,"Eighty-five participants met the criteria for inclusion and consented to participate in the study between September 2014 and January 2017 (Figure 1). Five participants withdrew between the screening and assessment visit. Seventy-nine participants completed the baseline assessment and were included in subsequent analysis. The recruitment and flow of patients through the study is shown in Figure 1, and the baseline demographic data are detailed in Table 1. Thirty three participants dropped out over Figure 1. Consort diagram. AFO, ankle-foot orthoses; FES, functional electrical stimulation. 6 Clinical Rehabilitation 00(0) the course of the study and although there was no statistically significant difference in drop-out rates between the groups, the proportion was higher in the ankle-foot orthoses group.",100.0
689,PRECIS-2,"For the primary outcome measure, walking speed as measured by the 5-minute self-selected walk test, a significant difference was observed between the groups (P = 0.005) with the functional electrical stimulation group consistently walking faster at all assessment points.",fulltext,"For the primary outcome measure, walking speed as measured by the 5-minute self-selected walk test, a significant difference was observed between the groups (P = 0.005) with the functional electrical stimulation group consistently walking faster at all assessment points.",100.0
689,PRECIS-2,Participants were recruited between September 2014 and January 2017 (Figure 1). Five participants withdrew between the screening and assessment visit. Seventy-nine participants completed the baseline assessment and were included in subsequent analysis.,fulltext,participate in the study between September 2014 and January 2017 (Figure 1). Five participants withdrew between the screening and assessment visit. Seventy-nine participants completed the baseline assessment and were included in subsequent analysis.,95.63492063492063
689,PRECIS-2,Eighty-five treatment-naïve people with Multiple Sclerosis with persistent (>three months) foot drop.,fulltext,Eighty-five treatment-naïve people with Multiple Sclerosis with persistent (>three months) foot drop.,100.0
689,PRECIS-2,"Participants randomized to receive a custom-made, AFO (n = 43) or FES device (n = 42).",fulltext,"Participants randomized to receive a custom-made, AFO (n = 43) or FES device (n = 42).",100.0
689,PRECIS-2,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,fulltext,Participants in both groups were instructed to gradually increase the wear of their devices over the first six weeks.,100.0
689,PRECIS-2,The primary aim of our study was to compare the clinical- and cost-effectiveness of ankle-foot orthoses and functional electrical stimulation over 12 months in people with Multiple Sclerosis presenting with foot drop.,fulltext,The primary aim of our study was to compare the clinical- and cost-effectiveness of ankle-foot orthoses and functional electrical stimulation over 12 months in people with Multiple Sclerosis presenting with foot drop.,100.0
689,PRECIS-2,"Potential participants were recruited from seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",fulltext,"Potential participants known to Multiple Sclerosis healthcare practitioners working across seven outpatient centres in Scotland – Ayrshire & Arran, Greater Glasgow & Clyde, Dumfries and Galloway, Lanarkshire, Lothian, Fife and Tayside – were informed of the study and issued with a participant information sheet.",97.72727272727273
690,PRECIS-2,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician or emergency medical services.",fulltext,"After a comprehensive assessment of the dyad needs based on direct observation and on visit 1 information (available via the eCRF), the HPA team defined the contents of the intervention, involving the dyad and the patient caring physician (the intervention was not intended to replace existing services)",96.28252788104089
690,PRECIS-2,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POS-S-MS).",fulltext,"The pre-specified primary endpoints were changes in patient quality of life (SEIQoL-DW) and symptom burden (PC Outcome Scale-Symptoms-MS, POSS-MS).",99.32432432432432
690,PRECIS-2,Adults with severe MS-carer dyads were assigned (2:1 ratio) to either HPA or usual care (UC).,fulltext,Adults with severe MS-carer dyads were assigned (2:1 ratio) to either HPA or usual care (UC).,100.0
690,PRECIS-2,0 dyads were lost to follow-up: 4 dyads discontinued intervention - 3 patients died (one after 12-week visit) - 1 withdrew consent (before 12-week visit). 1 dyad did not perform visit 3,fulltext,"ee dyads discontinued the intervention, one in the HPA group and two in the UC group (Figure 1); one HPA dyad completed the intervention but did not perform visit",51.35135135135135
690,PRECIS-2,50 dyads were analyzed. 2 dyads were excluded from analysis - 2 did not receive allocated intervention,fulltext, Dyads were randomly assigned (2:1) to receive HPA or UC. Allocat,42.15686274509803
690,PRECIS-2,"Based on the principles of PC,17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker. Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course.",fulltext,"Based on the principles of PC, 17 each center had a HPA team consisting of a physician (neurologist or physiatrist), a nurse (case manager and team leader), a psychologist, and a social worker. Nurses of the Milan and Rome centers had degrees and worked full time in PC; the Catania nurse attended a week-long individual training course.",100.0
690,PRECIS-2,"Expanded Disability Status Scale (EDSS) score ⩾ 8.0,14 complex symptoms,15 and ⩾2 unmet care needs.16",fulltext,"Expanded Disability Status Scale (EDSS) score ⩾ 8.0, 14 complex symptoms, 15 and ⩾2 unmet care needs. 1",99.00990099009901
690,PRECIS-2,"3 centers: 1 HPA team for each center. Number of dyads treated: 16 (Milan), 15 (Rome), 19 (Catania)",fulltext,"ss centers (Table 2) except for the number of visits performed by two or more HPs (Milan 4%, Rome 14%, Catani",63.63636363636363
691,PRECIS-2,Collecting detailed information at an individual level on the type and quantity of advice received as part of current local practice was not deemed feasible.,fulltext,Collecting detailed information at an individual level on the type and quantity of advice received as part of current local practice was not deemed feasible.,100.0
691,PRECIS-2,A total of 164 people were randomised (time from primary care) (figure 1). First follow-up data are available for 146 (89%) and second follow-up for 144 (88%).,fulltext, A total of 164 people were randomised (nine from primary care) (figure 1). First follow-up data are available for 146 (89%) and second follow-up for 144 (88%),98.11320754716981
691,PRECIS-2,Individuals who had attended a fatigue management programme in the past 3 months (see protocol col).,fulltext,Individuals who had attended a fatigue management programme in the past ,72.0
691,PRECIS-2,"The aim of the intervention is to help people normalise their fatigue experiences, learn helpful ways of thinking about fatigue and use their energy more effectively. The intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists).",fulltext,"The aim of the intervention is to help people normalise their fatigue experiences, learn helpful ways of thinking about fatigue and use available energy more effectively. The intervention consists of six sessions (∼90 min duration) held weekly and facilitated in groups of 6–12 by two health professionals with experience of working with people with MS and group-work (such as occupational therapists, nurses or physiotherapists).",99.06103286384976
691,PRECIS-2,Participants randomised to the CLP arm of the trial received current local practice advice and information provision about MS-fatigue to more detailed individualised management advice from a variety of health professionals.,fulltext,Participants randomised to the CLP arm of the trial received current local practice only. This could have ranged from general advice and information provision about MS-fatigue to more detailed individualised management advice from a variety of health professionals.,100.0
691,PRECIS-2,There were statistically significantly greater improvements in fatigue self-efficacy in the FACETS arm compared with the CLP arm.,fulltext, There were statistically significantly greater improvements in fatigue self-efficacy in the FACETS arm at follow-up 1 and 2 compared with the CLP arm,99.2248062015504
691,PRECIS-2,These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)).,fulltext,These were: (1) fatigue severity (Global Fatigue Severity (GFS) subscale of the Fatigue Assessment Instrument (FAI)).,100.0
691,PRECIS-2,Three-centre parallel arm randomised controlled trial with economic evaluation.,fulltext,Three-centre parallel arm randomised controlled trial with economic evaluation.,100.0
691,PRECIS-2,"First follow-up data are available for 146 (89%) and second follow-up for 144 (88%). Recruitment was 39 from the South West, 75 from the Poole centre and 50 from the Poole centre. In all, 84 participants were randomised to FACETS and 80 to CLP.",fulltext," First follow-up data are available for 146 (89%) and second follow-up for 144 (88%). Recruitment was 39 from the Bristol centre, 75 from the Southampton/Portsmouth Centre and 50 from the Poole centre. In all, 84 participants were randomised to FACETS and 80 to CLP",96.72131147540983
691,PRECIS-2,"Recruitment was 39 from the South West, 75 from the Poole centre and 50 from the Poole centre.",fulltext," Recruitment was 39 from the Bristol centre, 75 from the Southampton/Portsmouth Centre and 50 from the Poole centre",91.48936170212765
692,PRECIS-2,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext,"Participants were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",100.0
692,PRECIS-2,"Mobility, fatigue, and the impact of the disease on the patient's life were measured.",fulltext,"Mobility, fatigue, and the impact of the disease on the patient's life were measured.",100.0
692,PRECIS-2,"Thirty-five adults (N = 28 Females) were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",fulltext," were recruited from two hospitals in the Parisian region, in France receiving outpatient services for MS at a regional medical center.",79.41176470588236
692,PRECIS-2,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",fulltext,"Two measurement times are carried out in pre-post intervention, at baseline and after eight weeks.",100.0
692,PRECIS-2,All measurements were carried out at two phases of the study (eight weeks after randomization).,fulltext,All measurements were carried out at two phases of the study T1 (baseline) and T2 (eight weeks after randomization).,100.0
692,PRECIS-2,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors and aged between 18 and 65 (4) able to give informed consent and to understand French.",fulltext,"Inclusion criteria for the study included (1) a diagnosis of MS, (2) not currently engaged in rehabilitation, therapy or PA program and able to undertake PA without risk-factors (3) aged between 18 and 65 (4) able to give informed consent and to understand French.",98.86363636363636
692,PRECIS-2,"Participants were persevering in Physical Activity. Only, three of them dropped out the PA program before the end.",fulltext,"ic. Patients were persevering in Physical Activity. Only, three of them dropped out the PA program before the end.",95.6140350877193
692,PRECIS-2,"The aim of this study was to assess the efficacy of a PA program compared to two types of psychological interventions – Mindfulness and Implementation Intention – delivered via internet, in reducing consequences of MS. Effects of practicing were unrelated to degree of impairment (i.e., EDSS level).",fulltext,"The aim of this study was to assess the efficacy of a PA program compared to two types of psychological interventions – Mindfulness and Implementation Intention – delivered via internet, in reducing consequences of MS. Effects of practicing were unrelated to degree of impairment (i.e., EDSS level).",100.0
692,PRECIS-2,Participants were asked to describe the sensations and to evoke any situation that made the exercise easier or even harder to perform.,fulltext, were asked to describe the sensations and to evoke any event or situation that made the exercise easier or even harder to perform.,91.04477611940298
692,PRECIS-2,"The procedures for this study were approved by research ethics committees (CPP) «Ile de France XI » (ID: 2016-A00537-44), authorized from The National Agency for the Safety of Medicines and Health (ANSM) and registered under the identification number ID: NCT03785483.",fulltext,"The procedures for this study were approved by research ethics committees (CPP) «Ile de France XI » (ID: 2016-A00537-44), authorized from The National Agency for the Safety of Medicines and Health (ASNM) and registered under the identification number ID: NCT03785483.",99.625468164794
692,PRECIS-2,"The Mindfulness condition group received daily training in the form of pre-recorded sessions (6 sessions of 10 minutes each equal to 1 h/day) using TailorBuilder application, aiming at developing awareness of emotions and sensations.",fulltext," Mindfulness-Based Intervention group (MBI) (n = 12) received daily Mindfulness training in the form of prerecorded sessions (6 sessions of 10 minutes each equal to one hour/day) using TailorBuilder (TB) application, aiming at developing awareness of emotions and sensations.",96.56652360515021
693,PRECIS-2,"Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective study.",fulltext,"usion. Twenty patients with relapsing–remitting MS, primary progressive MS or secondary progressive MS, aged 26–50 years, with an EDSS not more than 6 and EDSS pyramidal functions score (EDSSpyr) more than 2 were included in the prospective",97.08333333333333
693,PRECIS-2,The same psychologist evaluated executive functions and selective attention before and after the training. For executive function the Mazes subtest of Executive module from the Neuropsychological Assessment battery (NAB) [17] and Tower of London Test (TOL) [18] were used. In the Mazes subtest we measured and evaluated the time for the completion of maze tasks with increasing difficulties.,fulltext,ctions the same psychologist evaluated executive functions and selective attention before and after the training. For executive function the Mazes subtest of Executive module from the Neuropsychological assessment battery (NAB) [17] and Tower of London Test (TOL) [18] were used. In the Mazes subtest we measured and evaluated the time for the completion of maze tasks with increasing diffic,98.20971867007673
693,PRECIS-2,"Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana. We used the following assessment tools and procedures:",fulltext,"ssment Examinations were performed by the members of Multiple Sclerosis Center at the Division of Neurology, University Medical Center Ljubljana. We used the following assessment tools and proc",96.37305699481865
693,PRECIS-2,"Data were analyzed by SPSS program for Windows®, version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ≤ 0.05.",fulltext,"alysis Data were analyzed by SPSS program for Windows ® , version 17.0. Wilcoxon signed ranks test was used to compare the difference before and after each program. Statistical significance was set at p ",96.51741293532339
693,PRECIS-2,"Objectives: Spasticity, cognitive impairment, depression and fatigue significantly reduce the quality of life in multiple sclerosis (MS) patients. To find out whether nonpharmalogical treatment approaches can reduce these symptoms we investigated effects of sports climbing (SC) and yoga on spasticity, cognitive impairment, mood change and fatigue in MS patients.",fulltext,"Objectives: Spasticity, cognitive impairment, depression and fatigue significantly reduce the quality of life in multiple sclerosis (MS) patients. To find out whether nonpharmalogical treatment approaches can reduce these symptoms we investigated effects of sports climbing (SC) and yoga on spasticity, cognitive impairment, mood change and fatigue in MS patients.",100.0
693,PRECIS-2,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,fulltext,Both programs were held once a week for 10 weeks. Participants were asked to attend at least 9 out of 10 SC or yoga sessions.,100.0
693,PRECIS-2,The study was approved by the National Medical Ethics Committee. Participants gave their written consent prior to the inclusion.,fulltext,ipants The study was approved by the National Medical Ethics Committee. Participants gave their written consent prior to the inc,94.53125
694,PRECIS-2,"MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS)9 score between 4 and 6.5 were eligible for inclusion. Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",fulltext,"MS patients older than 18 years who had a confirmed MS with spasticity of the lower limbs and an Expanded Disability Status Scale (EDSS) 9 score between 4 and 6.5 were eligible for inclusion. Patients who had received hippotherapy within the last 12 months, a body weight over 90 kg, no balance while sitting, and acute exacerbation during the 4-week period before start of the therapy were excluded.",100.0
694,PRECIS-2,"Hippotherapy as a complementary treatment can be defined as one-patient-one-horse physiotherapy treatment with and on the horse. The primary goals of hippotherapy are regulating muscle tone (reduction in spasticity) and breathing, strengthening the torso muscles, improving balance control and coordination, as well as gait. In addition, hippotherapy promotes social communication in the patients' lives and strengthens their self-esteem.",fulltext,"Hippotherapy as a complementary treatment can be defined as one-patient-one-horse physiotherapy treatment with and on the horse. The primary goals of hippotherapy are regulating muscle tone (reduction in spasticity) and breathing, strengthening the torso muscles, improving balance control and coordination, as well as gait. In addition, hippotherapy promotes social communication in the patients’ lives and strengthens their self-esteem.",100.0
694,PRECIS-2,"Analyses were based on the modified intention-to-treat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment. The primary endpoint change of BBS from baseline to 12 weeks was calculated using an analysis of covariance (ANCOVA) with the fixed effects group, center, age, gender, EDSS classification, and baseline BBS (type 2 sums of squares). Missing values were imputed through the last observation carried forward (LOCF) value.",fulltext," Analyses were based on the modified intention-totreat set (modified ITT). This set encompasses all randomized patients with valid baseline assessment. The primary endpoint change of BBS from baseline to 12 weeks was calculated using an analysis of covariance (ANCOVA) with the fixed effects group, center, age, gender, EDSS classification, and baseline BBS (type 2 sums of squares). Missing values were imputed through the last observation carried forward (LOCF) value",99.57446808510639
694,PRECIS-2,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment). Physiotherapists who assessed the endpoints in a separate room were blinded and explicitly trained not to question patients or hippotherapists. Patients were individually instructed to keep confidentiality of their allocation group.",fulltext,"Examinations and questionnaires were completed prior to the first hippotherapy session (baseline), after 6–7 weeks (interim assessment) and after 12 weeks (final assessment). Physiotherapists who assessed the endpoints in a separate room were blinded and explicitly trained not to question patients or hippotherapists. Patients were individually instructed to keep confidentiality of their allocation group.",100.0
694,PRECIS-2,"Under study conditions and within 12 weeks, BBS improved in both groups. In the intervention group, the change in BBS from baseline to week 12 was 6.00 points (95% CI: 4.2–7.8) versus 2.9 in the control group (95% CI: 1.5–4.4, derived from MMRM) (Table 2 and supplementary figure e-1). The mean difference in change from baseline between groups at 12 weeks was 3.07 points (95% CI: 1.00–5.14, p=0.004 (Table 2, MMRM)).",fulltext," Under study conditions and within 12 weeks, BBS improved in both groups. In the intervention group, the change in BBS from baseline to week 12 was 6.00 points (95% CI: 4.2–7.8) versus 2.9 in the control group (95% CI: 1.5–4.4, derived from MMRM) (Table 2 and supplementary figure e-1). The mean difference in change between groups after 12 weeks was 3.07 points (95% CI: 1.00–5.14, p = 0.004 (Table 2, MMRM))",96.41148325358851
694,PRECIS-2,A total of 70 adults with MS were recruited in five German centers and randomly allocated to the intervention group (12 weeks of hippotherapy) or the control group.,fulltext,A total of 70 adults with MS were recruited in five German centers and randomly allocated to the intervention group (12 weeks of hippotherapy) or the control group.,100.0
694,PRECIS-2,"The intervention group received hippotherapy (as defined by the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR))8 once a week for 12 weeks as an add-on therapy to their standard care, which remained unchanged. Patients in the control group continued their previous therapy. Over the study period, symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups.",fulltext,"the intervention group received hippotherapy (as defined by the regulations for hippotherapy of the Deutsches Kuratorium für Therapeutisches Reiten e.V. (DKThR)) 8 once a week for 12 weeks as an addon therapy to their standard care, which remained unchanged. Patients in the control group continued their previous therapy. Over the study period, symptomatic drug treatment, immunotherapy, and physiotherapy were kept unchanged in both groups.",99.75369458128078
695,PRECIS-2,"In the education group (EG), baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being. An occupational therapist (OT) then visited EG participants to provide education and to discuss a personalized 12-month health action plan.",fulltext,"In the education group (EG), baseline data were reviewed by an expert panel which advised on actions most likely to promote each individual's physical, social and psychological well-being. An occupational therapist (OT) then visited EG participants to provide education and information and to discuss a personalized 12-month health action plan.",100.0
695,PRECIS-2,Analyses were performed both with and without adjustment for baseline rates of events in the groups.,fulltext,Analyses were performed both with and without adjustment for baseline rates of events in the groups.,100.0
695,PRECIS-2,"Participants whose clinical features appeared incompatible with a recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",fulltext,"Participants whose clinical features appeared incompatible with the recorded diagnosis were excluded, as were those with neurological complications of primarily non-neurological conditions such as diabetes mellitus, or additional causes of severe disability.",99.609375
695,PRECIS-2,Setting: Participants' homes in the City of Nottingham.,fulltext,Setting: Participants' homes in the City of Nottingham.,100.0
695,PRECIS-2,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",fulltext,"Information on adverse events was collected by phone at two-monthly intervals between baseline and 12-month assessments, when a general enquiry was made without specific reference to falls or sores.",100.0
695,PRECIS-2,"An action plan was then proposed, and relevant phone numbers supplied. Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT",fulltext,"An action plan was then proposed, and relevant phone numbers supplied. Approximately two weeks later, EG participants received a single follow-through phone call from the research OT to confirm and reinforce the educational content of the visit, after which EG patients had no subsequent contact with the OT",100.0
695,PRECIS-2,"Fifty-seven eligible participants were withdrawn because there was insufficient evidence of an eligible diagnosis, and one because a progressive neurological condition was not the main cause of disability.",fulltext,"ere eligible and 116 (34%) consented; one was withdrawn because there was insufficient evidence of an eligible diagnosis, and one because a progressive neurological condition was not the major cause of disability.",89.26829268292683
695,PRECIS-2,Lost to follow-up: 2 Died: 3,fulltext,Lost to follow-up: Died: 3,92.85714285714286
695,PRECIS-2,The comparison group (CoG) received standardized printed information delivered to their home.,fulltext,The comparison group (CoG) received standardized printed information delivered to their home.,100.0
695,PRECIS-2,Lost to follow-up: 3 Died: 1,fulltext,Lost to follow-up: Died: 3,89.28571428571429
695,PRECIS-2,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",fulltext,"Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses: MS, PD and other causes of progressive parkinsonism, motor neurone disease, Huntington's disease and other degenerative disorders affecting the central nervous system, muscles or peripheral nerves.",100.0
695,PRECIS-2,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?' Participants were assessed at baseline and 12 months later.",fulltext,"Primary outcome measures were reports of one or more falls or skin sores. At interview, participants were asked 'In the past 12 months, have you fallen? Have you had a skin sore?' Participants were assessed at baseline and 12 months later.",100.0
695,PRECIS-2,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282 000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses:,fulltext,From July 1998 we approached the 177 GPs based within the City of Nottingham boundaries (population 282000). Participants eligible for inclusion were adults aged over 15 years with one of the following possible recorded diagnoses:,99.56709956709958
696,PRECIS-2,"Standardised MRI were performed using the same 3 T General Electric Signa Excite HD 12.0 (General Electric, Milwaukee, Wisconsin, USA) right-handed scanner using a multichannel head and neck coil at baseline, 6 and 12 months following the discontinuation of natalizumab therapy. For the TG, the MRI schedule was: baseline, 6 and 12 months after the last infusion.",fulltext,"Standardised MRI were performed using the same 3 T General Electric Signa Excite HD 12.0 (General Electric, Milwaukee, Wisconsin, USA) right-handed scanner using a multichannel head and neck coil at baseline, 6 and 12 months following the discontinuation of natalizumab therapy. For the TG, the MRI schedule was: baseline, 6 and 12 months after the last infusion.",100.0
696,PRECIS-2,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).",fulltext,"A physical examination and neurological assessment was administered at baseline, 3, 6 and 12 months postdiscontinuation (counted from the last natalizumab infusion), as well as during unscheduled visits due to relapses (within 3–5 days of any new symptom development).",100.0
696,PRECIS-2,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation group (IDG) versus a TG approach as measured by serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,fulltext,The primary objective of this study was to compare two modes of natalizumab cessation interventions: immediate discontinuation group (IDG) versus a TG approach as measured by serial MRI and number of relapses during a 12-month period in patients treated with natalizumab for at least 24 months.,100.0
696,PRECIS-2,"Seven participants in the IDG and three in the TG restarted natalizumab with an average of 11.4 months post-natalizumab discontinuation. There was a higher number of anti-JCV antibody positive patients in the IDG versus TG (p=0.035, table 1).",fulltext," 1). Seven participants in the IDG and three in the TG restarted natalizumab with an average of 11.4 months post-natalizumab discontinuation. There was a higher number of anti-JCV antibody positive patients in the IDG versus TG ( p=0.035, tabl",97.93388429752066
696,PRECIS-2,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study. Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria,1,2 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0.30 Candidates were excluded from the study if active disease was identified at baseline per clinical (presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).",fulltext,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study. Inclusion criteria consisted of: a diagnosis of relapsing MS according to McDonald criteria, 19 being on natalizumab therapy for 24 months or longer, aged between 18 and 65 years and an EDSS score of ≤7.0. 20 Candidates were excluded from the study if active disease was identified at baseline per clinical ( presence of a relapse during the previous 30 days) and/or MRI evaluation (active gadolinium (Gd)-enhancing lesions).",99.51456310679612
696,PRECIS-2,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMT: fingolimod, dimethyl fumarate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs) and tapered group (TG): patients administered two additional natalizumab infusions, one at 6 weeks and one at 8 weeks (14 weeks from study entry).",fulltext,"IDG: Patients who discontinued natalizumab therapy at once and initiated another DMT (interferon, GA therapy or an oral DMTfingolimod, dimethyl fumatate or teriflunomide) at 1–6 months following the last natalizumab infusion (1–2 months for the injectable DMTs and 3–6 months for the oral DMTs) and tapered group (TG): patients administered two additional natalizumab infusions, one at 6 weeks and one at 8 weeks (14 weeks from study entry).",99.32279909706546
696,PRECIS-2,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",fulltext,"Fifty patients with relapsing MS, followed at the Jacobs MS Center for Treatment and Research, Department of Neurology, University at Buffalo, Buffalo New York, USA, were enrolled in this study.",100.0
697,PRECIS-2,"Two baseline assessments were conducted 8 weeks apart to evaluate the stability of gait presentation, with presentation considered stable if there was no significant difference between baseline assessments.",fulltext,"Two baseline assessments were conducted 8 weeks apart to evaluate the stability of clinical presentation, with presentation considered stable if there was no significant difference between baseline assessments.",98.54368932038835
697,PRECIS-2,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,fulltext,Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia.,100.0
697,PRECIS-2,"The group program was conducted at a local community center for six participants and a physiotherapist allocated intervention (n = 26 center, n = 24 home), 47 completed post-assessment and 44 follow-up assessment.",fulltext," Community center-based and home-based exercise program. Participants: Fifty people with MS were randomized and completed allocated intervention (n = 26 center, n = 24 home), 47 completed post-assessment and 44 follow-up assessment.",74.64788732394366
697,PRECIS-2,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",fulltext,"Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",100.0
697,PRECIS-2,"Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia. Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other neurological or orthopedic condition that would affect their function.",fulltext,"Community dwelling people with MS were recruited through the Multiple Sclerosis Society of New South Wales and South Australia. Inclusion criteria were the following: diagnosis of MS made by a neurologist, able to walk 10 meters with or without an aid within 2 minutes, no relapse of their MS in the past 4 weeks, and no other ",82.36775818639799
697,PRECIS-2,"Participants in both groups were encouraged to work at a pace at which they could rest if they felt fatigue, or had a perceived exertion of greater than 7/10 on the modified Borg scale.",fulltext,"Participants were encouraged to work at a pace at which they could exercise for the full 6 minutes, but could rest if they felt fatigue, or had a perceived exertion of greater than 7/10 on the modified Borg scale.",91.89189189189189
697,PRECIS-2,"The exercise program for both groups included two, 60-minute sessions per week, held at least 2 days apart for 8 weeks. Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",fulltext,"The exercise program for both groups included two, 60-minute sessions per week, held at least 2 days apart for 8 weeks. Exercises were aimed at improving gait speed, endurance, and balance. They were individualized, specific, progressed in load, and performed at a moderate to high intensity.",100.0
697,PRECIS-2,"Participants in both groups were encouraged to maintain their usual activity levels and engagement in any other exercise throughout the trial, with any variation self-reported to the treating physiotherapist.",fulltext,"Participants in both groups were encouraged to maintain their usual activity levels and engagement in any other exercise throughout the trial, with any variation self-reported to the treating physiotherapist.",100.0
697,PRECIS-2,Fifty people with MS were randomized and completed baseline assessment; 47 completed post-assessment and 44 follow-up assessment.,fulltext,"Fifty people with MS were randomized and completed allocated intervention (n = 26 center, n = 24 home), 47 completed post-assessment and 44 follow-up assessment.",92.24806201550388
697,PRECIS-2,Data were analyzed according to the intention-to-treat principle. Differences between groups at baseline were analyzed using analysis of variance (ANOVA) for continuous data and Mann-Whitney U tests for interval data. Differences in outcome measures between the baseline and pre-assessments were compared using paired samples t-tests.,fulltext, Data were analyzed according to the intention-totreat principle. Differences between groups at baseline were analyzed using analysis of variance (ANOVA) for continuous data and Mann-Whitney U tests for interval data. Differences in outcome measures between the baseline and pre-assessments were compared using paired samples t-tests,99.40119760479041
697,PRECIS-2,The primary outcome was gait speed (10-meter walk test). Secondary outcomes were gait endurance (6-minute walk test) and balance (Berg Balance Scale).,fulltext,The primary outcome was gait speed (10-meter walk test). Secondary outcomes were gait endurance (6-minute walk test) and balance (Berg Balance Scale).,100.0
705,PRECIS-2,"The 12-week active phase of the intervention included 12 weekly, 90-min sessions delivered at local hockey club facilities by trained Hockey FIT coaches.",fulltext,"-week active phase. The Hockey FIT program was delivered over 12 weekly, 90-min sessions by Hockey FIT coaches ",53.59477124183007
705,PRECIS-2,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,fulltext,We analyzed outcome data to examine the potential effectiveness of the Hockey FIT program on the basis of an intent-to-treat approach.,100.0
705,PRECIS-2,Residuals from models were examined to assess normality and constant variance assumptions. t-tests (continuous variables) and chi-square tests (categorical variables) were used to examine between-group differences at baseline.,fulltext," t-tests (continuous variables) and Fisher exact tests (categorical variables). In addition, we conducted a sensitivity analysis for our primary outcome (i.e., differences ",44.690265486725664
705,PRECIS-2,"At baseline, 12 wk, and 12 months, all participants attended measurement sessions.",fulltext, Participants were deemed as all-completers if they attended the 12-wk measurement sessions ,60.97560975609756
705,PRECIS-2,One individual withdrew after randomization because he was displeased with the comparator group. The intervention group began Hockey FIT within 3 wk of baseline measurement.,fulltext,One individual withdrew after randomization because he was displeased with allocation to the comparator group. The intervention group began Hockey FIT within 3 wk of baseline measurement.,100.0
705,PRECIS-2,"The full study protocol has been published elsewhere (14). Briefly, we conducted a pilot, pragmatic randomized controlled trial (pRCT; parallel groups, stratified by site) in Ontario, Canada.",fulltext,"The full study protocol has been published elsewhere (14). Briefly, we conducted a pilot, pragmatic randomized controlled trial (pRCT; parallel groups, stratified by site) in Ontario, Canada.",100.0
705,PRECIS-2,"A sample size calculation for the definitive RCT was based on a 5% difference in weight between intervention and comparator at 12 months (20). Assuming an SD of 19.9%, 80% power, a 0.05 two-sided significance level, and a conservative 25% loss to follow-up estimate, 335 men in each arm (670 total) would be required.",fulltext,"A sample size calculation for the definitive RCT was based on a 5% difference in weight loss between intervention and comparator at 12 months (20). Assuming an SD of 19.9%, 80% power, a 0.05 two-sided significance level, and a conservative 25% loss to follow-up estimate, 335 men in each arm (670 total) would be required.",100.0
705,PRECIS-2,Eighty male fans of two ice hockey teams from the Ontario Hockey League (the London Knights and the Sarnia Sting) were recruited and randomized to either intervention (Hockey FIT) or comparator (wait-list control).,fulltext,Eighty male fans of two ice hockey teams from the Ontario Hockey League (40 men from each of London and Sarnia) were recruited and randomized to either intervention (Hockey FIT) or comparator (wait-list control).,90.65420560747664
705,PRECIS-2,HealtheSteps smartphone app designed to help participants maintain their PA and exercise goals in the long term.,fulltext,HealtheSteps TM smartphone app designed to help participants maintain their PA and exercise goals in the long term.,100.0
705,PRECIS-2,"By 12 months, improvements were still observed within the intervention group for these outcomes but differences between groups were not statistically significant.",fulltext,"By 12 months, improvements were still observed within the intervention group for most of these outcomes. No statistically significant differences between groups were ",80.24691358024691
705,PRECIS-2,"Secondary outcome measures included the following: 1. Objectively measured clinical characteristics: BMI (calculated from weight and height; kg·m−2), waist circumference (cm), and resting systolic and diastolic blood pressure (BP; mm Hg)",fulltext,"Secondary outcome measures included the following: 1. Objectively measured clinical characteristics: BMI (calculated from weight and height; kgIm j2 ), waist circumference (cm), and resting systolic and diastolic blood pressure (BP; mm Hg)",99.57805907172997
705,PRECIS-2,"Recruitment occurred using a variety of methods (e.g., hockey team email blasts and social media, posters, traditional media advertisements, word of mouth, direct contact at team arena). Eligible participants were male 35–65 yr old with a BMI of ≥28 kg·m−2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",fulltext,"Recruitment occurred using a variety of methods (e.g., hockey team e-mail blasts and social media accounts, study Web site (http://hockeyfansintraining.org/), posters, traditional media advertisements, word of mouth, direct contact at team arena). Eligible participants were male 35–65 yr old with a BMI of Q28 kgIm j2 and met PA safety requirements (i.e., no risk indicated by the Physical Activity Readiness Questionnaire [36] or clearance from a health care provider).",99.51100244498777
705,PRECIS-2,"Coaches were trained to deliver the intervention, including provision of dietary information, practice of behavior change techniques, and safe exercise sessions plus incremental pedometer walking.",fulltext,"meetings including provision of dietary information, practice of behavior change techniques, and safe exercise sessions plus incremental pedometer walking)",77.55102040816327
705,PRECIS-2,"A group-based lifestyle intervention, the Hockey Fans in Training (Hockey FIT) program, was developed to engage men through being a fan of Major Junior hockey in Canada.",fulltext," Hockey Fans in Training (Hockey FIT) is a novel, gendersensitized weight loss and healthy lifestyle program that engages men through being a fan of Major Junior hockey in Canada.",69.23076923076923
705,PRECIS-2,Our planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,fulltext, planned primary outcome for the definitive trial was the difference between groups in mean weight loss (kg) and percentage weight change from baseline to 12 wk.,98.17073170731707
712,PRECIS-2,The intensity of the pain was evaluated using the Visual Analogue Scale (VAS).,fulltext,The intensity of the pain was evaluated using the Visual Analogue Scale (VAS).,100.0
712,PRECIS-2,"The VAS was used and reused immediately after the treatment (VAS20) and 60 minutes after the treatment, once consent had been given by the pregnant women in labor to participate in the study.",fulltext,"The VAS was used and reused immediately after the treatment (VAS20) and 60 minutes after the treatment, once consent had been given by the pregnant women in labor to participate in the study.",100.0
712,PRECIS-2,"The averages for the pain measured using the VAS were not different for the three groups that were a part of the study (p-value=0.0929), however they were less in the acupressure groups immediately after receiving the treatment (p-value=<0.0001).",fulltext,"The averages for the pain measured using the VAS were not different for the three groups that were a part of the study (p-value=0.0929), however they were less in the acupressure groups immediately after receiving the treatment (p-value=<0.0001).",100.0
712,PRECIS-2,Analyzed (n = 52) (VAS60* and the Perception of pain after 60 mins) (n = 44),fulltext, VAS60 variables and based on the perception of pain with 60 min,56.57894736842105
712,PRECIS-2,The study was evaluated and approved by the Ethics Committee on Local Research (Opinion Case Number 182.421). All of the participants in the study agreed to take part in the tests and they signed a consent form demonstrating that they had decided to take part based on their own free will in accordance with the country's laws.,fulltext,The study was evaluated and approved by the Ethics Committee on Local Research (Opinion Case Number 182.421). All of the participants in the study agreed to take part in the tests and they signed a consent form demonstrating that they had decided to take part based on their own free will in accordance with the country's laws.,100.0
712,PRECIS-2,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",fulltext,"The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",100.0
712,PRECIS-2,"The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups: acupressure (SP6), touch group (TG)/placebo and the control group (CG).",fulltext,"The pregnant women in labor were allocated through a sequential list of random numbers in blocks of six patients generated using the program Excel® and they were distributed in three groups: acupressure (SP6), touch group (TG)/placebo and the control ",95.80152671755725
712,PRECIS-2,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes. The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",fulltext,"We selected 156 pregnant women in their ≥ 37 week/s, who had cervical dilations of ≥ 4 cm and with two or more contractions in 10 minutes. The pregnant women were randomly divided into three groups at a university hospital in the suburbs of Sao Paulo, Brazil, in order to receive either acupressure treatment, a placebo or participate as part of a control group.",100.0
712,PRECIS-2,Objective: to analyze the effects of acupressure on the sanyinjiao point for pregnant women in labor at public maternity wards.,fulltext,Objective: to analyze the effects of acupressure on the sanyinjiao point for pregnant women in labor at public maternity wards.,100.0
712,PRECIS-2,The acupressure was applied on the sanyinjiao point during the contractions for 20 minutes. Then the intensity of the pain was evaluated using the Visual Analogue Scale (VAS).,fulltext,The acupressure was applied on the sanyinjiao point during the contractions for 20 minutes. Then the intensity of the pain was evaluated using the Visual Analogue Scale (VAS).,100.0
713,PRECIS-2,"The theoretical framework, Partnership with people with COPD and their families (Ingadottir & Jonsdottir 2010, Jonsdottir & Ingadottir 2011a,b), was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages.",fulltext,"The theoretical framework, Partnership with people with COPD and their families (Ingadottir & Jonsdottir 2010, Jonsdottir & Ingadottir 2011a,b), was the basis for this intervention. It was adjusted to the particular needs of young people with COPD in its early stages.",100.0
713,PRECIS-2,The intervention was an addition to traditional health care which the control group received.,fulltext,The intervention was an addition to traditional health care which the control group received.,100.0
713,PRECIS-2,The treatment site was a clinical research centre located on a university-hospital campus. Enrolment ended when patients' registry in all possible clinical sites had been scanned. Data collection lasted from June 2009–March 2013.,fulltext,The treatment site was a clinical research centre located on a university-hospital campus. Enrolment ended when patients’ registry in all possible clinical sites had been scanned. Data collection lasted from June 2009–March 2013.,100.0
713,PRECIS-2,"At the first appointment, after signing an informed consent, the first data collection took place. Participants input information privately into an electronic database and the research staff conducted clinical measurements. Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",fulltext,"At the first appointment, after signing an informed consent, the first data collection took place. Participants input information privately into an electronic database and the research staff conducted clinical measurements. Data were collected at baseline and at month 12. Additionally, data collection was carried out in the experimental group at month 6 after the last treatment session.",100.0
713,PRECIS-2,Descriptive statistics were used to convey characteristics of patients. Differences in characteristics between experimental and control groups were tested statistically using an unpaired independent group t-test and the Chi-squared test. The group (intervention) × time interaction from a repeated measures analysis of variance was used to measure whether or not the effect of intervention was statistically significant for variables that followed an approximate normal distribution (logarithm transformation was applied to the variable one plus self-reported physical exercise (IPAQ) to achieve normality).,fulltext,Descriptive statistics were used to convey characteristics of patients. Differences in characteristics between experimental and control groups were tested statistically using an unpaired independent group t-test and the Chi-squared test. The group (intervention) 9 time interaction from a repeated analysis of variance was used to measure whether or not the effect of intervention was statistically significant for variables that followed an approximately normal distribution (logarithm transformation was applied to the variable one plus self-reported physical exercise (IPAQ) to achieve normality).,98.35255354200989
713,PRECIS-2,The intervention was provided for 6 months with a subsequent follow-up for additional 6 months. The control group received usual care.,fulltext,The intervention was provided for 6 months with a subsequent follow-up for additional 6 months. The control group received usual care.,100.0
713,PRECIS-2,Intention-to-treat analysis was not carried out.,fulltext,Intention-to-treat analysis was not carried out.,100.0
713,PRECIS-2,"The following data were collected: Demographic data, smoking status (point prevalence abstinence) measured in exhaled breathing by a carbon monoxide monitor (piCO+Smokerlyzer®) where the cut-off point for abstinence was considered ≤6 (Middleton & Morice 2000). Self-reported exacerbations were measured by the question: 'How often during the previous 6 months have you had a serious exacerbation of the lungs?' Satisfaction with participation in the research was measured at month 12 by a nine-item five-point Likert-scale question: 'To what degree do you agree or disagree with the following statements about participation in the research?' The items were: useful, important, worth the time, constructive, informative, organized, easy, entertaining and demanding.",fulltext,"The following data were collected: Demographic data, smoking status (point prevalence abstinence) measured in exhaled breathing by a carbon monoxide monitor (piCO + Smokerlyzer â ) where the cut-off point for abstinence was considered ≤6 (Middleton & Morice 2000). Self-reported exacerbations were measured by the question: ‘How often during the previous 6 months have you had a serious exacerbation of the lungs?’ Satisfaction with participation in the research was measured at month 12 by a nine-item five-point Likert-scale question: ‘To what degree do you agree or disagree with the following statements about participation in the research?’ The items were: useful, important, worth the time, constructive, informative, organized, easy, entertaining and demanding.",100.0
713,PRECIS-2,"St. George's Respiratory Questionnaire (SGRQ-C) is an HRQL instrument, specially designed for people with breathing problems (Jones 2002, 2009). The shortened version it contains 40 items with Likert-type and dichotomous questions, which are aggregated into a total score and three subscales: symptoms; activity and impact. Each of the three subscales and the total score is scaled separately in the range 0-100. Higher scores reflect less quality of life. A score change of four units is considered clinically significant (Jones 2002). The instrument is considered valid, repeatable and sensitive (Jones et al. 1992).",fulltext,"St. George’s Respiratory Questionnaire (SGRQ-C) is an HRQL instrument, specially designed for people with breathing problems (Jones 2002, 2008). In its shortened version it contains 40 items with Likert-type and dichotomous questions, which are aggregated into a total score and three subscales: symptoms; activity and impact. Each of the three subscales and the total score is scaled separately in the range 0-100. Higher scores reflect less quality of life. A score change of four units is considered clinically significant (Jones 2002). The instrument is considered valid, repeatable and sensitive (Jones et al. 1992).",99.51456310679612
713,PRECIS-2,"Patient-centred focus of SMP has been highlighted, but has not yet been incorporated into research (Jonsdottir 2013, Kaptein et al. 2014). Findings from the evaluation of SMPs show that the age of the participants is high. This fact needs consideration as symptoms of COPD start to emerge in middle age (GOLD 2014).",fulltext,"Patient-centred focus of SMP has been highlighted, but has not yet been incorporated into research (Jonsdottir 2013, Kaptein et al. 2014). Findings from the evaluation of SMPs show that the age of the participants is high. This fact needs consideration as symptoms of COPD start to emerge in middle age (GOLD 2014).",100.0
713,PRECIS-2,Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease. No criteria were set for family members accompanying the patients.,fulltext,Inclusion criteria were patients aged 45-65 with mild and moderate COPD (grade II and III) as the primary disease. No criteria were set for family members accompanying the patients.,100.0
713,PRECIS-2,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,fulltext,All potentially relevant patients (n = 291) were contacted for enrolment in the study from primary healthcare settings (n = 8) and the offices of private lung physicians (n = 6) in the Reykjavik capital area of Iceland.,100.0
714,PRECIS-2,Setting Four general practices in England.,fulltext,Setting Four general practices in England.,100.0
714,PRECIS-2,We used the χ2 test or Fisher's exact test (for small numbers) to analyse categorical data.,fulltext,We used the ˜ 2 test or Fisher’s exact text (for small numbers) to analyse categorical data.,97.8021978021978
714,PRECIS-2,"Outcome measures—Primary outcome measures were the proportion of patients reviewed in the three months of randomisation and change in asthma related quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",fulltext,"Outcome measures — Primary outcome measures were the proportion of patients reviewed within three months of randomisation and change in asthma related quality of life, as measured by the Juniper mini asthma quality of life questionnaire.",98.72340425531915
714,PRECIS-2,"Recruitment—From a total of 56 062 patients we identified 3860 adults on the practice's asthma registers, of whom 1813 had requested a bronchodilator in the previous six months.",fulltext,"Recruitment— From a total of 56 062 patients we identified 3860 adults on the practices’ asthma registers, of whom 1813 had requested a bronchodilator in the previous six months.",99.43502824858757
714,PRECIS-2,"Recruitment—From a total of 56 062 patients we identified 3860 adults on the practice's asthma registers, of whom 1813 had requested a bronchodilator in the previous six months. Of these 1200 were randomised to either telephone review or face to face consultation with the asthma nurse.",fulltext,"Recruitment— From a total of 56 062 patients we identified 3860 adults on the practices’ asthma registers, of whom 1813 had requested a bronchodilator in the previous six months. Of the 1239 patients (69%) who were due for an annual review, ",74.82517482517483
714,PRECIS-2,Nurses were given no instructions about the content of the review except that it should reflect their normal practice and take approximately 20 minutes.,fulltext,nurses were given no instructions about the content of the review except that it should reflect their normal practice and be appropriate,87.5
714,PRECIS-2,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary.,fulltext,Nurses arranged any follow up consultations (whether in the surgery or by telephone) they deemed clinically necessary.,100.0
714,PRECIS-2,"Correspondence to: H Pinnock, Department of General Practice, University of Aberdeen, Foresterhill Health Centre, Aberdeen AB25 2AY",fulltext,"Department of General Practice and Primary Care, University of Aberdeen, Foresterhill Health Centre, Aberdeen AB25 2AY",77.09923664122138
714,PRECIS-2,Data from records (n=135),fulltext,Data from records (n=135),100.0
714,PRECIS-2,Participants 278 adults who had not been reviewed in the previous 11 months.,fulltext,Participants 278 adults who had not been reviewed in the previous 11 months.,100.0
714,PRECIS-2,"Guidelines on the management of asthma emphasise the importance of regular review, and systematic recall",fulltext,"Guidelines on the management of asthma emphasise the importance of regular review, and systematic recall",100.0
715,PRECIS-2,"The rheumatologists and CNS delivering the interventions did not have any special training as they were expected to undertake their 'normal' practice, having agreed to follow the study protocol.",fulltext,"The rheumatologists and CNS delivering the interventions did not have any special training as they were expected to undertake their 'normal' practice, having agreed to follow the study protocol.",100.0
715,PRECIS-2,"The NLC interventions usually include allocated clinic time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",fulltext,"The NLC interventions usually include allocated 30-min time slots in which the CNS takes history, performs physical examination, pain control, prescribing or recommending medication and dosage changes, intra-articular or intramuscular steroid injections, provision of patient education, psychosocial support and ordering blood tests or X-rays.",98.83381924198251
715,PRECIS-2,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria); 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",fulltext,"The inclusion criteria were: a positive diagnosis of RA (1987 American College of Rheumatology (ACR) criteria), 29 age 18 years or older and the ability to complete questionnaires unaided. Exclusions were: unstabilised concomitant disease, awaiting surgery and already receiving care from the practitioners involved in the study.",100.0
715,PRECIS-2,"After gaining patient consent, demographics and disease activity scores in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",fulltext,"After gaining patient consent, demographics and disease activity score in 28 joints (DAS28), patients were randomly assigned using a remote secure telephone randomisation service provided by Leeds University Clinical Trials Research Unit.",99.581589958159
715,PRECIS-2,Details of the costs applied to units of resource use are provided in supplementary table S1 (available online only).,fulltext,Details of the costs applied to units of resource use are provided in supplementary table S1 (available online only).,100.0
715,PRECIS-2,"Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.",fulltext,"Patients were seen by their respective practitioners at baseline and at weeks 13, 26, 39 and 52.",100.0
715,PRECIS-2,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit. Other secondary outcome measures were at baseline, weeks 26 and 52: RA quality of life; health assessment questionnaire disability index; hospital anxiety and depression scale; arthritis self-efficacy scale; and Leeds satisfaction questionnaire (LSQ).",fulltext,"The primary outcome was DAS28 and secondary outcomes were pain severity (pain-VAS), fatigue (fatigue-VAS) and duration of morning stiffness measured at each study visit. Other secondary outcome measures were at baseline, weeks 26 and 52: RA quality of life; 31 health assessment questionnaire disability index; 32 hospital anxiety and depression scale; 33 arthritis self-efficacy scale; 34 and Leeds satisfaction questionnaire (LSQ).",100.0
715,PRECIS-2,"ITT analysis at all individual follow-up time points and for the primary endpoint (ie, average DAS change). Figure 2 graphically displays the difference between groups in the DAS28 change over the 12-month follow-up period. Table 2 shows the descriptive and inferential results for the DAS28.",fulltext,"P and ITT analyses at all individual follow-up time points and for the primary endpoint (ie, average DAS change). Figure 2 graphically displays the difference between groups in the DAS28 change over the 12-month follow-up period. Table 2 shows the descriptive and inferential results for the ",97.6027397260274
715,PRECIS-2,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor. Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level. The CNS have experience in running nurse-led clinics and usually have a postgraduate qualification in rheumatology nursing and/or prescribing.",fulltext,"This study required three practitioners at each centre; a CNS, a rheumatologist and a blind independent assessor. Nine CNS and 10 rheumatologists delivered the interventions. The CNS had a median experience of 10 years in their current post while the rheumatologists had a median of 9 years at consultant level. The CNS have experience in running nurse-led clinics and usually have a postgraduate qualification in rheumatology nursing and/ or prescribing.",100.0
722,PRECIS-2,"All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",fulltext,"All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone.",100.0
722,PRECIS-2,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,fulltext,Participants attended the primary healthcare centres for trial assessments at randomization and 12 month intervals thereafter.,100.0
722,PRECIS-2,lack of differences in BP and cholesterol,fulltext, differences in BP and cholesterol,82.92682926829268
722,PRECIS-2,"All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone. BP (measured with the Omron 705CP II device) and fasting blood samples (measured at local laboratories) were obtained at baseline, 12 months, 24 months and the final visit.",fulltext,"All participants were also reviewed one month post-randomization and at intervening six month intervals, but these could be conducted by telephone. BP (measured with the Omron 705CP II device) and fasting lipids (measured at local laboratories) levels were obtained at baseline, 12 months, 24 months and the final visit.",96.875
722,PRECIS-2,"Participants comprised 50.6% Indigenous Australians and 60.8% had established CVD. At baseline, use of combination treatment was 50.1%.",fulltext,"Participants comprised 50.6% Indigenous Australians and 60.8% had established CVD. At baseline, use of combination treatment was 50.1%.",100.0
722,PRECIS-2,"Analyses of change in systolic BP and total cholesterol were conducted using longitudinal linear mixed models including all values collected during follow-up. Models included treatment, visit, treatment-by-visit interaction, and the baseline systolic BP or total cholesterol.",fulltext,"Analyses of change in systolic BP and total cholesterol were conducted using longitudinal linear mixed models including all values collected during follow-up. Models included treatment, visit, treatment-by-visit interaction, and the baseline systolic BP or total cholesterol.",100.0
722,PRECIS-2,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and ≥2 BP lowering therapies for ≥4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",fulltext,"Primary outcomes were self-reported use of indicated combination treatment (antiplatelet, statin and 2 BP lowering therapies for 4 of the previous seven days) at study end; and changes in systolic BP and total cholesterol from baseline to study end.",100.0
722,PRECIS-2,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between January 2010 and May 2012 (Figure 1). Failure to recruit the planned number of participants reflected insufficient resources to continue enrolment.,fulltext,A total of 623 participants were randomized from 33 centres (12 Aboriginal Medical Services) between 922 European Journal of Preventive Cardiology 22(7) Downloaded from https://academic.oup.com/eurjpc/article/22/7/920/5927084 by Inactive user on 17 July 2023 January 2010 and May 2012 (Figure 1). Failure to recruit the planned number of participants reflected insufficient resources to continue enrolment.,100.0
722,PRECIS-2,"For BP, the most relevant improvement was in combination BP lowering medication from 58% to 76%. However, since combination BP lowering versus placebo achieves around a 10mmHg systolic BP (SBP) difference in patients with similar BP profiles, this 18% absolute difference would be expected to result in only a 1.8mmHg difference in SBP.",fulltext,"For BP, the most relevant improvement was in combination BP lowering medication from 58% to 76%. However, since combination BP lowering versus placebo achieves around a 10 mmHg systolic BP (SBP) difference in patients with similar BP profiles, this 18% absolute difference would be expected to result in only a 1.8 mmHg difference in SBP.",100.0
722,PRECIS-2,"At one extreme, patients ineligible for any concessions were charged the standard co-payment (approximately AUD$35/month for each medication). At the other extreme, the polypill was dispensed without charge at Indigenous health services operating under the Section 100 scheme of the National Health Act.",fulltext,"At one extreme, patients ineligible for any concessions were charged the standard co-payment (approximately AUD$35/month for each medication). At the other extreme, the polypill was dispensed without charge at Indigenous health services operating under the Section 100 scheme of the National Health Act.",100.0
725,PRECIS-2,"Valid OSS responses were recorded for 232 patients (93%) at 6 months, 225 (90%) at 12 months, and 215 (86%) at 24 months,",fulltext,"Valid OSS responses were recorded for 232 patients (93%) at 6 months, 225 (90%) at 12 months, and 215 (86%) at 24 months,",100.0
725,PRECIS-2,"Primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population.12 The OSS provides a total score based on the patient's subjective assessment of pain and function. It contains 12 items, each with 5 categories of response, and a range of total scores of 0 (worst outcome) to 48 (best outcome).13 The OSS was collected by postal questionnaires at 6, 12, and 24 months.",fulltext,"primary outcome was the Oxford Shoulder Score (OSS), which is a shoulder-specific outcome measure validated in a UK population. 12 The OSS provides a total score based on the patient’s subjective assessment of pain and function. It contains 12 items, each with 5 categories of response, and a range of total scores of 0 (worst outcome) to 48 (best outcome). 13 The OSS was collected by postal questionnaires at 6, 12, and 24 months.",100.0
725,PRECIS-2,"Of 1250 patients screened, 563 (45%) were eligible and 687 (55%) were ineligible (Figure 1). The most common reason for exclusion (>1 reason per patient possible) was that a patient had co-morbidities that precluded surgery or anesthetic. Of the 563 eligible patients, 250 (44%) consented to take part in the trial (Figure 1). These patients were randomized to surgical or nonsurgical treatment between September 2008 and April 2011.",fulltext,"s Of 1250 patients screened, 563 (45%) were eligible and 687 (55%) were ineligible (Figure 1). The most common reason for exclusion (>1 reason per patient possible) was that a patient had coSurgical vs Nonsurgical Treatment of Adults With Fractures Original Investigation Research jama.com (Reprinted) JAMA March 10, 2015 Volume 313, Number 10 1039 Copyright 2015 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ by a Universität Basel User on 07/17/2023 Copyright 2015 American Medical Association. All rights reserved. morbidities that precluded surgery or anesthetic. Of the 563 eligible patients, 250 (44%) consented to take part in the trial (Figure 1). These patients were randomized to surgical or nonsurgical treatment between September 2008 and April 201",99.53810623556582
725,PRECIS-2,Fracture fixation or humeral head replacement were performed by surgeons experienced in these techniques. Nonsurgical treatment was sling immobilization. Standardized outpatient and community-based rehabilitation was provided to both groups.,fulltext,Fracture fixation or humeral head replacement were performed by surgeons experienced in these techniques. Nonsurgical treatment was sling immobilization. Standardized outpatient and community-based rehabilitation was provided to both groups.,100.0
725,PRECIS-2,To evaluate the clinical effectiveness of surgical vs nonsurgical treatment for adults with displaced fractures of the proximal humerus involving the surgical neck.,fulltext,To evaluate the clinical effectiveness of surgical vs nonsurgical treatment for adults with displaced fractures of the proximal humerus involving the surgical neck.,100.0
725,PRECIS-2,"A pragmatic, multicenter, parallel-group, randomized clinical trial, the Proximal Fracture of the Humerus Evaluation by Randomization (PROFHER) trial, recruited 250 patients aged 16 years or older (mean age, 66 years [range, 24-92 years]; 192 [77%] were female; and 249 [99.6%] were white) who presented at the orthopedic departments of 32 acute UK National Health Service hospitals between September 2008 and April 2011 within 3 weeks after sustaining a displaced fracture of the proximal humerus involving the surgical neck.",fulltext,"A pragmatic, multicenter, parallel-group, randomized clinical trial, the Proximal Fracture of the Humerus Evaluation by Randomization (PROFHER) trial, recruited 250 patients aged 16 years or older (mean age, 66 years [range, 24-92 years]; 192 [77%] were female; and 249 [99.6%] were white) who presented at the orthopedic departments of 32 acute UK National Health Service hospitals between September 2008 and April 2011 within 3 weeks after sustaining a displaced fracture of the proximal humerus involving the surgical neck.",100.0
725,PRECIS-2,"The primary analysis compared OSS data over 2 years (at 6, 12, and 24 months) using a mixed-effect model with an unstructured covariance pattern. Missing outcome data were predicted by age, sex, and health status at baseline (EuroQol 5D). An unstructured covariance pattern was selected for the repeated measurements as the least restrictive structure, which resulted in better model fit based on log-likelihood values than more constrained patterns. Estimates of the difference in OSS between treatment groups were assessed overall and at individual time points.",fulltext,"The primary analysis compared OSS data from the surgical and nonsurgical treatment groups over all 3 follow-up assessments (6, 12, and 24 months). A multilevel, randomslope model was fitted to the data with time points nested in patients to allow for clustering of data within each patient. This model adjusted for the fixed effects of treatment group, time (6, 12, or 24 months), treatment × time interaction, tuberosity involvement at baseline (yes or no), age (<65 years or ≥65 years), sex, and health status at baseline (EuroQol 5D). An unstructured covariance pattern was selected for the repeated measurements as the least restrictive structure, which resulted in better model fit based on log-likelihood values than more constrained patterns. Estimates of the difference in OSS between treatment groups were assessed overall and at individual time points.",92.89520426287744
725,PRECIS-2,The data for 231 patients (114 in surgical group and 117 in nonsurgical group) were included in the primary analysis.,fulltext,The data for 231 patients (114 in surgical group and 117 in nonsurgical group) were included in the primary analysis.,100.0
733,PRECIS-2,"Adherence was assessed by class registers in FaME classes and self-completion diaries returned by participants every 4 weeks during the intervention and every 3 months in the subsequent year, and from reports given in follow-up telephone interviews using the Phone-FITT questionnaire.",fulltext,"ervices was recorded at follow-up assessments. Falls were ascertained from diaries returned by participants every 4 weeks during the intervention and every 3 months in the subsequent year, and from reports given in follow-up telephone interviews using the Phone-FITT questionnaire.",86.26760563380282
733,PRECIS-2,Patients were excluded if they: • had experienced ≥3 falls in the previous year; • had unstable clinical conditions; • would be unable to follow instructions about exercise safely; or • were receiving palliative care.,fulltext,Patients were excluded if they: • had experienced ≥3 falls in the previous year; • had unstable clinical conditions; • would be unable to follow instructions about exercise safely; or • were receiving palliative care.,100.0
733,PRECIS-2,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.,fulltext,Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP. Patients were eligible to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.,100.0
733,PRECIS-2,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",fulltext,"The FaME intervention took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",100.0
733,PRECIS-2,"The trial took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",fulltext," took place in a group once a week and included exercises to be carried out at home, unsupervised, twice weekly. The OEP was undertaken at home, unsupervised, and comprised exercises to be done three times per week.",95.98214285714286
733,PRECIS-2,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people. Both interventions were delivered for 24 weeks. Participants in the usual-care arm were not offered either programme.",fulltext,"Volunteer peer mentors supported participants in the OEP arm, and weekly FaME classes were run in local venues by postural stability instructors trained to work with older people. Both interventions were delivered for 24 weeks. Participants in the usual-care arm were not offered either programme.",100.0
733,PRECIS-2,Participants in the usual-care arm were not offered either programme.,fulltext,Participants in the usual-care arm were not offered either programme.,100.0
733,PRECIS-2,Participants were assessed at baseline and after 6 months (intervention end) and 12 months by self-completion questionnaire and physical assessment.,fulltext,"Participants were followed up every 6 months after the end of the intervention period, until 24 months.",45.270270270270274
733,PRECIS-2,The primary outcome was the proportion of participants reporting at least one fall in the 12 months following randomisation.,fulltext,The primary outcome was the proportion of participants who reported reaching ,56.4516129032258
733,PRECIS-2,"A total of 1254 (43%) eligible patients from 43 general practices in London, Nottingham, and Derby were enrolled.",fulltext," from 43 general practices in London, Nottingham, and Derby. Method Practices were randomised ",61.946902654867266
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham. Patients aged ≥65 years were identified by searches of computerised medical records and invited to participate by letter from their GP. Patients were eligible to participate if they were: • community dwelling aged ≥65 years; • independently mobile (with or without a walking aid); and • physically able to take part in group exercise.",100.0
733,PRECIS-2,Data on falls were collected prospectively from randomisation: participants recorded falls and the reasons for them daily in falls diaries.,fulltext, Falls were ascertained from diaries returned by participants every 4 weeks during the ,41.72661870503597
733,PRECIS-2,There was no evidence of difference in outcome between adherers and non-adherers in any analysis (data not shown).,fulltext, No evidence of difference in outcome was apparent between adherers and non-adherers in any analysis (data not shown).,92.10526315789474
733,PRECIS-2,The proportions of participants whose weekly falls per person year during intervention exceeded 150 minutes were tabulated by treatment arm.,fulltext,"The proportions of participants whose weekly MVPA exceeded 150 minutes, and those who reported zero MVPA, were tabulated ",60.0
733,PRECIS-2,Participants were followed up for 12 months after randomisation. Data on falls were collected prospectively from randomisation: participants recorded falls and the reasons for them daily in falls diaries.,prompt,"-randomisation participants, includes only completers or those following the treat",26.470588235294112
733,PRECIS-2,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",fulltext,"Practices were recruited with assistance from Primary Care Research Networks for London, Derby, and Nottingham.",100.0
